<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">63835</article-id><article-id pub-id-type="doi">10.7554/eLife.63835</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cell Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Medicine</subject></subj-group></article-categories><title-group><article-title>Remodeling of whole-body lipid metabolism and a diabetic-like phenotype caused by loss of CDK1 and hepatocyte division</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-210459"><name><surname>Ow</surname><given-names>Jin Rong</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-7468-691X</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-210460"><name><surname>Cadez</surname><given-names>Matias J</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-210461"><name><surname>Zafer</surname><given-names>Gözde</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-210462"><name><surname>Foo</surname><given-names>Juat Chin</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="fund6"/><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-210463"><name><surname>Li</surname><given-names>Hong Yu</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-210464"><name><surname>Ghosh</surname><given-names>Soumita</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-193225"><name><surname>Wollmann</surname><given-names>Heike</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-210465"><name><surname>Cazenave-Gassiot</surname><given-names>Amaury</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund6"/><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-210466"><name><surname>Ong</surname><given-names>Chee Bing</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-149862"><name><surname>Wenk</surname><given-names>Markus R</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund6"/><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-155377"><name><surname>Han</surname><given-names>Weiping</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-5023-2104</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con11"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-210467"><name><surname>Choi</surname><given-names>Hyungwon</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-6687-3088</contrib-id><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="other" rid="fund5"/><xref ref-type="fn" rid="con12"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-210468"><name><surname>Kaldis</surname><given-names>Philipp</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-7247-7591</contrib-id><email>philipp.kaldis@med.lu.se</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="other" rid="fund7"/><xref ref-type="other" rid="fund8"/><xref ref-type="other" rid="fund4"/><xref ref-type="fn" rid="con13"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution>Institute of Molecular and Cell Biology (IMCB), A*STAR (Agency for Science, Technology and Research)</institution><addr-line><named-content content-type="city">Singapore</named-content></addr-line><country>Singapore</country></aff><aff id="aff2"><label>2</label><institution>Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore (NUS)</institution><addr-line><named-content content-type="city">Singapore</named-content></addr-line><country>Singapore</country></aff><aff id="aff3"><label>3</label><institution>Singapore Lipidomics Incubator (SLING), Life Sciences Institute, National University of Singapore (NUS)</institution><addr-line><named-content content-type="city">Singapore</named-content></addr-line><country>Singapore</country></aff><aff id="aff4"><label>4</label><institution>Laboratory of Metabolic Medicine, Singapore Bioimaging Consortium (SBIC), A*STAR</institution><addr-line><named-content content-type="city">Singapore</named-content></addr-line><country>Singapore</country></aff><aff id="aff5"><label>5</label><institution>Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore (NUS)</institution><addr-line><named-content content-type="city">Singapore</named-content></addr-line><country>Singapore</country></aff><aff id="aff6"><label>6</label><institution>Biological Resource Centre (BRC), A*STAR</institution><addr-line><named-content content-type="city">Singapore</named-content></addr-line><country>Singapore</country></aff><aff id="aff7"><label>7</label><institution>Department of Clinical Sciences, Lund University, Clinical Research Centre (CRC)</institution><addr-line><named-content content-type="city">Malmö</named-content></addr-line><country>Sweden</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>James</surname><given-names>David E</given-names></name><role>Reviewing Editor</role><aff><institution>The University of Sydney</institution><country>Australia</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>James</surname><given-names>David E</given-names></name><role>Senior Editor</role><aff><institution>The University of Sydney</institution><country>Australia</country></aff></contrib></contrib-group><pub-date date-type="publication" publication-format="electronic"><day>21</day><month>12</month><year>2020</year></pub-date><pub-date pub-type="collection"><year>2020</year></pub-date><volume>9</volume><elocation-id>e63835</elocation-id><history><date date-type="received" iso-8601-date="2020-10-08"><day>08</day><month>10</month><year>2020</year></date><date date-type="accepted" iso-8601-date="2020-12-19"><day>19</day><month>12</month><year>2020</year></date></history><permissions><copyright-statement>© 2020, Ow et al</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>Ow et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-63835-v2.pdf"/><abstract><p>Cell cycle progression and lipid metabolism are well-coordinated processes required for proper cell proliferation. In liver diseases that arise from dysregulated lipid metabolism, proliferation is diminished. To study the outcome of CDK1 loss and blocked hepatocyte proliferation on lipid metabolism and the consequent impact on whole-body physiology, we performed lipidomics, metabolomics, and RNA-seq analyses on a mouse model. We observed reduced triacylglycerides in liver of young mice, caused by oxidative stress that activated FOXO1 to promote expression of <italic>Pnpla2</italic>/ATGL. Additionally, we discovered that hepatocytes displayed malfunctioning β-oxidation, reflected by increased acylcarnitines (ACs) and reduced β-hydroxybutyrate. This led to elevated plasma free fatty acids (FFAs), which were transported to the adipose tissue for storage and triggered greater insulin secretion. Upon aging, chronic hyperinsulinemia resulted in insulin resistance and hepatic steatosis through activation of LXR. Here, we demonstrate that loss of hepatocyte proliferation is not only an outcome but also possibly a causative factor for liver pathology.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>liver</kwd><kwd>lipid metabolism</kwd><kwd>insulin resistance</kwd><kwd>hepatic steatosis</kwd><kwd>cell cycle</kwd><kwd>CDK1</kwd><kwd>diabetes</kwd><kwd>hyperinsulinemia</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001348</institution-id><institution>Agency for Science, Technology and Research</institution></institution-wrap></funding-source><award-id>IAF-ICP I1901E0040</award-id><principal-award-recipient><name><surname>Cazenave-Gassiot</surname><given-names>Amaury</given-names></name><name><surname>Wenk</surname><given-names>Markus R</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution>Singapore International Graduate Award</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Zafer</surname><given-names>Gözde</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001381</institution-id><institution>National Research Foundation Singapore</institution></institution-wrap></funding-source><award-id>NRF2016-CRP001-103</award-id><principal-award-recipient><name><surname>Kaldis</surname><given-names>Philipp</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001349</institution-id><institution>National Medical Research Council</institution></institution-wrap></funding-source><award-id>NMRC-CG-M009</award-id><principal-award-recipient><name><surname>Choi</surname><given-names>Hyungwon</given-names></name></principal-award-recipient></award-group><award-group id="fund6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001352</institution-id><institution>National University of Singapore</institution></institution-wrap></funding-source><award-id>Life Sciences Institute</award-id><principal-award-recipient><name><surname>Foo</surname><given-names>Juat Chin</given-names></name><name><surname>Cazenave-Gassiot</surname><given-names>Amaury</given-names></name><name><surname>Wenk</surname><given-names>Markus R</given-names></name></principal-award-recipient></award-group><award-group id="fund7"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100007633</institution-id><institution>Swedish Foundation for Strategic Environmental Research</institution></institution-wrap></funding-source><award-id>Dnr IRC15-0067</award-id><principal-award-recipient><name><surname>Kaldis</surname><given-names>Philipp</given-names></name></principal-award-recipient></award-group><award-group id="fund8"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004359</institution-id><institution>Swedish Research Council</institution></institution-wrap></funding-source><award-id>Dnr 2009-1039</award-id><principal-award-recipient><name><surname>Kaldis</surname><given-names>Philipp</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Loss of hepatic <italic>Cdk1</italic> leads to oxidative stress, increased fatty acids in blood, and hyperinsulinemia, which resulted in insulin resistance and hepatic steatosis, similar as in diabetes.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Lipid metabolism is closely linked to cell proliferation, especially since cell division requires the synthesis of phospholipids (PLs) that make up the plasma membrane. Earlier studies highlighted the requirement for synthesis of phosphatidylcholine, a major PL of the cell membrane, in cell cycle progression (<xref ref-type="bibr" rid="bib112">Tercé et al., 1994</xref>). More recently, it was discovered that de novo fatty acid synthesis was essential to provide the fatty acids needed for PL synthesis because inhibition of fatty acid synthesis led to cell cycle arrest at the G<sub>2</sub>/M transition and prevented the exit from mitosis (<xref ref-type="bibr" rid="bib99">Scaglia et al., 2014</xref>). This was supported by the finding that enzymes involved in fatty acid synthesis were more thermally stable in mitosis and early G<sub>1</sub> phase (<xref ref-type="bibr" rid="bib7">Becher et al., 2018</xref>). Therefore, it is not surprising that a close coordination between lipid metabolism and cell cycle progression is required. Nevertheless, how this coordination is ensured at a molecular level remains to be determined.</p><p>The liver, as the metabolic center of the body, is constantly exposed to toxins that can trigger parenchymal hepatocyte cell death. To replace the dying cells, fully differentiated hepatocytes self-renew to regenerate the liver (<xref ref-type="bibr" rid="bib74">Miyaoka and Miyajima, 2013</xref>), with up to 0.5% of hepatocytes dividing at any particular time in non-diseased liver (<xref ref-type="bibr" rid="bib65">Macdonald, 1961</xref>). Nevertheless, it is known that hepatocytes exhibit proliferative defects in the diseased liver (<xref ref-type="bibr" rid="bib125">Yang et al., 2001</xref>; <xref ref-type="bibr" rid="bib130">Zhao et al., 2002</xref>; <xref ref-type="bibr" rid="bib117">Veteläinen et al., 2007</xref>). For example, in patients with non-alcoholic steatohepatitis (NASH), oxidative stress activates the DNA damage checkpoint resulting in cell cycle arrest (<xref ref-type="bibr" rid="bib29">Gentric et al., 2015</xref>). Hepatic steatosis can also cause premature replicative senescence by promoting chronic liver damage and inducing hepatocytes to cycle continuously until they senesce (<xref ref-type="bibr" rid="bib32">Han et al., 2008</xref>), with liver samples from patients diagnosed with non-alcoholic fatty liver disease (NAFLD) or cirrhosis exhibiting increased senescence markers and reduced telomere length (<xref ref-type="bibr" rid="bib47">Kitada et al., 1995</xref>; <xref ref-type="bibr" rid="bib118">Wiemann et al., 2002</xref>; <xref ref-type="bibr" rid="bib3">Aravinthan et al., 2013a</xref>). While this could imply that the loss of hepatocyte proliferation occurs in the liver as a result of liver disease, looking at it from a different angle, the association between senescence and liver disease can also be indicative that a block of hepatocyte proliferation could exacerbate liver disease. Intriguingly, it has been shown that the induction of senescence in hepatocytes causes age-dependent hepatic steatosis through an impairment of fatty acid oxidation (FAO; <xref ref-type="bibr" rid="bib81">Ogrodnik et al., 2017</xref>). However, little else is known about how blocking of the cell cycle affects lipid metabolism and the ensuing impact on whole body metabolism.</p><p>p21<sup>Cip1/Waf1</sup> has been observed to be overexpressed consistently in several types of liver disease (<xref ref-type="bibr" rid="bib3">Aravinthan et al., 2013a</xref>; <xref ref-type="bibr" rid="bib4">Aravinthan et al., 2013b</xref>) and cholangiopathies (<xref ref-type="bibr" rid="bib26">Ferreira-Gonzalez et al., 2018</xref>) and inhibits the activity of cyclin-dependent kinases (CDKs). CDK1 is a cell cycle regulator essential for mitosis (<xref ref-type="bibr" rid="bib63">Lohka et al., 1988</xref>) with inhibition of CDK1 activity resulting in cell cycle arrest, blocked cell proliferation, and senescence (<xref ref-type="bibr" rid="bib41">Itzhaki et al., 1997</xref>; <xref ref-type="bibr" rid="bib23">Diril et al., 2012</xref>). We have previously shown that by specifically deleting <italic>Cdk1</italic> in hepatocytes using Albumin-Cre (<italic>Cdk1</italic> cKO), we were able to prevent hepatocytes from undergoing cell division in vivo (<xref ref-type="bibr" rid="bib23">Diril et al., 2012</xref>). Consequently, these hepatocytes underwent hypertrophy during regeneration after partial hepatectomy, leading to remodeling of glucose metabolism (<xref ref-type="bibr" rid="bib10">Caldez et al., 2018</xref>).</p><p>Here, we use the same mouse model of impaired hepatocyte proliferation, aiming to delineate the impact of loss of proliferation on lipid metabolism in the liver and how this affects whole body physiology. Through the use of lipidomics, metabolomics, RNA-seq, ChIP, and biochemical assays, we discovered that <italic>Cdk1</italic> cKO liver contains less triacylglycerides (TGs) as a result of oxidative stress-mediated lipolysis. Furthermore, arrested hepatocytes exhibit defective FAO, leading to release of FFAs into the blood that get stored as TGs in the adipose tissue and maybe in other tissues. The increase in FFAs in the blood triggers chronic hyperinsulinemia which, over time, results in insulin resistance, hepatic steatosis, and the progression of liver disease. Thus, we present evidence supporting the idea that liver disease is not only the cause for impairment of hepatocyte proliferation but it may also be an outcome.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Oxidative stress mediates lipolysis in the liver</title><p>Since hepatocyte proliferation is known to contribute to the maintenance and regeneration of the liver and we had previously shown that loss of hepatic CDK1 leads to changes in lipid metabolism upon induction of liver regeneration (<xref ref-type="bibr" rid="bib72">Miettinen et al., 2014</xref>), we performed comprehensive lipidomic analyses using mass spectrometry on liver from 8-week-old Alb-Cre, which we henceforth denote as control (Ctrl), and <italic>Cdk1</italic> cKO mice. After QC filtering, we reliably measured 237 lipid species (TGs, PLs, and ACs). PLs, which comprised the majority of the measured species (196 of the 237 species), were generally unchanged (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>). The most apparent change in lipid profile from the lipidomics data was that <italic>Cdk1</italic> cKO liver contained less TGs than control liver (<xref ref-type="fig" rid="fig1">Figure 1A</xref>, <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>), which we separately confirmed with biochemical TG assays (<xref ref-type="fig" rid="fig1">Figure 1B</xref>; p=0.0022). This was despite both control and <italic>Cdk1</italic> cKO mice eating the same amount of food (<xref ref-type="fig" rid="fig1">Figure 1C</xref>; p=0.6825), implying that this change was not due to a difference in food intake. We then checked for TG levels in hepatocytes isolated from 8-week-old mice and noted that <italic>Cdk1</italic> cKO hepatocyte TG levels were significantly decreased as well (<xref ref-type="fig" rid="fig1">Figure 1D</xref>; p=0.0012), illustrating that the reduction in whole liver TG levels were, in part, due to the decrease of TGs in hepatocytes. Plasma TG (<xref ref-type="fig" rid="fig1">Figure 1E</xref>; p=0.0043) and plasma low-density lipoproteins (LDL)/very-low-density lipoproteins (VLDL) were also reduced (<xref ref-type="fig" rid="fig1">Figure 1F</xref>; p=0.0043) with a corresponding increase in high-density lipoproteins (<xref ref-type="fig" rid="fig1">Figure 1G</xref>; p=0.0022) in <italic>Cdk1</italic> cKO liver compared to control. As VLDLs are the main mode of hepatic TG secretion into the blood stream (<xref ref-type="bibr" rid="bib16">Choi and Ginsberg, 2011</xref>), this suggested that the reduction in hepatic TGs was not due to an increase in secretion of TGs, but likely a change in TG synthesis or TG breakdown in the liver. To address this, we screened a panel of lipogenic and lipolytic genes for changes in gene expression, and interestingly, a specific increase of the lipolytic gene <italic>Pnpla2</italic> became evident (<xref ref-type="fig" rid="fig1">Figure 1H</xref>; p=0.0022). <italic>Pnpla2</italic> encodes the ATGL protein, which is the main rate-limiting enzyme responsible for breaking down TGs (<xref ref-type="bibr" rid="bib131">Zimmermann et al., 2004</xref>), and accordingly, the protein levels of ATGL were increased in <italic>Cdk1</italic> cKO liver (<xref ref-type="fig" rid="fig1">Figure 1I–J</xref>; p&lt;0.0001). Over-expression of ATGL is sufficient to induce lipolysis in the liver (<xref ref-type="bibr" rid="bib92">Reid et al., 2008</xref>), indicating that the reduced levels of hepatic TGs in <italic>Cdk1</italic> cKO liver might be due to increased lipolysis mediated by higher levels of <italic>Pnpla2</italic>/ATGL.</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Oxidative stress results in Foxo1-dependent activation of <italic>Pnpla2</italic> in young <italic>Cdk1</italic> cKO liver.</title><p>(<bold>A</bold>) Heat map of triacylglyceride (TG) species in whole liver of control (Ctrl) and <italic>Cdk1</italic> cKO mice as measured by mass spectrometry (lipidomics). Data is available in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>. TG species are also ordered as in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>. (<bold>B</bold>) Hepatic TG levels as quantified by biochemical assays (n = 6 per genotype). (<bold>C</bold>) Food intake of control and <italic>Cdk1</italic> cKO mice tracked over 2 weeks (6- to 8-week-old) and represented as average daily intake. (<bold>D</bold>) TG from isolated primary hepatocytes (n = 3 per genotype), (<bold>E</bold>) plasma TG, (<bold>F</bold>) plasma LDL/VLDL-cholesterol and (<bold>G</bold>) plasma HDL-cholesterol levels as quantified by biochemical assays (n = 6 per genotype for plasma biochemical assays). (<bold>H</bold>) qPCR for lipogenic and lipolytic genes in whole liver (n = 6 per genotype). (<bold>I</bold>) Immunoblot of liver lysates for ATGL, with HSP90 as loading control. (<bold>J</bold>) Quantification of ATGL protein levels from immunoblot. Error bars represent S.D. (<bold>K</bold>) Immunoblot of liver lysates for carbonylated proteins, probed for Dinitrophenol (DNP) hydrazone <italic>﻿</italic>after DNP derivation, with HSP90 as loading control. (<bold>L</bold>) qPCR for <italic>Foxo1</italic> and <italic>Foxq1</italic> in whole liver (n = 5 per genotype). (<bold>M</bold>) Immunoblot of liver lysates for FOXO1, with HSP90 as loading control. (<bold>N</bold>) Quantification of FOXO1 protein levels from immunoblot. Error bars represent S.D. (<bold>O</bold>) Enrichment of FOXO1 localization at promoters of <italic>Pdk4</italic> and <italic>Pnpla2</italic> in isolated primary hepatocytes upon ChIP-qPCR after normalization to input (n = 3 per genotype). Error bars represent S.E.M. unless otherwise indicated. All experiments were performed on tissue samples or cells from 8-week-old mice. All source data are available in <xref ref-type="supplementary-material" rid="supp10">Supplementary file 10</xref> unless specifically indicated.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-63835-fig1-v2.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>NAC treatment and silencing of <italic>Pnpla2</italic> can reverse the reduction of triacylglyceride (TG) phenotype.</title><p>(<bold>A</bold>) qPCR for oxidative stress-associated genes in whole liver (at least n = 5 per genotype). (<bold>B</bold>) Immunoblot of liver lysates for carbonylated proteins, probed for DNP after DNP derivation. HSP90 serves as loading control. (<bold>C</bold>) qPCR for oxidative stress-associated genes and (<bold>D</bold>) <italic>Foxo1</italic>, <italic>Pnpla2,</italic> and <italic>Lipe</italic> in liver of control (Ctrl) or <italic>Cdk1</italic> cKO mice fed with normal water or water containing NAC (n = 5 per genotype). (<bold>E</bold>) Hepatic TG and (<bold>F</bold>) plasma FFA levels of Ctrl or <italic>Cdk1</italic> cKO mice fed with normal water or water containing NAC measured by biochemical assay (n = 5 per condition). (<bold>G</bold>) qPCR for <italic>Pnpla2</italic> in liver of Ctrl mice or <italic>Cdk1</italic> cKO mice injected with empty vector or pLKO-shPnpla2 (n = 5 per condition). (<bold>H</bold>) Hepatic TG levels of Ctrl mice or <italic>Cdk1</italic> cKO mice injected with empty vector or pLKO-shPnpla2 (n = 5 per condition). (<bold>I</bold>) Correlation plot with relative <italic>Pnpla2</italic> mRNA expression as x-axis and hepatic TG levels as y-axis. Dotted lines represent 95% confidence intervals. Pearson’s correlation coefficient (r) and goodness-of-fit coefficient (R<sup>2</sup>) values are indicated in the plot. Error bars for all graphs represent S.E.M.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-63835-fig1-figsupp1-v2.tif"/></fig></fig-group><p>The specific increase of <italic>Pnpla2</italic> but not any other lipolytic genes implies that the upregulation of <italic>Pnpla2</italic> was not a result of a general increase in the lipolytic machinery. Interestingly, <italic>Pnpla2</italic> can be induced by the transcription factor FOXO1 (<xref ref-type="bibr" rid="bib14">Chakrabarti and Kandror, 2009</xref>; <xref ref-type="bibr" rid="bib129">Zhang et al., 2016</xref>), which is activated by mitochondria-dependent oxidative stress (<xref ref-type="bibr" rid="bib58">Lettieri Barbato et al., 2014</xref>). Since <italic>Cdk1</italic> cKO hepatocytes display impaired mitochondrial functions (<xref ref-type="bibr" rid="bib10">Caldez et al., 2018</xref>), we hypothesized that the induction of <italic>Pnpla2</italic> might be due to oxidative stress-dependent activation of FOXO1. Indeed, <italic>Cdk1</italic> cKO liver exhibited greater levels of oxidative stress, as seen by the induction of antioxidant enzymes <italic>Gpx1</italic>, <italic>Gpx2</italic>, <italic>Gpx3</italic>, and <italic>G6pdx</italic> (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A</xref>) and the increase in protein carbonylation, which is a good marker of oxidative stress (<xref ref-type="bibr" rid="bib21">Dalle-Donne et al., 2003</xref>; <xref ref-type="fig" rid="fig1">Figure 1K</xref>). Correspondingly, there was an increase of Foxo1 at both the mRNA (<xref ref-type="fig" rid="fig1">Figure 1L</xref>; p=0.0079) and protein level (<xref ref-type="fig" rid="fig1">Figure 1M–N</xref>; p=0.0065), leading to enhanced localization of FOXO1 by chromatin immunoprecipitation (ChIP) at the promoters of <italic>Pnpla2</italic> and <italic>Pdk4</italic>, a well-established target of FOXO1 (<xref ref-type="bibr" rid="bib54">Kwon et al., 2004</xref>) (<xref ref-type="fig" rid="fig1">Figure 1O</xref>; p=0.0419 for <italic>Pnpla2</italic> promoter and p=0.0275 for <italic>Pdk4</italic> promoter). Because FOXO1 transcriptional activity can be repressed by interaction with FOXQ1 (<xref ref-type="bibr" rid="bib20">Cui et al., 2016</xref>), we determined <italic>Foxq1</italic> expression and discovered that there was no significant difference in the mRNA levels of <italic>Foxq1</italic> (<xref ref-type="fig" rid="fig1">Figure 1L</xref>; p=0.5476). When we fed <italic>Cdk1</italic> cKO mice with the antioxidant N-acetylcysteine (NAC) to reduce systemic oxidative stress, we observed a reversal in the amount of protein carbonylation (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1B</xref>) and the mRNA expression of antioxidant enzymes (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1C</xref>), <italic>Foxo1,</italic> and <italic>Pnpla2</italic> (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1D</xref>). Furthermore, hepatic TG levels of NAC-fed <italic>Cdk1</italic> cKO mice recovered to control levels (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1E</xref>). This data supports the hypothesis that the reduction in hepatic TG levels in <italic>Cdk1</italic> cKO liver was in part due to oxidative stress and this was transmitted by the FOXO1-<italic>Pnpla2</italic>/ATGL axis.</p><p>To more conclusively show that the decrease in liver TGs is mediated by ATGL, we attempted to knockdown <italic>Pnpla2</italic> in the liver of <italic>Cdk1</italic> cKO mice. We performed hydrodynamic tail vein injections (<xref ref-type="bibr" rid="bib128">Yokoo et al., 2016</xref>) of a plasmid expressing short hairpin RNA (shRNA) targeting murine <italic>Pnpla2</italic> (pLKO-shPnpla2) to deliver the plasmid to the liver (see Materials and methods). We verified using qPCR that there was an increase of <italic>Pnpla2</italic> in the liver of <italic>Cdk1</italic> cKO mice (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1G</xref>), confirming our earlier findings (<xref ref-type="fig" rid="fig1">Figure 1H</xref>, <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1D</xref>). <italic>Cdk1</italic> cKO mice that were injected with pLKO-shPnpla2 displayed a reduction of <italic>Pnpla2</italic> expression in the liver, indicating successful knockdown of <italic>Pnpla2</italic>. We then analysed the hepatic TGs in these mice, and found that in <italic>Cdk1</italic> cKO mice with <italic>Pnpla2</italic> knockdown, hepatic TG levels were rescued to levels comparable with control (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1H</xref>). In addition, correlation analysis between relative <italic>Pnpla2</italic> mRNA expression and hepatic TG levels (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1I</xref>) proposed a negative linear relationship with a Pearson’s correlation coefficient of −0.84 (p-value&lt;0.0001), supporting the well-established TG lipase activity of ATGL (<xref ref-type="bibr" rid="bib131">Zimmermann et al., 2004</xref>; <xref ref-type="bibr" rid="bib92">Reid et al., 2008</xref>) and indicating that the increase of <italic>Pnpla2</italic> in the liver of <italic>Cdk1</italic> cKO mice is likely causative for the observed reduction of TGs.</p></sec><sec id="s2-2"><title>Defective FAO in hepatocytes</title><p>Another prominent observation from our extensive lipidomics data of the <italic>Cdk1</italic> cKO liver is that all the detected AC species were significantly increased (<xref ref-type="fig" rid="fig2">Figure 2A</xref>, <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>). This is mirrored by our lipidomic data on hepatocytes isolated from 8-week-old control and <italic>Cdk1</italic> cKO mice (<xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>), which, in all, reliably measured 240 lipid species. Although not statistically significant for most of the species due to the small sample size (n = 3) and large variability, a trend of increase in AC levels in isolated hepatocytes was observed (<xref ref-type="fig" rid="fig2">Figure 2B</xref>). AC is the form by which long-chain fatty acids are transported across the mitochondrial membrane into mitochondria for degradation via β-oxidation (<xref ref-type="bibr" rid="bib37">Houten et al., 2016</xref>). The accumulation of ACs in <italic>Cdk1</italic> cKO liver resembles that seen in patients and mouse models with defective mitochondrial FAO (<xref ref-type="bibr" rid="bib37">Houten et al., 2016</xref>; <xref ref-type="bibr" rid="bib56">Lee et al., 2016</xref>), implying FAO might be deficient in <italic>Cdk1</italic> cKO hepatocytes. This was further supported by a decrease in β-hydroxybutyrate (<xref ref-type="fig" rid="fig2">Figure 2C</xref>; p=0.0002), a metabolic product of β-oxidation (<xref ref-type="bibr" rid="bib30">Grabacka et al., 2016</xref>). When we performed FAO assays on primary hepatocytes from control and <italic>Cdk1</italic> cKO mice, we were able to confirm that <italic>Cdk1</italic> cKO hepatocytes display reduced basal and maximal capacity for performing FAO (<xref ref-type="fig" rid="fig2">Figure 2D–E</xref>; p&lt;0.0001 for basal FAO capacity and p=0.0018 for maximal FAO capacity).</p><fig id="fig2" position="float"><label>Figure 2.</label><caption><title><italic>Cdk1</italic> cKO hepatocytes have reduced capacity for fatty acid oxidation (FAO).</title><p>Relative acylcarnitine levels in liver (A; n = 5 per genotype) and primary hepatocytes (B; n = 3 per genotype) of control (Ctrl) and <italic>Cdk1</italic> cKO mice as measured by mass spectrometry. Data is available in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref> and <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>, respectively. (<bold>C</bold>) Hepatic β-hydroxybutyrate levels measured using biochemical assays (n = 8 per genotype). Error bars represent S.E.M. (<bold>D</bold>) FAO assays on isolated primary hepatocytes that were untreated, treated with FCCP to maximize oxidative capacity or treated with Etomoxir to block FAO. (<bold>E</bold>) Quantification of basal and maximal FAO capacity of isolated hepatocytes based on oxygen consumption signal of untreated and FCCP-treated hepatocytes, respectively, from the FAO assays. Statistical significance was calculated using unpaired two-tailed t-test with Welch’s correction. (<bold>F</bold>) qPCR for expression of FAO genes in whole liver (at least n = 4 per genotype). Error bars represent S.E.M. (<bold>G</bold>) Immunoblot of liver lysate, probed for HADHA and ACADVL with HSP90 as loading control. (<bold>H</bold>) Quantification of HADHA and ACADVL protein levels from immunoblot. (<bold>I</bold>) SIRT3 was immunoprecipitated from lysates of Ctrl or <italic>Cdk1</italic> cKO liver and probed for phosphorylated Ser/Thr (pSer/Thr). IgG was used as negative control. (<bold>J</bold>) Immunoblot of liver lysate, probed for SIRT3 with HSP90 as loading control. (<bold>K</bold>) CPT2 was immunoprecipitated from lysates of Ctrl or <italic>Cdk1</italic> cKO liver and probed for pan-acetylated residues (pan-Ac). IgG was used as negative control. Error bars represent S.D. unless otherwise indicated. All experiments were performed on tissue samples or cells from 8-week-old mice. All source data are available in <xref ref-type="supplementary-material" rid="supp10">Supplementary file 10</xref> unless specifically indicated.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-63835-fig2-v2.tif"/></fig><p>To explore the cause for this, we measured transcript levels of genes involved in mitochondrial β-oxidation. Unexpectedly, none of the genes tested showed any difference between control and <italic>Cdk1</italic> cKO hepatocytes, including <italic>Ppara</italic> (<xref ref-type="fig" rid="fig2">Figure 2F</xref>; p=0.1905), the master regulator of FAO (<xref ref-type="bibr" rid="bib30">Grabacka et al., 2016</xref>). Interestingly though, immunoblotting for HADHA and ACADVL, two key enzymes in the FAO pathway, revealed a decrease in protein levels of both enzymes (<xref ref-type="fig" rid="fig2">Figure 2G–H</xref>; p=0.0286 for both HADHA and ACADVL) despite unchanged transcript levels (<xref ref-type="fig" rid="fig2">Figure 2F</xref>; p=0.5476 for <italic>Acadvl</italic> and p=0.8414 for <italic>Hadha</italic>). This might be potentially explained by CDK1 modulation of mitochondrial import via phosphorylation of the outer membrane protein TOM6 (<xref ref-type="bibr" rid="bib33">Harbauer et al., 2014</xref>). In the absence of CDK1, reduced mitochondrial import of FAO enzymes could result in cytoplasmic accumulation that triggers ubiquitin-dependent degradation of these enzymes (<xref ref-type="bibr" rid="bib31">Habelhah et al., 2004</xref>; <xref ref-type="bibr" rid="bib9">Bragoszewski et al., 2013</xref>). A more recent finding showed that CDK1 can also enhance fatty acid import into the mitochondria by phosphorylating SIRT3 and augmenting SIRT3-mediated CPT2 dimerization into the functional fatty acid import complex to promote FAO (<xref ref-type="bibr" rid="bib61">Liu et al., 2020</xref>). We checked whether this mechanism was relevant in our system. Immunoprecipitation of SIRT3 followed by immunoblotting for phosphorylated Ser/Thr affirmed that SIRT3 was hypophosphorylated in <italic>Cdk1</italic> cKO liver (<xref ref-type="fig" rid="fig2">Figure 2I</xref>) with no impact on total SIRT3 protein levels (<xref ref-type="fig" rid="fig2">Figure 2J</xref>). In addition, we detected increased acetylated residues upon immunoprecipitation of CPT2 and probing for pan-acetylation (<xref ref-type="fig" rid="fig2">Figure 2K</xref>). Taken together, we discovered that <italic>Cdk1</italic> cKO hepatocytes display decreased FAO, possibly due to reduced mitochondrial import of FAO enzymes as well as fatty acids that are the substrates of these enzymes.</p></sec><sec id="s2-3"><title>Liver FFAs are released into the blood stream and affect peripheral tissues</title><p>With a continuous increase of non-esterified FFAs due to persistent lipolysis (<xref ref-type="fig" rid="fig1">Figure 1</xref>) and a block in fatty acid degradation (<xref ref-type="fig" rid="fig2">Figure 2</xref>) in the liver, we investigated whether there was an increase in secretion of FFAs into the blood stream. Mass spectrometry analysis of plasma samples showed an increase in many detected FFA species in the plasma of <italic>Cdk1</italic> cKO mice (<xref ref-type="fig" rid="fig3">Figure 3A</xref>, <xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref>). Notably, treatment of <italic>Cdk1</italic> cKO mice with NAC, which reversed the hepatic TG phenotype (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1E</xref>), did not revert plasma FFA back to control levels (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1F</xref>), although levels were insignificantly yet visibly lower. This would suggest that the increase in plasma FFAs is in part dependent on the lipolysis of TGs mediated by ATGL, and in part also dependent on impaired FAO in <italic>Cdk1</italic> cKO hepatocytes. As plasma FFA can be taken up and stored as TGs in white adipose tissue (WAT), we investigated whether the increase in plasma FFA resulted in an increase in storage of FFA in the adipose tissue. MRI revealed an overall increase in fat mass in <italic>Cdk1</italic> cKO mice (<xref ref-type="fig" rid="fig3">Figure 3B</xref>; p=0.0079), with a higher subcutaneous white adipose tissue (scWAT) weight to body weight ratio and epididymal white adipose tissue (epWAT) weight to body weight ratio (<xref ref-type="fig" rid="fig3">Figure 3C</xref>; p&lt;0.0001 for both scWAT and epWAT to body weight ratio). This might, in part, explain the more pronounced increase in body weight of <italic>Cdk1</italic> cKO mice (<xref ref-type="fig" rid="fig3">Figure 3D–E</xref>) despite the similar food intake between both groups of mice (<xref ref-type="fig" rid="fig1">Figure 1C</xref>). Histological staining of the scWAT and epWAT (<xref ref-type="fig" rid="fig3">Figure 3F</xref>) indicated that adipocytes were significantly increased in size, from 494 (±49)μm<sup>2</sup> in control scWAT to 692 (±63)μm<sup>2</sup> in <italic>Cdk1</italic> cKO scWAT and 589 (±86)μm<sup>2</sup> in control epWAT to 1066 (±153)μm<sup>2</sup> in <italic>Cdk1</italic> cKO epWAT (<xref ref-type="fig" rid="fig3">Figure 3G</xref>; p=0.0079 for both scWAT and epWAT). Biochemical assays further confirmed that <italic>Cdk1</italic> cKO WAT contained higher levels of TGs (<xref ref-type="fig" rid="fig3">Figure 3H</xref>; p=0.0079 for both scWAT and epWAT). When we then probed <italic>Cdk1</italic> cKO WAT for the expression of genes involved with fatty acid synthesis, we found that <italic>Acaca</italic>, <italic>Fasn</italic>, and <italic>Scd1</italic> were decreased (<xref ref-type="fig" rid="fig3">Figure 3I–J</xref>), implying that the increase in TGs was not due to increases in WAT fatty acid synthesis. Instead, this repression of de novo lipogenesis parallels what is seen in mice fed with high fat diet, whereby there is elevated supply of dietary fat to the WAT via the blood stream (<xref ref-type="bibr" rid="bib106">Shillabeer et al., 1990</xref>; <xref ref-type="bibr" rid="bib113">Tovar et al., 2011</xref>). These results thus suggest that the increase of plasma FFA led to elevated storage of FFA as TGs in WAT of <italic>Cdk1</italic> cKO mice.</p><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Free fatty acids (FFAs) are transported to the adipose tissue for storage in young <italic>Cdk1</italic> cKO mice.</title><p>(<bold>A</bold>) Relative plasma FFA levels in control (Ctrl) and <italic>Cdk1</italic> cKO mice as measured by mass spectrometry (n = 5 per genotype). Data is available in <xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref>. (<bold>B</bold>) Ratio of total fat mass, as measured by magnetic resonance imaging, to body weight (n = 5 for each genotype). (<bold>C</bold>) Ratio of subcutaneous WAT (scWAT) or epididymal WAT (epWAT) weight to body weight (n = 10 per genotype). (<bold>D</bold>) Body weight change between start and end of 2-week food intake tracking period. (<bold>E</bold>) Ratio of body weight change to food intake. (<bold>F</bold>) Representative H and E image of scWAT and epWAT from control and <italic>Cdk1</italic> cKO mice. Scale bar represents 100 μm in all panels. (<bold>G</bold>) Quantification of size of adipocytes from H and E images (at least 500 adipocytes per mouse were measured, n = 5 per genotype). (<bold>H</bold>) Adipose triacylglyceride levels from scWAT and epWAT measured using biochemical assays (n = 5 per genotype). qPCR for lipogenic genes in scWAT (<bold>I</bold>) and epWAT (<bold>J</bold>) of control and <italic>Cdk1</italic> cKO mice (at least n = 4 per genotype). Error bars for all graphs represent S.E.M. All experiments were performed on tissue samples from 8-week-old mice. All source data are available in <xref ref-type="supplementary-material" rid="supp10">Supplementary file 10</xref> unless specifically indicated.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-63835-fig3-v2.tif"/></fig><p>Higher levels of plasma FFA can affect peripheral tissue besides WAT. For example, the expression of FAO enzymes in the skeletal muscle are boosted in the presence of elevated plasma FFA levels (<xref ref-type="bibr" rid="bib28">Garcia-Roves et al., 2007</xref>). In accordance with this, we observed increased expression of various FAO-associated genes in the skeletal muscle of <italic>Cdk1</italic> cKO mice compared to control mice (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). Of particular interest is the fact that plasma FFAs are also known to promote insulin secretion by pancreatic β-cells even in the fasting state (<xref ref-type="bibr" rid="bib40">Itoh et al., 2003</xref>; <xref ref-type="bibr" rid="bib12">Cen et al., 2016</xref>). Interestingly, we detected increased plasma insulin in <italic>Cdk1</italic> cKO mice (<xref ref-type="fig" rid="fig4">Figure 4B</xref>; p=0.0499), a state known as hyperinsulinemia, despite there being no difference in the transcript level of <italic>Ins2</italic> between <italic>Cdk1</italic> cKO and control pancreas (<xref ref-type="fig" rid="fig4">Figure 4C</xref>; p=0.8413). Furthermore, <italic>Cdk1</italic> cKO mice displayed reduced blood glucose levels (<xref ref-type="fig" rid="fig4">Figure 4D</xref>; p&lt;0.0001) and greater hepatic glycogen content (<xref ref-type="fig" rid="fig4">Figure 4E</xref>; p=0.0079), both of which are phenotypes associated with enhanced insulin signaling. This was confirmed by immunoblotting (<xref ref-type="fig" rid="fig4">Figure 4F</xref>), where we observed enhanced phosphorylation of INSRB (<xref ref-type="fig" rid="fig4">Figure 4G</xref>; p=0.0312) and AKT (<xref ref-type="fig" rid="fig4">Figure 4H</xref>; p=0.0042) in <italic>Cdk1</italic> cKO liver. When we performed glucose tolerance tests (<xref ref-type="fig" rid="fig4">Figure 4I</xref>), <italic>Cdk1</italic> cKO mice were more glucose tolerant and responded better to exogenous glucose, as seen from a lower area under the curve (<xref ref-type="fig" rid="fig4">Figure 4J</xref>; p&lt;0.0001), which is likely a result of the increased insulin levels (<xref ref-type="fig" rid="fig4">Figure 4B</xref>). Taken together, our data suggests that the elevated plasma FFA promotes insulin secretion and maintains a hyperinsulinemic condition in <italic>Cdk1</italic> cKO mice.</p><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Increased plasma fatty acids affect peripheral tissues and induce insulin signaling in young <italic>Cdk1</italic> cKO mice.</title><p>(<bold>A</bold>) qPCR for fatty acid oxidation genes in skeletal muscle (quadriceps) from control (Ctrl) and <italic>Cdk1</italic> cKO mice (n = 5 per genotype). (<bold>B</bold>) Plasma insulin level examined with ELISA (n = 8 per genotype). (<bold>C</bold>) qPCR for <italic>Ins2</italic> in pancreas of Ctrl and <italic>Cdk1</italic> cKO mice (n = 5 per genotype). (<bold>D</bold>) Fed state blood glucose measurements using glucose meter (at least n = 8 per genotype). (<bold>E</bold>) Hepatic glycogen content measured with biochemical assays (n = 5 per genotype). (<bold>F</bold>) Immunoblot of liver lysate probed for INSRB, phosphorylated INSRB at Y1151/1152 (pY1151/1152-INSRB), AKT, and phosphorylated AKT at T308 (pT308-AKT). HSP90 serves as loading control. (<bold>G</bold>) Quantification of pY1151/1152-INSRB levels normalized to total INSRB protein and (<bold>H</bold>) pT308-AKT levels normalized to total AKT protein from immunoblot. Error bars for immunoblot quantifications represent S.D. Blood glucose measurements (<bold>I</bold>) and area under curve analysis (<bold>J</bold>) from intraperitoneal glucose tolerance test (at least n = 10 per genotype). Error bars for all graphs represent S.E.M. unless otherwise indicated. All experiments were performed on tissue samples from 8-week-old mice. All source data are available in <xref ref-type="supplementary-material" rid="supp10">Supplementary file 10</xref>.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-63835-fig4-v2.tif"/></fig></sec><sec id="s2-4"><title>Aged mice exhibit insulin resistance and liver disease</title><p>Chronic hyperinsulinemia can lead to insulin resistance in patients (<xref ref-type="bibr" rid="bib77">Morita et al., 2017</xref>), hence we wondered whether plasma insulin remained high in <italic>Cdk1</italic> cKO mice over time. We analyzed plasma insulin levels of 6- and 12-month-old mice and found that plasma insulin was increased from an average of 0.6 ng/mL in control mice to 1.4 ng/mL in <italic>Cdk1</italic> cKO mice at 6 months old and from an average of 1 ng/mL in control mice to 2 ng/mL in <italic>Cdk1</italic> cKO mice at 12 months old (<xref ref-type="fig" rid="fig5">Figure 5A</xref>; p=0.0079 for both 6 and 12 months). This paralleled the consistently higher levels of plasma FFAs in <italic>Cdk1</italic> cKO mice compared to age-matched control mice at 6 and 12 months (<xref ref-type="fig" rid="fig5">Figure 5B</xref>; p=0.0079 for both 6 and 12 months). When we checked for insulin signaling in the aged liver by immunoblotting (<xref ref-type="fig" rid="fig5">Figure 5C</xref>), we noticed the levels of total INSRB protein was reduced (<xref ref-type="fig" rid="fig5">Figure 5D</xref>; p=0.0220), which might be due to chronic exposure to hyperinsulinemia (<xref ref-type="bibr" rid="bib96">Ronnett et al., 1982</xref>; <xref ref-type="bibr" rid="bib83">Palsgaard et al., 2009</xref>) that can, in part, lead to insulin resistance. We also detected hypophosphorylated INSRB, even after normalizing to total INSRB levels (<xref ref-type="fig" rid="fig5">Figure 5E</xref>; p=0.0289), and hypophosphorylated AKT (<xref ref-type="fig" rid="fig5">Figure 5F</xref>; p=0.0191), suggesting that insulin signaling was impaired in the liver despite higher plasma insulin levels. A similar observation was made from immunoblots of epWAT collected from aged <italic>Cdk1</italic> cKO mice (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1A</xref>), whereby we noted decreased INSRB protein (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1B</xref>; p=0.0253) and hypophosphorylated INSRB (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1C</xref>; p&lt;0.0001) and AKT (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1D</xref>; p=0.0034), hinting at defective insulin signaling in adipose tissues as well. This was supported by the change in expression of a number of adipokines in the epWAT. In particular, adiponectin (<italic>Adipoq</italic>) expression was diminished and resistin (<italic>Retn</italic>) expression was increased (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1E</xref>), both of which are associated with insulin resistance (<xref ref-type="bibr" rid="bib45">Kadowaki, 2006</xref>; <xref ref-type="bibr" rid="bib43">Jiang et al., 2016</xref>), especially since adiponectin represses the expression of gluconeogenic genes in hepatocytes and promotes membrane localization of GLUT4 in myocytes to increase the uptake of glucose (<xref ref-type="bibr" rid="bib19">Combs et al., 2001</xref>; <xref ref-type="bibr" rid="bib124">Yamauchi et al., 2002</xref>). We also observed an increase in expression of <italic>Fgf21</italic> and <italic>Gdf15</italic> (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1E</xref>), which reflects the state of metabolic stress that the mice are in <xref ref-type="bibr" rid="bib67">Manoli et al., 2018</xref>; <xref ref-type="bibr" rid="bib86">Patel et al., 2019</xref>. Aged <italic>Cdk1</italic> cKO mice displayed increased blood glucose levels (<xref ref-type="fig" rid="fig5">Figure 5G</xref>; p&lt;0.0001) and reduced hepatic glycogen content (<xref ref-type="fig" rid="fig5">Figure 5H</xref>; p=0.0079), indicating that 12-month-old <italic>Cdk1</italic> cKO mice had developed insulin resistance. When we performed glucose and insulin tolerance tests in 12-month-old mice, <italic>Cdk1</italic> cKO mice were more glucose intolerant (<xref ref-type="fig" rid="fig5">Figure 5I–J</xref>; p=0.0057) and less insulin sensitive (<xref ref-type="fig" rid="fig5">Figure 5K–L</xref>; p=0.0079) than control mice. Taken together, aged <italic>Cdk1</italic> cKO mice develop insulin resistance, possibly due to chronic hyperinsulinemia.</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Aged <italic>Cdk1</italic> cKO mice develop insulin resistance.</title><p>(<bold>A</bold>) Plasma insulin levels measured at 6 and 12 months old by ELISA (n = 5 per genotype per age). Error bars represent S.E.M. (<bold>B</bold>) Plasma FFA levels measured at 6 and 12 months old by biochemical assays (n = 5 per genotype per age). Error bars represent S.E.M. (<bold>C</bold>) Immunoblot of liver lysates from 12-month-old mice, probed for INSRB, phosphorylated INSRB at Y1151/1152 (pY1151/1152-INSRB), AKT, and phosphorylated AKT at T308 (pT308-AKT), with HSP90 as loading control. Quantification of total INSRB protein levels (<bold>D</bold>), pY1151/1152-INSRB levels normalized to total INSRB protein (<bold>E</bold>), and pT308-AKT normalized to total AKT protein (<bold>F</bold>) from immunoblot. (<bold>G</bold>) Fed state blood glucose measurements (at least n = 8 per genotype) and (<bold>H</bold>) hepatic glycogen content of 12-month-old mice (n = 5 per genotype). Error bars represent S.E.M. (<bold>I</bold>) Blood glucose measurements and (<bold>J</bold>) area under curve analysis from intraperitoneal glucose tolerance test (ipGTT) of 6- and 12-month-old mice (at least n = 5 per genotype). (<bold>K</bold>) Blood glucose measurements and (<bold>L</bold>) area above curve analysis from intraperitoneal insulin tolerance test (ipITT) of 6- and 12-month-old mice (n = 5 per genotype). Error bars represent S.D. unless otherwise stated. All source data are available in <xref ref-type="supplementary-material" rid="supp10">Supplementary file 10</xref>.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-63835-fig5-v2.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title>Adipose tissue from aged <italic>Cdk1</italic> cKO mice exhibit reduced insulin signaling.</title><p>(<bold>A</bold>) Immunoblot of epWAT lysates from 12-month-old mice, probed for INSRB, phosphorylated INSRB at Y1151/1152 (pY1151/1152-INSRB), AKT, and phosphorylated AKT at T308 (pT308-AKT), with HSP90 as loading control. Quantification of total INSRB protein levels (<bold>B</bold>), pY1151/1152-INSRB levels normalized to total INSRB protein (<bold>C</bold>), and pT308-AKT normalized to total AKT protein (<bold>D</bold>) from immunoblot. (<bold>E</bold>) qPCR for adipokines in adipose tissue of 12-month-old Ctrl and <italic>Cdk1</italic> cKO mice (n = 5 per genotype).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-63835-fig5-figsupp1-v2.tif"/></fig></fig-group><p>Hepatic steatosis is present in up to 50% of patients with type 2 diabetes (<xref ref-type="bibr" rid="bib95">Roden, 2006</xref>). Thus, we investigated whether steatosis had developed in the liver of aged <italic>Cdk1</italic> cKO mice. Histopathological analysis of hematoxylin and eosin (H and E)-stained liver sections from 12-month-old mice by a certified pathologist revealed the presence of macrovesicular fatty changes in aged <italic>Cdk1</italic> cKO mice, with control mice scoring 0, indicating the lack of any observable fatty changes, while <italic>Cdk1</italic> cKO mice were more variable with an average score of 1.8, but with some scoring as high as 4 (<xref ref-type="supplementary-material" rid="supp4">Supplementary file 4</xref>). This was confirmed by Oil Red O staining that illustrated the presence of lipid droplets in most aged <italic>Cdk1</italic> cKO mice but not in any of the aged control mice (<xref ref-type="fig" rid="fig6">Figure 6A</xref>). Additionally, TG assays (<xref ref-type="fig" rid="fig6">Figure 6B</xref>; p=0.0079) confirmed higher levels of hepatic TG in <italic>Cdk1</italic> cKO liver relative to control. There was also greater expression of <italic>Acaca</italic>, <italic>Fasn</italic>, <italic>Mogat1</italic>, and <italic>Cidec</italic> (<xref ref-type="fig" rid="fig6">Figure 6C</xref>), which are genes associated with lipogenesis and lipid accumulation, as well as increased protein level of the lipogenic transcription factor SREBP1c (<xref ref-type="fig" rid="fig6">Figure 6D–E</xref>; p&lt;0.0001). Even at 12 months old, lipidomics analysis (390 species detected) indicated that there were elevated levels of nearly all the 180 TG species detected (<xref ref-type="fig" rid="fig6">Figure 6F</xref>, <xref ref-type="supplementary-material" rid="supp5">Supplementary file 5</xref>), which could be correlated to the presence of insulin resistance (<xref ref-type="fig" rid="fig5">Figure 5</xref>). Hence, we present convincing data that aged <italic>Cdk1</italic> cKO mice develop hepatic steatosis, possibly through the upregulation of the lipogenic pathway but the mechanisms for this need to be further investigated (see below).</p><fig-group><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>Aged <italic>Cdk1</italic> cKO mice develop hepatic steatosis progressing to steatohepatitis.</title><p>(<bold>A</bold>) Representative H&amp;E, Oil Red O, and Sirius Red staining of 12-month-old control (Ctrl) and <italic>Cdk1</italic> cKO liver sections. Scale bar represents 100 μm in all panels. (<bold>B</bold>) Hepatic triacylglycerides (TGs) measured by biochemical assays (n = 5 per genotype). (<bold>C</bold>) qPCR of genes associated with lipogenesis and lipid accumulation in whole liver (n = 5 per genotype). (<bold>D</bold>) Immunoblot of liver lysates from 12-month-old mice, probed for SREBP1c. HSP90 image is reused from <xref ref-type="fig" rid="fig5">Figure 5C</xref> as samples were ran on the same blot. (<bold>E</bold>) Quantification of SREBP1c protein level from immunoblot. Error bars represent S.D. (<bold>F</bold>) Heat map of TG species in whole liver of 12-month-old Ctrl and <italic>Cdk1</italic> cKO mice as measured by mass spectrometry (lipidomics). Data is available in <xref ref-type="supplementary-material" rid="supp5">Supplementary file 5</xref>. (<bold>G</bold>) Quantification of percentage of Sirius-Red-positive area (five images per mouse, n = 5 per genotype). (<bold>H</bold>) Heat map of diacylglyceride species in whole liver of Ctrl and <italic>Cdk1</italic> cKO mice as measured by mass spectrometry (metabolomics). Relative levels of acylcarnitines (<bold>I</bold>), retinol metabolism metabolites (<bold>J</bold>), glutathione redox status (<bold>K</bold>), and purine catabolism metabolites (<bold>L</bold>) from metabolomics data. Metabolomics data was previously published (<xref ref-type="bibr" rid="bib79">Narayanaswamy et al., 2020</xref>). Error bars represent S.E.M. unless otherwise stated. All source data (besides metabolomics data) are available in <xref ref-type="supplementary-material" rid="supp10">Supplementary file 10</xref>.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-63835-fig6-v2.tif"/></fig><fig id="fig6s1" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 1.</label><caption><title>Purine catabolism pathway.</title><p>Metabolites that were increased in the metabolomics analysis of aged <italic>Cdk1</italic> cKO mice are highlighted in red. Enzymes with known associations to liver metabolic disease are included. ADA: Adenosine deaminase. XDH: Xanthine dehydrogenase.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-63835-fig6-figsupp1-v2.tif"/></fig></fig-group><p>About 20% of patients with NAFLD progress to NASH, characterized by the development of fibrosis (<xref ref-type="bibr" rid="bib25">Farrell and Larter, 2006</xref>). Therefore, we also probed whether aged <italic>Cdk1</italic> cKO mice develop liver fibrosis. Sirius Red staining indicated that aged <italic>Cdk1</italic> cKO mice exhibited more fibrotic areas compared to control (<xref ref-type="fig" rid="fig6">Figure 6G</xref>; p=0.0043), with some mice developing parenchymal and bridging fibrosis (<xref ref-type="fig" rid="fig6">Figure 6A</xref>). In our histopathology analysis, aged control mice scored 0, whereas aged <italic>Cdk1</italic> cKO mice had an average score of 1.4, with some scoring up to 3 (<xref ref-type="supplementary-material" rid="supp4">Supplementary file 4</xref>). Coupled to the presence of hepatocyte ballooning in <italic>Cdk1</italic> cKO liver (<xref ref-type="fig" rid="fig6">Figure 6A</xref>), another histological feature of NASH (<xref ref-type="bibr" rid="bib55">Lackner, 2011</xref>), our histological data supports the progression to a NASH-like state in aged <italic>Cdk1</italic> cKO liver.</p><p>We recently published a detailed metabolomics analysis of aged control and <italic>Cdk1</italic> cKO liver (<xref ref-type="bibr" rid="bib79">Narayanaswamy et al., 2020</xref>) and wanted to perform a more in-depth inspection of this metabolomics data by correlating changes in metabolites to the phenotypes and providing biological context to the findings. There was a substantial amount of lipids identified in the metabolomics data, likely due to the method of metabolite extraction used (<xref ref-type="bibr" rid="bib79">Narayanaswamy et al., 2020</xref>). Nevertheless, in line with our lipidomics data (<xref ref-type="fig" rid="fig6">Figure 6F</xref>) and histological observations (<xref ref-type="fig" rid="fig6">Figure 6A</xref>), TGs were increased in <italic>Cdk1</italic> cKO liver, as were diacylglycerides (<xref ref-type="fig" rid="fig6">Figure 6H</xref>). We also found that most detected AC species were increased in aged <italic>Cdk1</italic> cKO liver (<xref ref-type="fig" rid="fig6">Figure 6I</xref>), similar to what was seen in 8-week-old <italic>Cdk1</italic> cKO liver (<xref ref-type="fig" rid="fig2">Figure 2A–B</xref>), which might imply that the loss of FAO in <italic>Cdk1</italic> cKO hepatocytes (<xref ref-type="fig" rid="fig2">Figure 2C–E</xref>) was sustained in aging. Acetylcarnitine, a subspecies of ACs, was the only AC species reduced and among the most diminished metabolites in aged <italic>Cdk1</italic> cKO liver (<xref ref-type="fig" rid="fig6">Figure 6I</xref>). This could be due to the diversion of acetyl-CoA toward the lipogenic pathway (<xref ref-type="fig" rid="fig6">Figure 6C–E</xref>), thereby reducing the need for carnitine to buffer acetyl-CoA levels in cells. Other notable metabolites that were changed in aged <italic>Cdk1</italic> cKO liver compared to control include retinol and retinal (<xref ref-type="fig" rid="fig6">Figure 6J</xref>), which were the most decreased metabolites observed in the metabolomics data, and both oxidized and reduced forms of glutathione (<xref ref-type="fig" rid="fig6">Figure 6K</xref>). Decreases of hepatic retinol and retinal (<xref ref-type="fig" rid="fig6">Figure 6J</xref>) might be an outcome of hepatic stellate cell activation, as evidenced by the increased fibrosis (<xref ref-type="fig" rid="fig6">Figure 6A</xref>), and the resultant loss of lipid droplets in these cells, which are the main stores of retinoids in the liver (<xref ref-type="bibr" rid="bib79">Narayanaswamy et al., 2020</xref>). The increase of oxidized glutathione and decrease of reduced glutathione could reflect the altered redox status in <italic>Cdk1</italic> cKO liver that was evident even in young mice (<xref ref-type="fig" rid="fig1">Figure 1</xref>).</p><p>Interestingly, metabolites from the purine metabolism pathway, namely inosine, guanosine, xanthosine, and urate, were elevated (<xref ref-type="fig" rid="fig6">Figure 6L</xref>, <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1</xref>). This is particularly intriguing because adenosine deaminase (ADA), the enzyme that catalyzes the conversion of adenosine to inosine, is known to be more active in type 2 diabetic patients (<xref ref-type="bibr" rid="bib53">Kurtul et al., 2004</xref>) and is associated with liver fibrosis in NAFLD (<xref ref-type="bibr" rid="bib44">Jiang et al., 2018</xref>). Increases in ADA activity can lead to an increased flux through the purine metabolic pathway, eventually leading to increased production of urate by xanthine dehydrogenase (XDH) as the final step in the pathway (<xref ref-type="bibr" rid="bib66">Mandal and Mount, 2015</xref>). In fact, the presence of elevated serum urate level is a biomarker and risk factor for fatty liver disease (<xref ref-type="bibr" rid="bib42">Jensen et al., 2018</xref>), and greater XDH activity has been suggested as a causative factor for the development of insulin resistance and NAFLD through increasing oxidative stress via production of hydrogen peroxide (<xref ref-type="bibr" rid="bib46">Kelley et al., 2010</xref>; <xref ref-type="bibr" rid="bib122">Xu et al., 2015</xref>). Therefore, our independent metabolomics analyses confirm some of the main points of our study.</p></sec><sec id="s2-5"><title>Transcriptomics of aged mice suggest progression of the disease-like phenotype</title><p>To better understand changes happening in aged <italic>Cdk1</italic> cKO liver, we performed transcriptomic analysis on 12-month-old control and <italic>Cdk1</italic> cKO liver by RNA-seq, using equivalent parts of the liver. Principal component analysis of the transcriptomic data indicated that control and <italic>Cdk1</italic> cKO samples clustered separately along the PC1 axis, with the PC1 axis accounting for 68.7% of the variability among the samples, and that the transcriptomes of aged control samples were more similar to each other while those of <italic>Cdk1</italic> cKO liver were more heterogeneous (<xref ref-type="fig" rid="fig7">Figure 7A</xref>). We identified a total of 12,143 genes, including 310 genes that were upregulated and 72 that were downregulated in <italic>Cdk1</italic> cKO liver relative to control (<xref ref-type="fig" rid="fig7">Figure 7B</xref>, <xref ref-type="supplementary-material" rid="supp6">Supplementary file 6</xref>). Some of the top upregulated were predicted genes with relatively unknown functions, such as <italic>Gm14295, Gm11007</italic>, and <italic>Gm2007</italic>, although we also found genes such as <italic>Gsta1</italic>, an oxidative stress response gene that is one of the most differentially expressed between normal liver and steatotic liver (<xref ref-type="bibr" rid="bib34">Hennig et al., 2014</xref>), and retinol metabolism genes including <italic>Cyp2b9, Cyp2b13</italic>, and <italic>Rdh9</italic>, which is part of a predictive signature for fibrosis in a mouse model for NASH (<xref ref-type="bibr" rid="bib115">van Koppen et al., 2018</xref>). Among the top downregulated genes, we identified <italic>Foxq1</italic>, an established repressor of FOXO1 (<xref ref-type="bibr" rid="bib20">Cui et al., 2016</xref>), confirming the presence of insulin resistance in which FOXO1 is hyperactive. Interestingly, <italic>Foxq1</italic> was expressed at normal levels in the 8-week-old <italic>Cdk1</italic> cKO mice (see <xref ref-type="fig" rid="fig1">Figure 1L</xref>), indicating that with age, there is an adaptive process regulating FOXQ1/FOXO1 activity. When we compared the RNA-seq data to a 20-gene signature associated with severe NAFLD/NASH relative to mild NAFLD (<xref ref-type="bibr" rid="bib78">Moylan et al., 2014</xref>), the gene signature appeared to be expressed substantially higher in aged <italic>Cdk1</italic> cKO liver than in aged control liver (<xref ref-type="fig" rid="fig7">Figure 7C</xref>). We further validated selected targets within the gene signature via qPCR and confirmed that these genes were upregulated in aged <italic>Cdk1</italic> cKO liver (<xref ref-type="fig" rid="fig7">Figure 7D</xref>).</p><fig id="fig7" position="float"><label>Figure 7.</label><caption><title>Transcriptomic analysis of aged <italic>Cdk1</italic> cKO mice.</title><p>(<bold>A</bold>) Principal component analysis of RNA-seq data from 12-month-old mice. (<bold>B</bold>) Volcano plot of RNA-seq data. Significantly differentially expressed genes (q-value &lt;0.1) are represented by red dots, while non-significant genes by black dots. (<bold>C</bold>) Heat map of expression data from RNA-seq of genes from a severe NAFLD 20-gene signature. RNA-seq data is available in <xref ref-type="supplementary-material" rid="supp6">Supplementary file 6</xref>. (<bold>D</bold>) qPCR validation of selected genes from the 20-gene signature (n = 5 per genotype). (<bold>E</bold>) KEGG pathway analysis of differentially expressed genes (red for upregulated genes, green for downregulated genes) from RNA-seq data. Number of genes over the total number of genes associated with each KEGG term is indicated at the end of the respective bars. (<bold>F</bold>) ChIP enrichment analysis (ChEA) of differentially expressed genes from RNA-seq data. KEGG and ChEA data are available in <xref ref-type="supplementary-material" rid="supp7">Supplementary file 7</xref>. (<bold>G</bold>) Enrichment of LXRα localization at promoters of <italic>Srebf1</italic> and <italic>Scd1</italic> upon ChIP-qPCR after normalization to input. Error bars for all graphs represent S.E.M. Source data for qPCR and ChIP-qPCR are available in <xref ref-type="supplementary-material" rid="supp10">Supplementary file 10</xref>.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-63835-fig7-v2.tif"/></fig><p>KEGG pathway analysis (<xref ref-type="fig" rid="fig7">Figure 7E</xref>, <xref ref-type="supplementary-material" rid="supp7">Supplementary file 7</xref>) indicated a number of pathways are enriched among upregulated (red) and downregulated (green) genes from the RNA-seq. The most significantly enriched pathway, ‘retinol metabolism’, as well as enrichment of ‘TGF-beta signaling pathway’, provide support for the presence of fibrosis in <italic>Cdk1</italic> cKO liver (<xref ref-type="bibr" rid="bib57">Lee and Jeong, 2012</xref>; <xref ref-type="bibr" rid="bib70">Meng et al., 2016</xref>) and confirmed our metabolomics data (<xref ref-type="fig" rid="fig6">Figure 6J</xref>). Multiple KEGG terms associated with cancer, such as ‘chemical carcinogenesis’, ‘cell cycle’ and ‘hepatocellular carcinoma’ were also enriched for upregulated genes (<xref ref-type="fig" rid="fig7">Figure 7E</xref>). On the other hand, KEGG pathway analysis of downregulated genes only highlighted the term ‘steroid hormone biosynthesis’ (<xref ref-type="fig" rid="fig7">Figure 7E</xref>). Nevertheless, a closer inspection of genes classified under this term revealed <italic>Hsd3b5</italic> and <italic>Cyp2c70</italic> for which downregulation is associated with development of NAFLD in mouse models (<xref ref-type="bibr" rid="bib36">Hou et al., 2019</xref>). ChIP enrichment analysis (ChEA) was also performed on the transcriptomic data to identify transcription factors whose downstream targets are enriched among differentially expressed genes (<xref ref-type="fig" rid="fig7">Figure 7F</xref>, <xref ref-type="supplementary-material" rid="supp7">Supplementary file 7</xref>). LXR, a glucose-responsive lipogenic nuclear receptor (<xref ref-type="bibr" rid="bib73">Mitro et al., 2007</xref>), was the most significant transcription factor identified. LXR binds to DNA as a heterodimer with RXR (<xref ref-type="bibr" rid="bib119">Willy et al., 1995</xref>), which also appears as an enriched transcription factor, indicating that the LXR-RXR heterodimer may be more active in the aged <italic>Cdk1 cKO</italic> liver. Indeed, ChIP-qPCR for LXRα identified increased binding of LXRα at promoters of <italic>Srebf1</italic> and <italic>Scd1</italic> (<xref ref-type="fig" rid="fig7">Figure 7G</xref>; p=0.0093 for <italic>Srebf1</italic> promoter and p=0.0213 for <italic>Scd1</italic> promoter), both of which are lipogenic genes and are direct targets of LXR (<xref ref-type="bibr" rid="bib93">Repa, 2000</xref>; <xref ref-type="bibr" rid="bib18">Chu et al., 2006</xref>), suggesting that LXR might be directly responsible for the increase in SREBP1c levels (<xref ref-type="fig" rid="fig6">Figure 6D–E</xref>) and therefore lead indirectly to hepatic steatosis. Notably, OCT4, a transcription factor commonly associated with pluripotency in stem cells (<xref ref-type="bibr" rid="bib15">Chambers and Tomlinson, 2009</xref>), was also selected by ChEA (<xref ref-type="fig" rid="fig7">Figure 7F</xref>). This concurs with the enrichment of the KEGG term ‘signaling pathways regulating pluripotency of stem cells’ (<xref ref-type="fig" rid="fig7">Figure 7H</xref>) and suggests potential OCT4-driven oncogenic de-differentiation of hepatocytes (<xref ref-type="bibr" rid="bib127">Yin et al., 2015</xref>; <xref ref-type="bibr" rid="bib110">Sun et al., 2017</xref>).</p><p>In conclusion, our findings suggest that upon loss of CDK1, hepatocytes become defective in FAO oxidation, causing excessive FFAs to promote hyperinsulinemia. Over time, chronic hyperinsulinemia culminates in the development of liver disease and a diabetes-like phenotype, as observed in aged <italic>Cdk1</italic> cKO liver by the presence of insulin resistance and a NASH-like phenotype that is potentially on course to oncogenesis (<xref ref-type="bibr" rid="bib123">Xu et al., 2017</xref>).</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>In this study, we aimed to understand the impact of loss of CDK1 and the subsequent impairment of hepatocyte proliferation on lipid metabolism by performing lipidomics, metabolomics, and RNA-seq analyses on liver samples from our mouse model of defective hepatocyte proliferation, the <italic>Cdk1</italic> cKO mouse. One of the main observations was that TGs were reduced in the hepatocytes of <italic>Cdk1</italic> cKO mice when compared to age-matched control mice (<xref ref-type="fig" rid="fig1">Figure 1A–D</xref>). This is likely caused by increased oxidative stress-dependent induction of FOXO1-mediated transcription of <italic>Pnpla2</italic> (<xref ref-type="fig" rid="fig1">Figure 1</xref>), the gene coding for ATGL, the main enzyme involved in breaking down TGs to diacylglycerides (<xref ref-type="bibr" rid="bib131">Zimmermann et al., 2004</xref>). Our findings contrast a previous study using the HepG2 hepatoma cell line, which showed that hydrogen peroxide-induced oxidative stress can instead lead to lipid accumulation via SREBP1c action (<xref ref-type="bibr" rid="bib102">Sekiya et al., 2008</xref>). However, we believe this is because the study utilized very high levels of hydrogen peroxide to induce oxidative stress. Although physiological levels of oxidation can trigger SIRT1 activity leading to FOXO1 activation (<xref ref-type="bibr" rid="bib1">Alcendor et al., 2007</xref>; <xref ref-type="bibr" rid="bib90">Prozorovski et al., 2008</xref>; <xref ref-type="bibr" rid="bib13">Chakrabarti et al., 2011</xref>), high levels of hydrogen peroxide can cause proteasome-mediated degradation of SIRT1 protein (<xref ref-type="bibr" rid="bib126">Yang et al., 2007</xref>), thereby preventing the SIRT1-FOXO1-ATGL pathway from being effective. Furthermore, since SIRT1 can inhibit the transcriptional capability of SREBP1c (<xref ref-type="bibr" rid="bib88">Ponugoti et al., 2010</xref>), the loss of SIRT1 protein would also result in the derepression of SREBP1c.</p><p>Oxidative stress can induce FOXO1 activity through a number of different mechanisms (<xref ref-type="bibr" rid="bib48">Klotz et al., 2015</xref>). For instance, oxidative stress may promote the dimerization of the RNA-binding protein HuR, which can, in turn, bind to the 3′ untranslated region and enhance stability of the FOXO1 mRNA (<xref ref-type="bibr" rid="bib8">Benoit et al., 2010</xref>; <xref ref-type="bibr" rid="bib59">Li et al., 2013</xref>). This would in part explain the increase in FOXO1 mRNA observed in young <italic>Cdk1</italic> cKO liver (<xref ref-type="fig" rid="fig1">Figure 1L</xref>). As discussed above, oxidative stress can also trigger SIRT1 activity by increasing the NAD<sup>+</sup>/NADH ratio. SIRT1-dependent deacetylation of the FOXO1 protein can lead to nuclear trapping and increased FOXO1 localization on chromatin (<xref ref-type="bibr" rid="bib27">Frescas et al., 2005</xref>), which might be demonstrated by the relatively elevated amounts of FOXO1 protein found at the <italic>Pnpla2</italic> promoter (<xref ref-type="fig" rid="fig1">Figure 1O</xref>) when compared to the increase in FOXO1 protein level in <italic>Cdk1</italic> cKO liver (<xref ref-type="fig" rid="fig1">Figure 1M–N</xref>).</p><p>Besides a reduction in TGs, we also observed an increase of ACs (<xref ref-type="fig" rid="fig2">Figure 2A–B</xref>). Through β-hydroxybutyrate tests and FAO assays (<xref ref-type="fig" rid="fig2">Figure 2C–E</xref>), we suggest that this is due to <italic>Cdk1</italic> cKO hepatocytes being deficient in FAO. This can happen as a result of a reduction in FAO enzymes (<xref ref-type="fig" rid="fig2">Figure 2G–H</xref>) or by decreasing SIRT3-mediated fatty acid import into the mitochondria (<xref ref-type="fig" rid="fig2">Figure 2I–K</xref>). Notably, both these mechanisms are dependent on the loss of CDK1 activity (<xref ref-type="bibr" rid="bib33">Harbauer et al., 2014</xref>; <xref ref-type="bibr" rid="bib61">Liu et al., 2020</xref>). With relevance to senescence, during which CDK activities are repressed to prevent cell cycle progression and maintain the irreversible cell cycle exit state, the loss of CDK1 function can lead to a block of FAO in hepatocytes. Indeed, it was previously shown that hepatocytes induced to senesce by irradiation end up with impaired mitochondrial β-oxidation (<xref ref-type="bibr" rid="bib81">Ogrodnik et al., 2017</xref>). Hence, our findings provide a link between senescence and the loss of FAO in hepatocytes.</p><p>Impaired FAO, together with increased lipolysis, can lead to a buildup of FFAs. This can cause lipotoxicity and may explain a population of sub-G<sub>0</sub> hepatocytes seen in <italic>Cdk1</italic> cKO hepatocytes previously, in turn leading to immune infiltration and fibrosis (<xref ref-type="bibr" rid="bib22">Dewhurst et al., 2020</xref>). Excess FFAs can also enter the bloodstream (<xref ref-type="fig" rid="fig3">Figure 3A</xref>) and be taken up and stored as TGs in the adipose tissue (<xref ref-type="fig" rid="fig3">Figure 3H</xref>) or modulate responses in other peripheral organs. In particular, increased levels of FFA in the blood enhances insulin secretion by pancreatic β-cells (<xref ref-type="fig" rid="fig4">Figure 4B</xref>). This is because β-cells express the fatty acid receptor GPR40 (<xref ref-type="bibr" rid="bib40">Itoh et al., 2003</xref>), which, as a G-protein-coupled receptor, activates the phospholipase C pathway that triggers release of calcium ions from the endoplasmic reticulum and stimulates exocytosis of insulin from cytoplasmic insulin granules (<xref ref-type="bibr" rid="bib97">Rorsman and Ashcroft, 2018</xref>; <xref ref-type="bibr" rid="bib114">Usui et al., 2019</xref>). Alternatively, FFA can also promote upregulation of CYPD and increase the mitochondrial proton leak in β-cells, which enhances non-glucose-stimulated insulin secretion (<xref ref-type="bibr" rid="bib111">Taddeo et al., 2020</xref>).</p><p>Being the main organ that carries out gluconeogenesis, the liver is one of the targets for insulin activity (<xref ref-type="bibr" rid="bib87">Petersen and Shulman, 2018</xref>). Increased phosphorylation of INSRB, an insulin receptor subunit, and AKT (<xref ref-type="fig" rid="fig4">Figure 4F–H</xref>), a mediator of the insulin signaling pathway, reflects greater insulin signaling in young <italic>Cdk1</italic> cKO liver, in accordance with enhanced insulin secretion by the pancreas. Blood glucose levels were correspondingly decreased (<xref ref-type="fig" rid="fig4">Figure 4D</xref>) and hepatic glycogen storage was increased (<xref ref-type="fig" rid="fig4">Figure 4E</xref>). Paradoxically, FOXO1, which is normally phosphorylated and repressed by activated AKT upon insulin signaling (<xref ref-type="bibr" rid="bib64">Lu et al., 2012</xref>), was hyperactive in <italic>Cdk1</italic> cKO liver (<xref ref-type="fig" rid="fig1">Figure 1</xref>). This discrepancy can be resolved by the notion that Sirtuin-dependent activation of FOXO1 takes precedence over mitogen-dependent repression of FOXO1, and that in the presence of oxidative stress, insulin-mediated FOXO1 phosphorylation is abrogated (<xref ref-type="bibr" rid="bib27">Frescas et al., 2005</xref>).</p><p>While acute increases in insulin are important for maintaining blood glucose homeostasis, chronic insulin elevation, or chronic hyperinsulinemia, can lead to insulin resistance (<xref ref-type="bibr" rid="bib77">Morita et al., 2017</xref>). This can happen by downregulation of the insulin receptor through miR-27b (<xref ref-type="bibr" rid="bib107">Srivastava et al., 2018</xref>) or by constantly maintaining the insulin receptor in an ‘insulin refractory state’ whereby the insulin receptor has a lower ability to carry out auto-phosphorylation (<xref ref-type="bibr" rid="bib11">Catalano et al., 2014</xref>). Notably, hyperinsulinemia was sustained upon aging in <italic>Cdk1</italic> cKO mice (<xref ref-type="fig" rid="fig5">Figure 5A</xref>) given that this is a constitutive knockout model. As a result, aged <italic>Cdk1</italic> cKO mice develop hepatic insulin resistance, likely through reduced INSRB expression (<xref ref-type="fig" rid="fig5">Figure 5C–D</xref>) and reduced insulin receptor auto-phosphorylation (<xref ref-type="fig" rid="fig5">Figure 5E</xref>).</p><p>The development of insulin resistance in aged <italic>Cdk1</italic> cKO mice is supported by our observation of reduced insulin signaling (<xref ref-type="fig" rid="fig5">Figure 5C–F</xref>), increased blood glucose levels (<xref ref-type="fig" rid="fig5">Figure 5G</xref>), reduced glucose tolerance (<xref ref-type="fig" rid="fig5">Figure 5I–J</xref>), and diminished response to insulin (<xref ref-type="fig" rid="fig5">Figure 5K–L</xref>). Analysis of our published metabolomics data from aged <italic>Cdk1</italic> cKO mice (<xref ref-type="bibr" rid="bib79">Narayanaswamy et al., 2020</xref>) further reveals that purine metabolites were increased (<xref ref-type="fig" rid="fig6">Figure 6L</xref>). This is notable because an increase in purine metabolites, especially urate, is commonly observed in diabetic patients (<xref ref-type="bibr" rid="bib84">Papandreou et al., 2019</xref>; <xref ref-type="bibr" rid="bib116">Varadaiah et al., 2019</xref>). Nevertheless, the reason for this association between purine metabolites and insulin resistance remains unknown. One possibility is that upon insulin resistance, hyperglycemia, aggravated by hepatic gluconeogenesis and inhibition of glycogenesis, increases the flux through the pentose phosphate pathway (PPP) by increasing upstream metabolites. In the context of the <italic>Cdk1</italic> cKO mice, the presence of oxidative stress (<xref ref-type="fig" rid="fig1">Figure 1</xref>) may also exacerbate the situation by actively diverting glucose metabolites into the PPP to generate NADPH as the reducing cofactor for the oxidative stress response machinery (<xref ref-type="bibr" rid="bib2">Anastasiou et al., 2011</xref>; <xref ref-type="bibr" rid="bib50">Kuehne et al., 2015</xref>).</p><p>Insulin resistance is associated with hepatic steatosis, with about half of patients with type 2 diabetes also developing steatosis (<xref ref-type="bibr" rid="bib95">Roden, 2006</xref>). Similarly, aged <italic>Cdk1</italic> cKO mice develop hepatic steatosis with an accumulation of TGs (<xref ref-type="fig" rid="fig6">Figure 6A–B</xref>), in contrast to young <italic>Cdk1</italic> cKO mice which have reduced amounts of TGs instead (<xref ref-type="fig" rid="fig1">Figure 1</xref>). This change can happen for a multitude of reasons. While we show diminished response to insulin in the liver (<xref ref-type="fig" rid="fig5">Figure 5C–F</xref>), one can expect that chronic hyperinsulinemia would result in insulin resistance in various peripheral organs such as the adipose tissue (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref>), leading to the inability of peripheral tissues to perform insulin-mediated glucose uptake. Furthermore, FOXO1 is already active in young <italic>Cdk1</italic> cKO mice, exacerbating hyperglycemia (<xref ref-type="fig" rid="fig5">Figure 5G</xref>) via gluconeogenesis. The increase in blood glucose levels can then trigger the activity of LXR (<xref ref-type="bibr" rid="bib73">Mitro et al., 2007</xref>), which would in turn drive expression of <italic>Srebf1</italic> (<xref ref-type="fig" rid="fig6">Figure 6D–E</xref>, <xref ref-type="fig" rid="fig7">Figure 7G</xref>) and therefore lipogenesis. It is noteworthy that ChEA of RNA-seq data highlights LXR and RXR targets as being enriched among genes differentially expressed between <italic>Cdk1</italic> cKO and control mice (<xref ref-type="fig" rid="fig7">Figure 7F</xref>). As a result of increased LXR-dependent expression of lipogenic genes, the rate of lipogenesis likely increased over time in parallel with the progression of insulin resistance and eventually exceeded the rate of lipolysis. This would then lead to a net accumulation of lipids that caused the manifestation of steatosis, resulting in an inversion of the lipid phenotype in the liver of <italic>Cdk1</italic> cKO mice upon aging.</p><p>In addition to hepatic steatosis, we also observed increased fibrosis (<xref ref-type="fig" rid="fig6">Figure 6G</xref>) in the livers of aged <italic>Cdk1</italic> cKO mice. The presence of both these phenotypes is distinctive of NASH. Thus, it is unexpected that there was a lack of pro-inflammatory genes in the transcriptomics analysis of the aged mice (<xref ref-type="fig" rid="fig7">Figure 7</xref>). This would suggest that only the fibrotic aspect of NASH, but not the inflammatory aspect, was recapitulated. We hypothesize that this might be because hyperinsulinemia and insulin resistance mediate immune suppression (<xref ref-type="bibr" rid="bib68">Marín-Juez et al., 2014</xref>; <xref ref-type="bibr" rid="bib49">Knuever et al., 2015</xref>) by promoting the anti-inflammatory M2 phenotype in peripheral macrophages (<xref ref-type="bibr" rid="bib39">Ieronymaki et al., 2019</xref>), such as the hepatic Kupffer cells, and by sensitizing macrophages to pro-apoptotic signals (<xref ref-type="bibr" rid="bib103">Senokuchi et al., 2008</xref>). Despite the lack of an inflammatory response, liver fibrosis in aged <italic>Cdk1</italic> cKO mice could still be induced by factors released by steatotic hepatocytes that are sufficient to activate the fibrogenic hepatic stellate cells (<xref ref-type="bibr" rid="bib120">Wobser et al., 2009</xref>).</p><p>CDK1 is primarily known as a driver of cell division, although it also has lesser known metabolic roles involving the regulation of mitochondrial function (<xref ref-type="bibr" rid="bib33">Harbauer et al., 2014</xref>; <xref ref-type="bibr" rid="bib61">Liu et al., 2020</xref>). As such, we cannot exclude the possibility that our observations are a result of loss of CDK1 activity instead of the general loss of hepatocyte proliferation. At this moment, it is unclear whether the cell cycle and metabolic functions of CDK1 are connected or can be uncoupled because there are no <italic>Cdk1</italic> mutants known that drive only one of these functions. We believe that it is likely that the impact on CDK1-associated metabolic processes contribute to the phenotypes, because our model of metabolic adaptation in <italic>Cdk1</italic> cKO mice (<xref ref-type="fig" rid="fig8">Figure 8</xref>) occurs primarily due to dysfunctional FAO in the hepatocytes, which tend to be quiescent (<xref ref-type="fig" rid="fig2">Figure 2</xref>). Hence, a better understanding of how loss of hepatocyte proliferation impacts liver physiology may entail further studies and comparisons with other animal models sporting impaired hepatocyte division. Nevertheless, there are many physiological and pathological instances where CDK1 activity is disrupted, and it is in these settings that findings from the <italic>Cdk1</italic> cKO mice might be clinically applicable. For example, during aging, CDK1 activity is reduced, partly due to reduced CDK1 expression and partly due to induction of CDK inhibitors upon senescence (<xref ref-type="bibr" rid="bib108">Stein et al., 1991</xref>; <xref ref-type="bibr" rid="bib121">Wong and Riabowol, 1996</xref>; <xref ref-type="bibr" rid="bib69">McConnell et al., 1998</xref>; <xref ref-type="bibr" rid="bib91">Quadri et al., 1998</xref>), which may contribute to the reduction in hepatocyte proliferative capacity in aged liver (<xref ref-type="bibr" rid="bib101">Schmucker and Sanchez, 2011</xref>). Correspondingly, our data suggest that attenuated CDK1 function might contribute to age-related hyperinsulinemia (<xref ref-type="bibr" rid="bib52">Kurauti et al., 2019</xref>).</p><fig id="fig8" position="float"><label>Figure 8.</label><caption><title>Model of lipid remodeling in young and aged <italic>Cdk1</italic> cKO mice.</title><p>Upon knockout of <italic>Cdk1</italic> or senescence, whereby CDK1 activity is inhibited by CDK1 inhibitors, there is a block of FAO, leading to an accumulation of FFA in young <italic>Cdk1</italic> cKO mice. This is further exacerbated by mitochondrial oxidative stress that promotes FOXO1-dependent ATGL upregulation and increased lipolysis. The accumulated FFA then enter the bloodstream and is stored as TGs in adipocytes in the WAT. Elevated FFA levels in the bloodstream can also induce greater insulin secretion by pancreatic β-cells (hyperinsulinemia), leading to reduced blood glucose. However, over time, chronic hyperinsulinemia results in the development of insulin resistance in aged <italic>Cdk1</italic> cKO mice, which prevents the blood glucose lowering effect of insulin, causing hyperglycemia. Hyperglycemia, in turn, activates LXR activity and drives lipogenesis, eventually culminating in the manifestation of hepatic steatosis and a NAFLD-like phenotype.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-63835-fig8-v2.tif"/></fig><p>Meta-analyses of transcriptomics data from NAFLD patient livers have not identified CDK1 transcripts as being differentially expressed (<xref ref-type="bibr" rid="bib98">Ryaboshapkina and Hammar, 2017</xref>; <xref ref-type="bibr" rid="bib38">Huang et al., 2018</xref>), although aged <italic>Cdk1</italic> cKO mice develop steatotic livers. Still, hepatocytes from NAFLD patients display impaired proliferation, and with increasing evidence that senescence is rampant in the NAFLD liver (<xref ref-type="bibr" rid="bib85">Papatheodoridi et al., 2020</xref>), it is not implausible to imagine that CDK1 is hypoactive in such conditions. Notably, <xref ref-type="bibr" rid="bib81">Ogrodnik et al., 2017</xref> demonstrated that senescent hepatocytes contribute to development of hepatic steatosis as a result of defective mitochondrial FAO, and removal of these senescent hepatocytes ameliorates the phenotype. We provide a potential mechanistic pathway by which senescence can lead to steatosis, through inhibition of CDK1 activity, eventually leading to FFA-induced chronic hyperinsulinemia and the consequent insulin resistance. More recently, <xref ref-type="bibr" rid="bib82">Omori et al., 2020</xref> uncovered that senescence is also increased in the hepatic non-parenchymal cell population. Furthermore, they confirmed that elimination of senescent cells rescues the NASH phenotype. Hence, it will be interesting to explore whether the deletion of CDK1 in the non-parenchymal cells also induces liver steatosis.</p><p>One foreseeable limitation of our model is that senescence is observed in the liver of young <italic>Cdk1</italic> cKO mice, evident from the presence of senescence-associated β-galactosidase staining (<xref ref-type="fig" rid="fig9">Figure 9A</xref>) and the induction of senescence markers such as <italic>Cdkn1a</italic> [p21<sup>cip1/waf1</sup>], <italic>Cdkn1b</italic> [p27<sup>Kip1</sup>], and <italic>Cdkn2a</italic> [p16<sup>inka4a</sup>] (<xref ref-type="fig" rid="fig9">Figure 9B</xref>), in agreement with our previous findings (<xref ref-type="bibr" rid="bib22">Dewhurst et al., 2020</xref>). This suggests the possibility that non-CDK1-dependent senescent pathways, such as the senescence-associated secretory phenotype (SASP), may contribute to hepatic steatosis upon aging. A rescue of mitochondrial FAO in <italic>Cdk1</italic> cKO mice would help us delineate the relative contribution of the FFA-hyperinsulinemia pathway to the phenotypes seen in the aged mice. Another limitation of the <italic>Cdk1</italic> cKO mice is that senescence typically occurs in a mosaic fashion (<xref ref-type="bibr" rid="bib35">Herbig et al., 2003</xref>), while knockout of CDK1 occurs in all hepatocytes in the <italic>Cdk1</italic> cKO mouse (<xref ref-type="bibr" rid="bib22">Dewhurst et al., 2020</xref>). As such, not all the phenotypes seen in the aged <italic>Cdk1</italic> cKO mice might actually manifest during normal aging.</p><fig id="fig9" position="float"><label>Figure 9.</label><caption><title>Senescence develops in young <italic>Cdk1</italic> cKO mice.</title><p>(<bold>A</bold>) Representative image of senescence-associated β-galactosidase (SA β-gal) staining of liver sections from 8-week-old control (Ctrl) and <italic>Cdk1</italic> cKO mice. Scale bar represents 50 µm. (<bold>B</bold>) qPCR for <italic>Cdkn1a</italic> [p21<sup>cip1/waf1</sup>], <italic>Cdkn1b</italic> [p27<sup>Kip1</sup>], and <italic>Cdkn2a</italic> [p16<sup>inka4a</sup>] in liver from 8-week-old Ctrl and <italic>Cdk1</italic> cKO mice (n = 3 per genotype). Data is available in <xref ref-type="supplementary-material" rid="supp10">Supplementary file 10</xref>.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-63835-fig9-v2.tif"/></fig><p>In this study, using our mouse model in which hepatocytes lack CDK1, the <italic>Cdk1</italic> cKO mouse, we show that the liver, in the absence of any external stimuli, develops metabolic disease upon aging, which also affects other tissues. With these findings, our study proposes that the loss of CDK1 activity in hepatocytes, in addition to being an outcome of liver disease, can be a contributor to hepatic pathology and supports the concept that senotherapeutic drugs targeting senescent cells (<xref ref-type="bibr" rid="bib94">Ritschka et al., 2020</xref>) are potentially viable therapeutic options for treating liver metabolic diseases.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th>Reagent type <break/>(species) or <break/>resource</th><th>Designation</th><th>Source or <break/>reference</th><th>Identifiers</th><th>Additional <break/>information</th></tr></thead><tbody><tr><td>Gene (<italic>Mus musculus</italic>)</td><td><italic>Cdk1</italic></td><td>NCBI Gene</td><td>ID:12534</td><td/></tr><tr><td>Gene (<italic>Mus musculus</italic>)</td><td><italic>Cpt2</italic></td><td>NCBI Gene</td><td>ID:12896</td><td/></tr><tr><td>Gene (<italic>Mus musculus</italic>)</td><td><italic>Foxo1</italic></td><td>NCBI Gene</td><td>ID:56458</td><td/></tr><tr><td>Gene (<italic>Mus musculus</italic>)</td><td><italic>Pnpla2</italic></td><td>NCBI Gene</td><td>ID:66853</td><td/></tr><tr><td>Strain, strain background (<italic>Escherichia coli</italic>)</td><td>Stbl3</td><td>Thermo Fisher Scientific</td><td>Cat#:C7373-03</td><td>For cloning and maintaining lentiviral vectors</td></tr><tr><td>Genetic reagent (<italic>Mus musculus</italic>)</td><td>Alb-Cre</td><td>DOI: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/(sici)1526-968x(200002)26">10.1002/(sici)1526-968x(200002)26</ext-link>:2 &lt; 149::aid-gene16 &gt; 3.0.co;2 v</td><td>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/MGI:6258240">MGI:6258240</ext-link></td><td>Control to the <italic>Cdk1</italic> cKO mice</td></tr><tr><td>Genetic reagent (<italic>Mus musculus</italic>)</td><td><italic>Cdk1</italic> cKO</td><td>DOI: <break/><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1073/pnas.1115201109">10.1073/pnas.1115201109</ext-link></td><td>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/MGI:5318109">MGI:5318109</ext-link></td><td>Hepatocyte-specific knockout of <italic>Cdk1</italic> gene</td></tr><tr><td>Transfected construct (<italic>Mus musculus</italic>)</td><td>pLKO.1</td><td>Addgene</td><td>Cat#:#8453; RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/Addgene_10878">Addgene_10878</ext-link></td><td>Empty vector</td></tr><tr><td>Transfected construct (<italic>Mus musculus</italic>)</td><td>pLKO-shPnpla2</td><td>This paper</td><td/><td>Expression of shRNA against <italic>Pnpla2</italic> (sequence: GGAGAGAACGTCATCATAT)</td></tr><tr><td>Biological sample (<italic>Mus musculus</italic>, male)</td><td>Liver, subcutaneous WAT and epididymal WAT from <italic>Cdk1</italic> cKO mice</td><td>This paper</td><td/><td>Freshly isolated from 2-, -6, or 12-month-old <italic>Mus musculus</italic></td></tr><tr><td>Biological sample (<italic>Mus musculus</italic>, male)</td><td>Plasma from <italic>Cdk1</italic> cKO mice</td><td>This paper</td><td/><td>Freshly isolated from 2, 6, or 12 month old <italic>Mus musculus</italic></td></tr><tr><td>Antibody</td><td>Anti-ACADVL <break/>(Mouse monoclonal)</td><td>Santa Cruz Biotechnology</td><td>Cat#:sc-376239; RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_10989696">AB_10989696</ext-link></td><td>WB (1:1000)</td></tr><tr><td>Antibody</td><td>Anti-AKT <break/>(Rabbit polyclonal)</td><td>Cell Signaling</td><td>Cat#:#9272; RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_329827">AB_329827</ext-link></td><td>WB (1:2000)</td></tr><tr><td>Antibody</td><td>Anti-pT308-AKT <break/>(Rabbit polyclonal)</td><td>Cell Signaling</td><td>Cat#:#9275; RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_329829">AB_329829</ext-link></td><td>WB (1:500)</td></tr><tr><td>Antibody</td><td>Anti-ATGL (Mouse monoclonal)</td><td>Santa Cruz Biotechnology</td><td>Cat#:sc-365278; RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_10859044">AB_10859044</ext-link></td><td>WB (1:2000)</td></tr><tr><td>Antibody</td><td>Anti-CPT2 (Rabbit polyclonal)</td><td>Proteintech</td><td>Cat#:26555–1-AP; RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2880551">AB_2880551</ext-link></td><td>IP (2 µL per 500 µg protein), <break/>WB (1:2000)</td></tr><tr><td>Antibody</td><td>Anti-FOXO1 (Rabbit monoclonal)</td><td>Cell Signaling</td><td>Cat#:#2880; RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2106495">AB_2106495</ext-link></td><td>ChIP (2 µL per 10 µg chromatin), <break/>WB (1:1000)</td></tr><tr><td>Antibody</td><td>Anti-HADHA (Mouse monoclonal)</td><td>Santa Cruz Biotechnology</td><td>Cat#:sc-374497; RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_10987868">AB_10987868</ext-link></td><td>WB (1:500)</td></tr><tr><td>Antibody</td><td>Anti-HSP90 (Mouse monoclonal)</td><td>BD Transduction Laboratories</td><td>Cat#:610418; RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_397798">AB_397798</ext-link></td><td>WB (1:10,000)</td></tr><tr><td>Antibody</td><td>Anti-INSRB (Rabbit polyclonal)</td><td>Santa Cruz <break/>Biotechnology</td><td>Cat#:sc-711; RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_631835">AB_631835</ext-link></td><td>WB (1:2000)</td></tr><tr><td>Antibody</td><td>Anti-pY1151/1152-INSRB (Mouse monoclonal)</td><td>Santa Cruz Biotechnology</td><td>Cat#:sc-81500; RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_1125642">AB_1125642</ext-link></td><td>WB (1:500)</td></tr><tr><td>Antibody</td><td>Anti-LXRα (Mouse monoclonal)</td><td>Abcam</td><td>Cat#:ab41902; RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_776094">AB_776094</ext-link></td><td>ChIP (2 µL per 10 µg chromatin)</td></tr><tr><td>Antibody</td><td>Anti-pan-acetylation (Mouse monoclonal)</td><td>Proteintech</td><td>Cat#:66289–1-Ig; RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2881672">AB_2881672</ext-link></td><td>WB (1:1000)</td></tr><tr><td>Antibody</td><td>Anti-phospho-Ser/Thr (Rabbit polyclonal)</td><td>Abcam</td><td>Cat#:ab117253; RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_10903259">AB_10903259</ext-link></td><td>WB (1:4000)</td></tr><tr><td>Antibody</td><td>Anti-SIRT3 (Rabbit monoclonal)</td><td>Cell Signaling</td><td>Cat#:#5490; RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_10828246">AB_10828246</ext-link></td><td>IP (2 µL per 500 µg protein), <break/>WB (1:2000)</td></tr><tr><td>Antibody</td><td>Anti-SREBP1c (Rabbit polyclonal)</td><td>Abcam</td><td>Cat#:ab28481; RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_778069">AB_778069</ext-link></td><td>WB (1:1000)</td></tr><tr><td>Peptide, recombinant protein</td><td>Actrapid, fast-acting insulin</td><td>Novo Nordisk</td><td/><td/></tr><tr><td>Peptide, recombinant protein</td><td>rDNase</td><td>Macherey-Nagel</td><td>Cat#:740963</td><td/></tr><tr><td>Commercial assay or kit</td><td>Triglyceride Assay Kit</td><td>Abcam</td><td>Cat#:ab65336</td><td/></tr><tr><td>Commercial assay or kit</td><td>HDL and LDL/VLDL Cholesterol Assay Kit</td><td>Abcam</td><td>Cat#:ab65390</td><td/></tr><tr><td>Commercial assay or kit</td><td>Free Fatty Acid Assay Kit</td><td>Cell Biolabs</td><td>Cat#:STA-618</td><td/></tr><tr><td>Commercial assay or kit</td><td>β-Hydroxybutyrate (Ketone Body) Colorimetric Assay Kit</td><td>Cayman Chemicals</td><td>Cat#:700190</td><td/></tr><tr><td>Commercial assay or kit</td><td>Ultra Sensitive Mouse Insulin ELISA Kit</td><td>Crystal Chem</td><td>Cat#:90080</td><td/></tr><tr><td>Commercial assay or kit</td><td>Glycogen Assay Kit</td><td>Abcam</td><td>Cat#:ab83369</td><td/></tr><tr><td>Commercial assay or kit</td><td>Fatty Acid Oxidation Assay Kit</td><td>Abcam</td><td>Cat#:ab217602</td><td/></tr><tr><td>Commercial assay or kit</td><td>Extracellular Oxygen Consumption Assay Kit</td><td>Abcam</td><td>Cat#:ab197243</td><td/></tr><tr><td>Commercial assay or kit</td><td>Maxima First Strand cDNA Synthesis Kit</td><td>Thermo Fisher Scientific</td><td>Cat#:K1641</td><td/></tr><tr><td>Commercial assay or kit</td><td>Maxima SYBR Green qPCR Master Mix</td><td>Thermo Fisher Scientific</td><td>Cat#:K0221</td><td/></tr><tr><td>Commercial assay or kit</td><td>PureLink RNA Mini Kit</td><td>Thermo Fisher Scientific</td><td>Cat#:12183025</td><td/></tr><tr><td>Commercial assay or kit</td><td>Oxidized Protein Western Blot Detection Kit</td><td>Abcam</td><td>Cat#: ab178020</td><td/></tr><tr><td>Chemical compound, drug</td><td>N-acetylcysteine</td><td>Sigma-Aldrich</td><td>Cat#:A7250</td><td/></tr><tr><td>Software, algorithm</td><td>GraphPad Prism</td><td>GraphPad</td><td>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_002798">SCR_002798</ext-link></td><td>Version 6</td></tr><tr><td>Software, algorithm</td><td>STAR-mapper</td><td>DOI: <break/><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/bioinformatics/bts635">10.1093/bioinformatics/bts635</ext-link></td><td/><td>For RNA-seq analysis</td></tr><tr><td>Software, algorithm</td><td>RSEM</td><td>DOI:<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/1471-2105-12-323">10.1186/1471-2105-12-323</ext-link></td><td>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_013027">SCR_013027</ext-link></td><td>For RNA-seq analysis</td></tr><tr><td>Software, algorithm</td><td>ClustVis</td><td>DOI:<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/nar/gkv468">10.1093/nar/gkv468</ext-link></td><td>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_017133">SCR_017133</ext-link></td><td>For RNA-seq analysis</td></tr><tr><td>Software, algorithm</td><td>Enrichr</td><td>DOI:<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/nar/gkw377">10.1093/nar/gkw377</ext-link></td><td>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_001575">SCR_001575</ext-link></td><td>For RNA-seq analysis</td></tr><tr><td>Software, algorithm</td><td>MetaboKit</td><td>DOI:<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1039/d0mo00030b">10.1039/d0mo00030b</ext-link></td><td/><td>For untargeted metabolomics analysis</td></tr><tr><td>Other</td><td>Accu-Chek Performa Nano</td><td>Accu-Chek</td><td/><td>Blood glucose meter</td></tr><tr><td>Other</td><td>Accu-Chek test strips</td><td>Accu-Chek</td><td>Code 222</td><td>Test strips for blood glucose meter</td></tr></tbody></table></table-wrap><sec id="s4-1"><title>Genetic mouse models, animal experiments, and blood glucose test</title><p><italic>Cdk1</italic> cKO mice have been previously described (<xref ref-type="bibr" rid="bib23">Diril et al., 2012</xref>; <xref ref-type="bibr" rid="bib10">Caldez et al., 2018</xref>). Briefly, <italic>Cdk1</italic> cKO were established by crossing <italic>Cdk1<sup>fl/fl</sup></italic> mice with Albumin-Cre mice (<xref ref-type="bibr" rid="bib89">Postic and Magnuson, 2000</xref>; #003574, The Jackson Laboratory) for deletion of the <italic>Cdk1</italic> gene specifically in hepatocytes. The <italic>Cdk1<sup>fl/fl</sup></italic> Albumin-Cre mice will be designated as ‘<italic>Cdk1</italic> cKO’ throughout this study. Hence, <italic>Cdk1<sup>+/+</sup></italic> Alb-Cre mice were used as controls (Ctrl) to account for expression of the Cre recombinase in the hepatocytes. Mice were maintained on standard chow ad libitum under 12 hr light/dark cycle. Only male mice were used for experiments to avoid hormonal confounding. For food intake measurement, 5-week-old mice were individually housed and given 1 week to acclimatize, after which the amount of food eaten was measured for 2 weeks (6- to 8-week-old) as described previously (<xref ref-type="bibr" rid="bib6">Bachmanov et al., 2002</xref>). For N-acetylcysteine (NAC; A7250, Sigma-Aldrich) treatment, 6-week-old mice were fed with water containing 2 mg/mL NAC ad libitum for 2 weeks. As controls, mice were fed with normal water as usual. For <italic>Pnpla2</italic> knockdown in the liver, 40 µg of pLKO-shPnpla2 or empty vector were injected into 7-week-old mice by hydrodynamic tail vein injection (<xref ref-type="bibr" rid="bib128">Yokoo et al., 2016</xref>). In brief, plasmids were diluted in Ringer’s lactate solution at a volume corresponding to 10% body weight of mice and injected into the lateral tail vein within 10 s. Tissues were collected at the indicated ages. Blood was collected by cardiac puncture, transferred to a lithium heparin-coated Microvette 500 LH (20.1345.100, Sarstedt) and subsequently centrifuged at 14,000 rpm for 10 min at 4°C to collect plasma. Whole body fat mass was measured on live mice using EchoMRI Body Composition Analyzer (EchoMRI). Glucose tolerance tests (GTT) were performed by fasting mice for 16 hr followed by intraperitoneal injection of D-glucose at 1 g/kg body weight. Blood glucose was measured before injection and at 15, 30, 60, 90, and 120 min post-injection. For insulin tolerance tests (ITT), mice were fasted for 6 hr followed by intraperitoneal injection of insulin (Actrapid, Novo Nordisk) at 1 U/kg body weight and blood glucose was measured as above. Blood glucose measurements were performed on blood from tail snips using the Accu-Chek Performa Nano glucose meter (Roche) and Accu-Chek Performa test strips Code 222. Area under curve (AUC; for GTT) or area above curve (for ITT) was taken as the area above or below baseline (blood glucose level at 0 min), respectively, and calculated using GraphPad Prism version 6. All animal experiments were performed in accordance to protocols (#171268) approved by the A*STAR Institutional Animal Care and Use Committee (IACUC) based on the National Advisory Committee for Laboratory Animal Research (NACLAR) Guidelines.</p></sec><sec id="s4-2"><title>Biochemical assays</title><p>Hepatic and plasma TGs were measured using the Triglyceride Assay Kit (ab65336, Abcam), plasma cholesterols using the HDL and LDL/VLDL Cholesterol Assay Kit (ab65390, Abcam), plasma FFAs using FFA Assay Kit (STA-618, Cell Biolabs), hepatic β-hydroxybutyrate using β-hydroxybutyrate (Ketone Body) Colorimetric Assay Kit (700190, Cayman Chemicals), plasma insulin using the Ultra-Sensitive Mouse Insulin ELISA Kit (90080, Crystal Chem), and hepatic glycogen using the Glycogen Assay Kit (ab83369, Abcam) according to the manufacturer’s protocols. Signals were read using a TECAN Safire microplate reader at default parameters.</p></sec><sec id="s4-3"><title>Molecular cloning</title><p>shRNA targeting murine <italic>Pnpla2</italic> with the sequence 5′-<named-content content-type="sequence">GGAGAGAACGTCATCATAT</named-content>-3′ (<xref ref-type="bibr" rid="bib75">Miyoshi et al., 2007</xref>) were designed and inserted into the pLKO.1 vector as previously published (<xref ref-type="bibr" rid="bib76">Moffat et al., 2006</xref>) to generate the pLKO-shPnpla2 plasmid for knocking down <italic>Pnpla2</italic>. Plasmids were maintained and amplified in Stbl3 <italic>Escherichia coli</italic> cells (Thermo Fisher Scientific) and purified using EndoFree Plasmid Maxi Kit (Qiagen) before being used for hydrodynamic tail vein injection.</p></sec><sec id="s4-4"><title>β-oxidation assays</title><p>Hepatocytes were isolated and cultured as described previously (<xref ref-type="bibr" rid="bib10">Caldez et al., 2018</xref>). β-oxidation capabilities of isolated hepatocytes were then measured using the FFA Assay Kit (ab217602, Abcam) in combination with the Extracellular Oxygen Consumption Assay Kit (ab197243, Abcam) following manufacturer’s protocol. Signals were read using a TECAN Safire microplate reader with parameters as indicated in the assay protocol.</p></sec><sec id="s4-5"><title>Lipid extraction from liver tissue and plasma samples</title><p>Frozen liver tissues were lyophilized until constant dry weight in a vacuum concentrator. PBS (phosphate buffered saline) was added to the dried samples (30 µL per mg dry weight) and homogenized with homogenization beads using an Omni beadruptor homogenizer (speed: 3.50 m/s; cycle: six times; duration: 45 s, dwell time: 15 s, repeat four times). Homogenates were transferred to clean polypropylene tubes for lipid extraction. For lipid extraction, 20 μL of tissue homogenates were resuspended in 360 μL of chilled chloroform/methanol (1:2 v/v) containing internal standards. The samples were then placed on a rotary shaker (30 min, 4°C, 700 rpm). 120 μL of chilled chloroform and 100 μL of chilled milliQ water were then added, the samples vortexed again for 15 s, and centrifuged at 10,000 rpm for 7 min to separate the phases. The lower organic phases were collected and the remaining aqueous phases were re-extracted with 500 μL of chilled chloroform as above. The lower organic phases were combined with the first organic extracts. Lipid extracts were then dried in a vacuum concentrator, resuspended in chloroform/methanol (1:1 v/v) and kept at −80°C until LC-MS/MS analysis. Lipid extraction from 10 μL of plasma was performed as described above using half the volume of indicated reagents.</p></sec><sec id="s4-6"><title>Liquid chromatography with tandem mass spectrometry (LC-MS/MS) analysis of TGs, PLs, and ACs</title><p>Chromatography separation of TGs was achieved by RPLC on an Agilent Eclipse Plus C18 (100 × 2.1 mm, 1.8 μm), using an Agilent 1290 Infinity II LC system. The column temperature was 40°C, the autosampler was kept at 8°C, and 1 μL of sample was injected. Solvent A was acetonitrile/water (4:6 v/v), solvent B was acetonitrile/isopropanol (1:9 v/v), both solvent A and solvent B contained 10 mM ammonium formate. Gradient elution started at 20% solvent B, increased linearly to 60% in 2 min, then increased linearly to 100% solvent B in 10 min, held at 100% solvent B for 2 min, then brought back to 20% solvent B and held for 1.8 min (total run-time 15.8 min). The flow rate was 400 μL/min. The column effluent was introduced into an Agilent 6490 Triple Quadrupole MS system equipped with an electrospray ion source. MS parameters were as follows: Gas Temperature, 200°C; Gas Flow, 15 L/min; Nebulizer, 25 psi; Sheath Gas Heater, 250°C, Sheath Gas Flow, 12 L/min; Capillary, 3.5kV. TGs were measured in positive ionization, using both dynamic multiple reaction monitoring (dMRM) and single ion monitoring (SIM) (see <xref ref-type="supplementary-material" rid="supp8">Supplementary file 8</xref> for MRM lists). Data analysis was performed using Agilent MassHunter Quantitative Analysis (QQQ) software. The data were inspected manually to ensure peak integration by the software was appropriate. AUC of the integrated ion chromatogram peaks for each MRM transition were extracted to Microsoft Excel and normalized to the AUC of the d5-TG 48:0 internal standard.</p><p>Chromatography separation of PL and AC was achieved by hydrophilic interaction liquid chromatography (HILIC) on a Phenomenex Kinetex HILIC column (150 × 2.10 mm, 2.6 μM, 100 Å), using an Agilent 1290 Infinity II LC system. The column temperature was 50°C, the autosampler was kept at 8°C, and 1 μL of sample was injected. Solvent A and Solvent B were both acetonitrile/25 mM aqueous ammonium formate pH4.6 with distinct ratios (1:1 v/v and 19:1 v/v, respectively). Gradient elution started at 1% solvent A, increased linearly to 25% solvent A in 6 min, then increased linearly to 90% solvent A in 1 min, then decreased back at 1% solvent A in 0.1 min, and held for 3 min (total runtime 10.1 min). The flow rate was 500 μL/min. For phosphatidylserine analysis, a slightly different gradient was used: elution started at 1% solvent A, increased linearly to 75% solvent A in 6 min, then increased linearly to 90% A in 1 min, then decreased back at 1% A in 0.1 min, and held for 3 min; total runtime (10.1 min). The column effluent was subjected to MS and data analysis as described for TG with minor changes as described below. PLs and ACs were measured in positive or negative ionization, using multiple reaction monitoring (MRM) (see <xref ref-type="supplementary-material" rid="supp8">Supplementary file 8</xref> for MRM lists). Isotopic correction of AUC of the PLs and sphingomyelin was done using in-house R script. Corrected AUC were normalized to the AUC of class-specific internal standards.</p><p>For quality control, prior to lipid extraction, samples were randomized (using Excel random number generator) and quality control (QC) samples were prepared by pooling aliquots from each sample indicated by randomization. QC samples were used to monitor reproducibility of extraction, linearity and stability of instrument response. Blank extracts were also prepared by adding the extraction mixture to empty tubes, and used to monitor carry-over and contamination issues. Briefly, MRM transitions were kept for analysis only if they satisfied the following criteria: RSD &lt;25% over all QC samples, linearity curve R<sup>2</sup> &gt;0.9, and signal in the blank less than 10% of average signal in the QC sample. Heat maps were generated using Heatmapper (<xref ref-type="bibr" rid="bib5">Babicki et al., 2016</xref>).</p></sec><sec id="s4-7"><title>Non-esterified FFA extraction and LC-MRM analysis</title><p>FFAs were analyzed as described (<xref ref-type="bibr" rid="bib17">Christinat et al., 2016</xref>). Briefly, 50 µL of plasma was mixed with 450 µL of isopropanol containing 5 nmol internal standard palmitic acid-d4 (Sigma Aldrich) in 2 mL polypropylene tubes, vortexed for 5 s, and placed in a rotary shaker (30 min, 4°C, 700 rpm). The samples were then centrifuged (10 min, 15,000 rpm, 4°C) and 200 µL of supernatant was transferred to a new 2 mL tube. The solvent was evaporated in a vacuum centrifuge, and the samples were reconstituted in 100 µL of acetonitrile/water (1:1 v/v), transferred to an autosampler vial, and stored at −80°C. On the day of analysis, samples were thawed at room temperature for 30 min, vortexed for 5 s, sonicated for 1 min, and centrifuged for 5 min prior to LC/MS analysis.</p><p>Chromatographic separation of FFA was achieved by reverse phase liquid chromatography (RPLC) on a Waters Acquity CSH C18 150 × 2.1 mm column, in a Thermo Vanquish UHPLC system. The column temperature was 55°C, the autosampler was kept at 10°C, and 1 μL of sample was injected. Solvent A was acetonitrile/water (3:2 v/v), solvent B was acetonitrile/isopropanol (1:1 v/v), both solvent A and solvent B contained 10 mM ammonium acetate. Gradient elution started at 10% solvent B, which was held for 2 min, then increased linearly to 46% solvent B over 12 min, then to 100% solvent B over 3.5 min. The column was then flushed for 3 min with 100% solvent B and re-equilibrated under starting conditions for 3.5 min. The flow rate was 450 μL/min. The column effluent was introduced into a QExactive Plus quadrupole-orbitrap mass spectrometer via a HESI II ion source operating under the following conditions: spray voltage, 3 kV; capillary temperature, 350°C; sheath gas, 35 arbitrary units; aux gas, 10 arbitrary units; probe heater, 300°C; S-lens RF level, 50. Automatic gain control was set to 3E6 ions to enter the mass analyzer with a maximum ion time of 200 ms. Negative full scan profile spectra were acquired from 110 to 380 m/z at a resolution setting of 140,000 (FWHM at <italic>m/z</italic> 200). Data analysis was performed with Xcalibur Qual Browser, using the areas of extracted ion count chromatograms of deprotonated NEFAs with a mass tolerance of 5 ppm. Quantification was based on a one-point calibration with the internal standard palmitic acid d4.</p></sec><sec id="s4-8"><title>RNA isolation and quantitative real-time PCR (qPCR)</title><p>RNA was isolated from tissues using TRIzol reagent (Thermo Fisher Scientific) as per provided instructions, with an initial step of homogenizing the tissues in TRIzol reagent within a bead-containing Lysing Matrix D tube (MP Biomedicals) using the Precellys 24 homogeniser (Bertin Technologies). Complementary DNA (cDNA) was prepared from 2 μg of RNA with the Maxima First Strand cDNA Synthesis Kit (K1641, Thermo Fisher Scientific). qPCR was ran using the Maxima SYBR Green qPCR Master Mix (K0221, Thermo Fisher Scientific) with 10 ng of cDNA per reaction. Analysis was done with the 2<sup>-ΔΔCt</sup> method (<xref ref-type="bibr" rid="bib62">Livak and Schmittgen, 2001</xref>) using <italic>Eef2</italic> as loading control. Primers used are provided in <xref ref-type="supplementary-material" rid="supp9">Supplementary file 9</xref>.</p></sec><sec id="s4-9"><title>RNA sequencing (RNA-seq), data processing, and analysis</title><p>For RNA extraction, tissue was homogenized and lysed with TRIzol as described above. Upon phase separation, the aqueous phase was transferred to spin columns from the PureLink RNA Mini Kit (12183025, Thermo Fisher Scientific) and washed as instructed by the kit manual. DNase treatment (740963, Macherey-Nagel) was done on-column before eluting with nuclease-free water. Subsequent RNA fragmentation, library generation and sequencing were as described previously (<xref ref-type="bibr" rid="bib10">Caldez et al., 2018</xref>). For data analysis, sequence read alignment was done with STAR-mapper (<xref ref-type="bibr" rid="bib24">Dobin et al., 2013</xref>) and fragments per kilobase million (FPKM) quantification with RSEM (<xref ref-type="bibr" rid="bib60">Li and Dewey, 2011</xref>). FastQC was used to perform pre-alignment sequence read quality control, and upon inspection of the FPKM data, we decided not to do data normalization given the equal distribution of FPKM values across samples. A small fudge factor of 0.5 was added to all FPKM values to avoid artefacts associated with statistical analysis of extremely low abundance genes. Principal component analysis was performed using ClustVis (<xref ref-type="bibr" rid="bib71">Metsalu and Vilo, 2015</xref>). Differential expression analysis was performed by two sample T-tests and multiple testing corrected by calculating q-value (<xref ref-type="bibr" rid="bib109">Storey, 2002</xref>). Genes with q-value of &lt;0.05 and fold change of &gt;1.5 or &lt;0.66 were considered significantly differentially expressed. KEGG pathway and ChEA of these genes were then done using Enrichr (<xref ref-type="bibr" rid="bib51">Kuleshov et al., 2016</xref>). Raw sequencing data is available at NCBI GEO under accession number GSE159498 (<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE159498">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE159498</ext-link>).</p></sec><sec id="s4-10"><title>Untargeted metabolomics of whole liver</title><p>The semi-quantitative metabolomics data for 870 unique compounds has been published in <xref ref-type="bibr" rid="bib79">Narayanaswamy et al., 2020</xref>. We reprocessed the raw data with the latest version of MetaboKit software for improved accuracy in peak integration (August 2020). Metabolites with reliable quantification in at least three samples were used for analysis.</p></sec><sec id="s4-11"><title>Immunoprecipitation and immunoblotting</title><p>Proteins were extracted from tissues in RIPA buffer (50 mM Tris-HCl pH8.0, 50 mM NaCl, 1 mM EDTA, 1% NP-40, 0.1% sodium deoxycholate, supplemented with protease inhibitor) by homogenising in a pestle homogenizer, sonicated at high power for three cycles of 30 s ON/OFF on Bioruptor sonicator (Diagenode), and centrifuged at maximum speed for 10 min to remove cell debris. Proteins were then quantified using BCA Protein Assay (Thermo Fisher Scientific). Lysates were separated on polyacrylamide gels and transferred to PVDF membranes using the Bio-Rad Mini-Protean system. Probing and development of membrane were done as previously described (<xref ref-type="bibr" rid="bib10">Caldez et al., 2018</xref>). Antibodies used for immunoblotting are provided in the Key Resources Table. Quantification of blots was performed with Fiji software (<xref ref-type="bibr" rid="bib100">Schindelin et al., 2012</xref>). For detecting carbonylated proteins, 2,4-dinitrophenylhydrazine (DNP) derivation and the subsequent immunoblotting was performed using the Oxidized Protein Western Blot Detection Kit (ab178020, Abcam) following manufacturer’s instructions.</p><p>For immunoprecipitation, 500 μg of pre-cleared protein lysate was incubated with 2 μL of anti-SIRT3 (#5490, Cell Signaling) or anti-CPT2 (26555–1-AP, Proteintech) antibody overnight in IP buffer (50 mM Tris-HCl pH8.0, 150 mM NaCl, 0.15% NP-40, 10% glycerol) in the cold. Antibodies were captured with Protein A agarose beads (15918–014, Thermo Fisher Scientific) on rotation for 1 hr the following day, and washed with IP buffer thrice for 5 min each. Beads were then incubated with SDS loading dye for 5 min at 95°C with shaking before being loaded on a polyacrylamide gel for immunoblotting as described above.</p></sec><sec id="s4-12"><title>Chromatin immunoprecipitation</title><p>Isolated hepatocytes were fixed in 1% formalin in suspension for 10 min at room temperature and then quenched in 125 mM glycine. Cells were pelleted and washed twice with cold PBS, and subsequent steps of sonication and immunoprecipitation were performed as described (<xref ref-type="bibr" rid="bib105">Shang et al., 2002</xref>). Two µL of anti-FOXO1 (#2880, Cell Signaling) or anti-LXRα antibody (ab41902, Abcam) was used per ChIP sample. Primers used for ChIP-qPCR are listed in <xref ref-type="supplementary-material" rid="supp9">Supplementary file 9</xref>.</p></sec><sec id="s4-13"><title>Histology</title><p>H&amp;E staining and Oil Red O staining were performed as described (<xref ref-type="bibr" rid="bib80">Niska-Blakie et al., 2020</xref>), and senescence-associated β-galactosidase staining as previously published (<xref ref-type="bibr" rid="bib23">Diril et al., 2012</xref>). For Sirius Red staining, slides containing paraffin-embedded tissue were deparaffinized and rehydrated at room temperature. Slides were then incubated in Picro-Sirius Red solution (ab246832, Abcam) for 4 hr, washed in running water and dehydrated before being mounted with Eukitt Quick-hardening mounting medium (03989, Sigma-Aldrich). Images were taken using the Olympus BX-61 upright microscope with 20X air or 40X oil lens. Histopathological analysis of liver H and E and Sirius Red-stained sections was performed and scored by a qualified pathologist (C.B.O.) using a scale of 0–5 [0 – no abnormalities detected; 1 - minimal (&lt;1%); 2 – mild (1–25%); 3 – moderate (26–50%); 4 – marked (51–75%); 5 – severe (76–100%)] as described previously (<xref ref-type="bibr" rid="bib104">Shackelford et al., 2002</xref>). Quantification of Sirius-Red-positive areas was done using Fiji (<xref ref-type="bibr" rid="bib100">Schindelin et al., 2012</xref>). Measurement of adipocyte size was done with Adobe Photoshop CC 2018 using the Quick Selection tool to outline individual adipocytes followed by the Record Measurement function after the scale had been set.</p></sec><sec id="s4-14"><title>Statistical analysis</title><p>Statistical analyses were performed using Mann-Whitney non-parametric test, or unpaired two-tailed T-test with Welch’s correction for experiments involving isolated hepatocytes, immunoblot quantification and ChIP-qPCR, on GraphPad Prism version 6, and were considered significant when p-value&lt;0.05. Statistical significance was indicated as: p-value&lt;0.05 (*); p-value&lt;0.01 (**); p-value&lt;0.001 (***). Correlation analysis to derive Pearson’s correlation coefficient (r) and goodness-of-fit coefficient (R<sup>2</sup>) values was also performed using GraphPad Prism version 6.</p></sec></sec></body><back><ack id="ack"><title>Acknowledgements</title><p>We thank all present and past members of the Kaldis laboratory for discussions, input, and support. Special thanks go to Tan Qing Hui, Shiela Fransisco Margallo, Pangalingan Christie Chrisma Domingo, and Timothy Teck Chiew Chua for animal expertise. We acknowledge the Advanced Molecular Pathology Laboratory (AMPL) at the Institute of Cell and Molecular Biology (IMCB) for providing technical expertise support during histology processing.</p></ack><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Data curation, Formal analysis, Validation, Investigation, Visualization, Methodology, Writing - original draft, Writing - review and editing</p></fn><fn fn-type="con" id="con2"><p>Conceptualization, Data curation, Formal analysis, Validation, Investigation, Methodology, Writing - review and editing</p></fn><fn fn-type="con" id="con3"><p>Data curation, Investigation, Methodology</p></fn><fn fn-type="con" id="con4"><p>Data curation, Methodology</p></fn><fn fn-type="con" id="con5"><p>Data curation, Formal analysis, Investigation, Methodology</p></fn><fn fn-type="con" id="con6"><p>Software, Formal analysis, Validation, Methodology</p></fn><fn fn-type="con" id="con7"><p>Data curation, Formal analysis, Investigation, Methodology</p></fn><fn fn-type="con" id="con8"><p>Resources, Data curation, Formal analysis, Supervision, Methodology</p></fn><fn fn-type="con" id="con9"><p>Formal analysis, Visualization, Methodology</p></fn><fn fn-type="con" id="con10"><p>Resources, Supervision</p></fn><fn fn-type="con" id="con11"><p>Resources, Supervision</p></fn><fn fn-type="con" id="con12"><p>Resources, Software, Formal analysis, Supervision, Validation, Visualization, Methodology, Writing - review and editing</p></fn><fn fn-type="con" id="con13"><p>Conceptualization, Resources, Formal analysis, Supervision, Funding acquisition, Investigation, Writing - original draft, Project administration, Writing - review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: All animal experiments were performed in accordance to protocols (#171268) approved by the A*STAR Institutional Animal Care and Use Committee (IACUC) based on the National Advisory Committee for Laboratory Animal Research (NACLAR) Guidelines.</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>Lipidomics analysis of liver of 8-week-old control and <italic>Cdk1</italic> cKO mice.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-63835-supp1-v2.xlsx"/></supplementary-material><supplementary-material id="supp2"><label>Supplementary file 2.</label><caption><title>Lipidomics analysis of hepatocytes isolated from 8-week-old control and <italic>Cdk1</italic> cKO mice.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-63835-supp2-v2.xlsx"/></supplementary-material><supplementary-material id="supp3"><label>Supplementary file 3.</label><caption><title>Free fatty acid analysis of plasma from 8-week-old control and <italic>Cdk1</italic> cKO mice.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-63835-supp3-v2.xlsx"/></supplementary-material><supplementary-material id="supp4"><label>Supplementary file 4.</label><caption><title>Histopathological scoring of H and E liver sections from 12-month-old control and <italic>Cdk1</italic> cKO mice.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-63835-supp4-v2.xlsx"/></supplementary-material><supplementary-material id="supp5"><label>Supplementary file 5.</label><caption><title>Lipidomics analysis of liver of 12-month-old control and <italic>Cdk1</italic> cKO mice.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-63835-supp5-v2.xlsx"/></supplementary-material><supplementary-material id="supp6"><label>Supplementary file 6.</label><caption><title>List of total detected and differentially expressed genes from RNA-seq data from liver of 12-month-old control and <italic>Cdk1</italic> cKO mice.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-63835-supp6-v2.xlsx"/></supplementary-material><supplementary-material id="supp7"><label>Supplementary file 7.</label><caption><title>List of KEGG terms for up- and downregulated differentially expressed genes and list of transcription factors from ChIP enrichment analysis.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-63835-supp7-v2.xlsx"/></supplementary-material><supplementary-material id="supp8"><label>Supplementary file 8.</label><caption><title>MRM list for mass spectrometry lipidomics analysis.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-63835-supp8-v2.xlsx"/></supplementary-material><supplementary-material id="supp9"><label>Supplementary file 9.</label><caption><title>List of primers used for qPCR.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-63835-supp9-v2.xlsx"/></supplementary-material><supplementary-material id="supp10"><label>Supplementary file 10.</label><caption><title>Source data used for all figures.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-63835-supp10-v2.xlsx"/></supplementary-material><supplementary-material id="transrepform"><label>Transparent reporting form</label><media mime-subtype="docx" mimetype="application" xlink:href="elife-63835-transrepform-v2.docx"/></supplementary-material></sec><sec id="s7" sec-type="data-availability"><title>Data availability</title><p>Raw sequencing data is available at NCBI GEO under accession number GSE159498.</p><p>The following dataset was generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><name><surname>Ow</surname><given-names>J</given-names></name><name><surname>Caldez</surname><given-names>MJ</given-names></name><name><surname>Ghosh</surname><given-names>S</given-names></name><name><surname>Wollmann</surname><given-names>H</given-names></name><name><surname>Choi</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2020">2020</year><data-title>Remodelling of whole-body lipid metabolism and a diabetic-like phenotype caused by loss of hepatic CDK1 and hepatocyte division</data-title><source>NCBI Gene Expression Omnibus</source><pub-id assigning-authority="NCBI" pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE159498">GSE159498</pub-id></element-citation></p></sec><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alcendor</surname> <given-names>RR</given-names></name><name><surname>Gao</surname> <given-names>S</given-names></name><name><surname>Zhai</surname> <given-names>P</given-names></name><name><surname>Zablocki</surname> <given-names>D</given-names></name><name><surname>Holle</surname> <given-names>E</given-names></name><name><surname>Yu</surname> <given-names>X</given-names></name><name><surname>Tian</surname> <given-names>B</given-names></name><name><surname>Wagner</surname> <given-names>T</given-names></name><name><surname>Vatner</surname> <given-names>SF</given-names></name><name><surname>Sadoshima</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Sirt1 regulates aging and resistance to oxidative stress in the heart</article-title><source>Circulation Research</source><volume>100</volume><fpage>1512</fpage><lpage>1521</lpage><pub-id pub-id-type="doi">10.1161/01.RES.0000267723.65696.4a</pub-id><pub-id pub-id-type="pmid">17446436</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anastasiou</surname> <given-names>D</given-names></name><name><surname>Poulogiannis</surname> <given-names>G</given-names></name><name><surname>Asara</surname> <given-names>JM</given-names></name><name><surname>Boxer</surname> <given-names>MB</given-names></name><name><surname>Jiang</surname> <given-names>JK</given-names></name><name><surname>Shen</surname> <given-names>M</given-names></name><name><surname>Bellinger</surname> <given-names>G</given-names></name><name><surname>Sasaki</surname> <given-names>AT</given-names></name><name><surname>Locasale</surname> <given-names>JW</given-names></name><name><surname>Auld</surname> <given-names>DS</given-names></name><name><surname>Thomas</surname> <given-names>CJ</given-names></name><name><surname>Vander Heiden</surname> <given-names>MG</given-names></name><name><surname>Cantley</surname> <given-names>LC</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Inhibition of pyruvate kinase M2 by reactive oxygen species contributes to cellular antioxidant responses</article-title><source>Science</source><volume>334</volume><fpage>1278</fpage><lpage>1283</lpage><pub-id pub-id-type="doi">10.1126/science.1211485</pub-id><pub-id pub-id-type="pmid">22052977</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aravinthan</surname> <given-names>A</given-names></name><name><surname>Scarpini</surname> <given-names>C</given-names></name><name><surname>Tachtatzis</surname> <given-names>P</given-names></name><name><surname>Verma</surname> <given-names>S</given-names></name><name><surname>Penrhyn-Lowe</surname> <given-names>S</given-names></name><name><surname>Harvey</surname> <given-names>R</given-names></name><name><surname>Davies</surname> <given-names>SE</given-names></name><name><surname>Allison</surname> <given-names>M</given-names></name><name><surname>Coleman</surname> <given-names>N</given-names></name><name><surname>Alexander</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2013">2013a</year><article-title>Hepatocyte senescence predicts progression in non-alcohol-related fatty liver disease</article-title><source>Journal of Hepatology</source><volume>58</volume><fpage>549</fpage><lpage>556</lpage><pub-id pub-id-type="doi">10.1016/j.jhep.2012.10.031</pub-id><pub-id pub-id-type="pmid">23142622</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aravinthan</surname> <given-names>A</given-names></name><name><surname>Pietrosi</surname> <given-names>G</given-names></name><name><surname>Hoare</surname> <given-names>M</given-names></name><name><surname>Jupp</surname> <given-names>J</given-names></name><name><surname>Marshall</surname> <given-names>A</given-names></name><name><surname>Verrill</surname> <given-names>C</given-names></name><name><surname>Davies</surname> <given-names>S</given-names></name><name><surname>Bateman</surname> <given-names>A</given-names></name><name><surname>Sheron</surname> <given-names>N</given-names></name><name><surname>Allison</surname> <given-names>M</given-names></name><name><surname>Alexander</surname> <given-names>GJ</given-names></name></person-group><year iso-8601-date="2013">2013b</year><article-title>Hepatocyte expression of the senescence marker p21 is linked to fibrosis and an adverse liver-related outcome in alcohol-related liver disease</article-title><source>PLOS ONE</source><volume>8</volume><elocation-id>e72904</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0072904</pub-id><pub-id pub-id-type="pmid">24086266</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Babicki</surname> <given-names>S</given-names></name><name><surname>Arndt</surname> <given-names>D</given-names></name><name><surname>Marcu</surname> <given-names>A</given-names></name><name><surname>Liang</surname> <given-names>Y</given-names></name><name><surname>Grant</surname> <given-names>JR</given-names></name><name><surname>Maciejewski</surname> <given-names>A</given-names></name><name><surname>Wishart</surname> <given-names>DS</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Heatmapper: web-enabled heat mapping for all</article-title><source>Nucleic Acids Research</source><volume>44</volume><fpage>W147</fpage><lpage>W153</lpage><pub-id pub-id-type="doi">10.1093/nar/gkw419</pub-id><pub-id pub-id-type="pmid">27190236</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bachmanov</surname> <given-names>AA</given-names></name><name><surname>Reed</surname> <given-names>DR</given-names></name><name><surname>Beauchamp</surname> <given-names>GK</given-names></name><name><surname>Tordoff</surname> <given-names>MG</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Food intake, water intake, and drinking spout side preference of 28 mouse strains</article-title><source>Behavior Genetics</source><volume>32</volume><fpage>435</fpage><lpage>443</lpage><pub-id pub-id-type="doi">10.1023/A:1020884312053</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Becher</surname> <given-names>I</given-names></name><name><surname>Andrés-Pons</surname> <given-names>A</given-names></name><name><surname>Romanov</surname> <given-names>N</given-names></name><name><surname>Stein</surname> <given-names>F</given-names></name><name><surname>Schramm</surname> <given-names>M</given-names></name><name><surname>Baudin</surname> <given-names>F</given-names></name><name><surname>Helm</surname> <given-names>D</given-names></name><name><surname>Kurzawa</surname> <given-names>N</given-names></name><name><surname>Mateus</surname> <given-names>A</given-names></name><name><surname>Mackmull</surname> <given-names>MT</given-names></name><name><surname>Typas</surname> <given-names>A</given-names></name><name><surname>Müller</surname> <given-names>CW</given-names></name><name><surname>Bork</surname> <given-names>P</given-names></name><name><surname>Beck</surname> <given-names>M</given-names></name><name><surname>Savitski</surname> <given-names>MM</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Pervasive protein thermal stability variation during the cell cycle</article-title><source>Cell</source><volume>173</volume><fpage>1495</fpage><lpage>1507</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2018.03.053</pub-id><pub-id pub-id-type="pmid">29706546</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benoit</surname> <given-names>RM</given-names></name><name><surname>Meisner</surname> <given-names>NC</given-names></name><name><surname>Kallen</surname> <given-names>J</given-names></name><name><surname>Graff</surname> <given-names>P</given-names></name><name><surname>Hemmig</surname> <given-names>R</given-names></name><name><surname>Cèbe</surname> <given-names>R</given-names></name><name><surname>Ostermeier</surname> <given-names>C</given-names></name><name><surname>Widmer</surname> <given-names>H</given-names></name><name><surname>Auer</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>The x-ray crystal structure of the first RNA recognition motif and site-directed mutagenesis suggest a possible HuR redox sensing mechanism</article-title><source>Journal of Molecular Biology</source><volume>397</volume><fpage>1231</fpage><lpage>1244</lpage><pub-id pub-id-type="doi">10.1016/j.jmb.2010.02.043</pub-id><pub-id pub-id-type="pmid">20219472</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bragoszewski</surname> <given-names>P</given-names></name><name><surname>Gornicka</surname> <given-names>A</given-names></name><name><surname>Sztolsztener</surname> <given-names>ME</given-names></name><name><surname>Chacinska</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>The ubiquitin-proteasome system regulates mitochondrial intermembrane space proteins</article-title><source>Molecular and Cellular Biology</source><volume>33</volume><fpage>2136</fpage><lpage>2148</lpage><pub-id pub-id-type="doi">10.1128/MCB.01579-12</pub-id><pub-id pub-id-type="pmid">23508107</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Caldez</surname> <given-names>MJ</given-names></name><name><surname>Van Hul</surname> <given-names>N</given-names></name><name><surname>Koh</surname> <given-names>HWL</given-names></name><name><surname>Teo</surname> <given-names>XQ</given-names></name><name><surname>Fan</surname> <given-names>JJ</given-names></name><name><surname>Tan</surname> <given-names>PY</given-names></name><name><surname>Dewhurst</surname> <given-names>MR</given-names></name><name><surname>Too</surname> <given-names>PG</given-names></name><name><surname>Talib</surname> <given-names>SZA</given-names></name><name><surname>Chiang</surname> <given-names>BE</given-names></name><name><surname>Stünkel</surname> <given-names>W</given-names></name><name><surname>Yu</surname> <given-names>H</given-names></name><name><surname>Lee</surname> <given-names>P</given-names></name><name><surname>Fuhrer</surname> <given-names>T</given-names></name><name><surname>Choi</surname> <given-names>H</given-names></name><name><surname>Björklund</surname> <given-names>M</given-names></name><name><surname>Kaldis</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Metabolic remodeling during liver regeneration</article-title><source>Developmental Cell</source><volume>47</volume><fpage>425</fpage><lpage>438</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2018.09.020</pub-id><pub-id pub-id-type="pmid">30344111</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Catalano</surname> <given-names>KJ</given-names></name><name><surname>Maddux</surname> <given-names>BA</given-names></name><name><surname>Szary</surname> <given-names>J</given-names></name><name><surname>Youngren</surname> <given-names>JF</given-names></name><name><surname>Goldfine</surname> <given-names>ID</given-names></name><name><surname>Schaufele</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Insulin resistance induced by hyperinsulinemia coincides with a persistent alteration at the insulin receptor tyrosine kinase domain</article-title><source>PLOS ONE</source><volume>9</volume><elocation-id>e108693</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0108693</pub-id><pub-id pub-id-type="pmid">25259572</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cen</surname> <given-names>J</given-names></name><name><surname>Sargsyan</surname> <given-names>E</given-names></name><name><surname>Bergsten</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Fatty acids stimulate insulin secretion from human pancreatic islets at fasting glucose concentrations via mitochondria-dependent and -independent mechanisms</article-title><source>Nutrition &amp; Metabolism</source><volume>13</volume><elocation-id>59</elocation-id><pub-id pub-id-type="doi">10.1186/s12986-016-0119-5</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chakrabarti</surname> <given-names>P</given-names></name><name><surname>English</surname> <given-names>T</given-names></name><name><surname>Karki</surname> <given-names>S</given-names></name><name><surname>Qiang</surname> <given-names>L</given-names></name><name><surname>Tao</surname> <given-names>R</given-names></name><name><surname>Kim</surname> <given-names>J</given-names></name><name><surname>Luo</surname> <given-names>Z</given-names></name><name><surname>Farmer</surname> <given-names>SR</given-names></name><name><surname>Kandror</surname> <given-names>KV</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>SIRT1 controls lipolysis in adipocytes via FOXO1-mediated expression of ATGL</article-title><source>Journal of Lipid Research</source><volume>52</volume><fpage>1693</fpage><lpage>1701</lpage><pub-id pub-id-type="doi">10.1194/jlr.M014647</pub-id><pub-id pub-id-type="pmid">21743036</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chakrabarti</surname> <given-names>P</given-names></name><name><surname>Kandror</surname> <given-names>KV</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>FoxO1 controls Insulin-dependent adipose triglyceride lipase (ATGL) Expression and lipolysis in adipocytes</article-title><source>Journal of Biological Chemistry</source><volume>284</volume><fpage>13296</fpage><lpage>13300</lpage><pub-id pub-id-type="doi">10.1074/jbc.C800241200</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chambers</surname> <given-names>I</given-names></name><name><surname>Tomlinson</surname> <given-names>SR</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>The transcriptional foundation of pluripotency</article-title><source>Development</source><volume>136</volume><fpage>2311</fpage><lpage>2322</lpage><pub-id pub-id-type="doi">10.1242/dev.024398</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname> <given-names>SH</given-names></name><name><surname>Ginsberg</surname> <given-names>HN</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Increased very low density lipoprotein (VLDL) secretion, hepatic steatosis, and insulin resistance</article-title><source>Trends in Endocrinology &amp; Metabolism</source><volume>22</volume><fpage>353</fpage><lpage>363</lpage><pub-id pub-id-type="doi">10.1016/j.tem.2011.04.007</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Christinat</surname> <given-names>N</given-names></name><name><surname>Morin-Rivron</surname> <given-names>D</given-names></name><name><surname>Masoodi</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>High-Throughput quantitative lipidomics analysis of nonesterified fatty acids in human plasma</article-title><source>Journal of Proteome Research</source><volume>15</volume><fpage>2228</fpage><lpage>2235</lpage><pub-id pub-id-type="doi">10.1021/acs.jproteome.6b00198</pub-id><pub-id pub-id-type="pmid">27185515</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chu</surname> <given-names>K</given-names></name><name><surname>Miyazaki</surname> <given-names>M</given-names></name><name><surname>Man</surname> <given-names>WC</given-names></name><name><surname>Ntambi</surname> <given-names>JM</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Stearoyl-coenzyme A desaturase 1 deficiency protects against hypertriglyceridemia and increases plasma high-density lipoprotein cholesterol induced by liver X receptor activation</article-title><source>Molecular and Cellular Biology</source><volume>26</volume><fpage>6786</fpage><lpage>6798</lpage><pub-id pub-id-type="doi">10.1128/MCB.00077-06</pub-id><pub-id pub-id-type="pmid">16943421</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Combs</surname> <given-names>TP</given-names></name><name><surname>Berg</surname> <given-names>AH</given-names></name><name><surname>Obici</surname> <given-names>S</given-names></name><name><surname>Scherer</surname> <given-names>PE</given-names></name><name><surname>Rossetti</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Endogenous glucose production is inhibited by the adipose-derived protein Acrp30</article-title><source>Journal of Clinical Investigation</source><volume>108</volume><fpage>1875</fpage><lpage>1881</lpage><pub-id pub-id-type="doi">10.1172/JCI14120</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cui</surname> <given-names>Y</given-names></name><name><surname>Qiao</surname> <given-names>A</given-names></name><name><surname>Jiao</surname> <given-names>T</given-names></name><name><surname>Zhang</surname> <given-names>H</given-names></name><name><surname>Xue</surname> <given-names>Y</given-names></name><name><surname>Zou</surname> <given-names>Y</given-names></name><name><surname>Cui</surname> <given-names>A</given-names></name><name><surname>Fang</surname> <given-names>F</given-names></name><name><surname>Chang</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The hepatic FOXQ1 transcription factor regulates glucose metabolism in mice</article-title><source>Diabetologia</source><volume>59</volume><fpage>2229</fpage><lpage>2239</lpage><pub-id pub-id-type="doi">10.1007/s00125-016-4043-z</pub-id><pub-id pub-id-type="pmid">27421728</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dalle-Donne</surname> <given-names>I</given-names></name><name><surname>Giustarini</surname> <given-names>D</given-names></name><name><surname>Colombo</surname> <given-names>R</given-names></name><name><surname>Rossi</surname> <given-names>R</given-names></name><name><surname>Milzani</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Protein carbonylation in human diseases</article-title><source>Trends in Molecular Medicine</source><volume>9</volume><fpage>169</fpage><lpage>176</lpage><pub-id pub-id-type="doi">10.1016/S1471-4914(03)00031-5</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dewhurst</surname> <given-names>MR</given-names></name><name><surname>Ow</surname> <given-names>JR</given-names></name><name><surname>Zafer</surname> <given-names>G</given-names></name><name><surname>van Hul</surname> <given-names>NKM</given-names></name><name><surname>Wollmann</surname> <given-names>H</given-names></name><name><surname>Bisteau</surname> <given-names>X</given-names></name><name><surname>Brough</surname> <given-names>D</given-names></name><name><surname>Choi</surname> <given-names>H</given-names></name><name><surname>Kaldis</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Loss of hepatocyte cell division leads to liver inflammation and fibrosis</article-title><source>PLOS Genetics</source><volume>16</volume><elocation-id>e1009084</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1009084</pub-id><pub-id pub-id-type="pmid">33147210</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Diril</surname> <given-names>MK</given-names></name><name><surname>Ratnacaram</surname> <given-names>CK</given-names></name><name><surname>Padmakumar</surname> <given-names>VC</given-names></name><name><surname>Du</surname> <given-names>T</given-names></name><name><surname>Wasser</surname> <given-names>M</given-names></name><name><surname>Coppola</surname> <given-names>V</given-names></name><name><surname>Tessarollo</surname> <given-names>L</given-names></name><name><surname>Kaldis</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Cyclin-dependent kinase 1 (Cdk1) is essential for cell division and suppression of DNA re-replication but not for liver regeneration</article-title><source>PNAS</source><volume>109</volume><fpage>3826</fpage><lpage>3831</lpage><pub-id pub-id-type="doi">10.1073/pnas.1115201109</pub-id><pub-id pub-id-type="pmid">22355113</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dobin</surname> <given-names>A</given-names></name><name><surname>Davis</surname> <given-names>CA</given-names></name><name><surname>Schlesinger</surname> <given-names>F</given-names></name><name><surname>Drenkow</surname> <given-names>J</given-names></name><name><surname>Zaleski</surname> <given-names>C</given-names></name><name><surname>Jha</surname> <given-names>S</given-names></name><name><surname>Batut</surname> <given-names>P</given-names></name><name><surname>Chaisson</surname> <given-names>M</given-names></name><name><surname>Gingeras</surname> <given-names>TR</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>STAR: ultrafast universal RNA-seq aligner</article-title><source>Bioinformatics</source><volume>29</volume><fpage>15</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/bts635</pub-id><pub-id pub-id-type="pmid">23104886</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Farrell</surname> <given-names>GC</given-names></name><name><surname>Larter</surname> <given-names>CZ</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Nonalcoholic fatty liver disease: From steatosis to cirrhosis</article-title><source>Hepatology</source><volume>43</volume><fpage>S99</fpage><lpage>S112</lpage><pub-id pub-id-type="doi">10.1002/hep.20973</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferreira-Gonzalez</surname> <given-names>S</given-names></name><name><surname>Lu</surname> <given-names>WY</given-names></name><name><surname>Raven</surname> <given-names>A</given-names></name><name><surname>Dwyer</surname> <given-names>B</given-names></name><name><surname>Man</surname> <given-names>TY</given-names></name><name><surname>O'Duibhir</surname> <given-names>E</given-names></name><name><surname>Lewis</surname> <given-names>PJS</given-names></name><name><surname>Campana</surname> <given-names>L</given-names></name><name><surname>Kendall</surname> <given-names>TJ</given-names></name><name><surname>Bird</surname> <given-names>TG</given-names></name><name><surname>Tarrats</surname> <given-names>N</given-names></name><name><surname>Acosta</surname> <given-names>JC</given-names></name><name><surname>Boulter</surname> <given-names>L</given-names></name><name><surname>Forbes</surname> <given-names>SJ</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Paracrine cellular senescence exacerbates biliary injury and impairs regeneration</article-title><source>Nature Communications</source><volume>9</volume><elocation-id>1020</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-018-03299-5</pub-id><pub-id pub-id-type="pmid">29523787</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frescas</surname> <given-names>D</given-names></name><name><surname>Valenti</surname> <given-names>L</given-names></name><name><surname>Accili</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Nuclear trapping of the forkhead transcription factor FoxO1 via Sirt-dependent deacetylation promotes expression of glucogenetic genes</article-title><source>Journal of Biological Chemistry</source><volume>280</volume><fpage>20589</fpage><lpage>20595</lpage><pub-id pub-id-type="doi">10.1074/jbc.M412357200</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garcia-Roves</surname> <given-names>P</given-names></name><name><surname>Huss</surname> <given-names>JM</given-names></name><name><surname>Han</surname> <given-names>DH</given-names></name><name><surname>Hancock</surname> <given-names>CR</given-names></name><name><surname>Iglesias-Gutierrez</surname> <given-names>E</given-names></name><name><surname>Chen</surname> <given-names>M</given-names></name><name><surname>Holloszy</surname> <given-names>JO</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Raising plasma fatty acid concentration induces increased biogenesis of mitochondria in skeletal muscle</article-title><source>PNAS</source><volume>104</volume><fpage>10709</fpage><lpage>10713</lpage><pub-id pub-id-type="doi">10.1073/pnas.0704024104</pub-id><pub-id pub-id-type="pmid">17548828</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gentric</surname> <given-names>G</given-names></name><name><surname>Maillet</surname> <given-names>V</given-names></name><name><surname>Paradis</surname> <given-names>V</given-names></name><name><surname>Couton</surname> <given-names>D</given-names></name><name><surname>L’Hermitte</surname> <given-names>A</given-names></name><name><surname>Panasyuk</surname> <given-names>G</given-names></name><name><surname>Fromenty</surname> <given-names>B</given-names></name><name><surname>Celton-Morizur</surname> <given-names>S</given-names></name><name><surname>Desdouets</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Oxidative stress promotes pathologic polyploidization in nonalcoholic fatty liver disease</article-title><source>Journal of Clinical Investigation</source><volume>125</volume><fpage>981</fpage><lpage>992</lpage><pub-id pub-id-type="doi">10.1172/JCI73957</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grabacka</surname> <given-names>M</given-names></name><name><surname>Pierzchalska</surname> <given-names>M</given-names></name><name><surname>Dean</surname> <given-names>M</given-names></name><name><surname>Reiss</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Regulation of ketone body metabolism and the role of PPARα</article-title><source>International Journal of Molecular Sciences</source><volume>17</volume><elocation-id>2093</elocation-id><pub-id pub-id-type="doi">10.3390/ijms17122093</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Habelhah</surname> <given-names>H</given-names></name><name><surname>Laine</surname> <given-names>A</given-names></name><name><surname>Erdjument-Bromage</surname> <given-names>H</given-names></name><name><surname>Tempst</surname> <given-names>P</given-names></name><name><surname>Gershwin</surname> <given-names>ME</given-names></name><name><surname>Bowtell</surname> <given-names>DDL</given-names></name><name><surname>Ronai</surname> <given-names>Z</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Regulation of 2-Oxoglutarate (α-Ketoglutarate) Dehydrogenase stability by the RING finger ubiquitin ligase siah</article-title><source>Journal of Biological Chemistry</source><volume>279</volume><fpage>53782</fpage><lpage>53788</lpage><pub-id pub-id-type="doi">10.1074/jbc.M410315200</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Han</surname> <given-names>MS</given-names></name><name><surname>Park</surname> <given-names>SY</given-names></name><name><surname>Shinzawa</surname> <given-names>K</given-names></name><name><surname>Kim</surname> <given-names>S</given-names></name><name><surname>Chung</surname> <given-names>KW</given-names></name><name><surname>Lee</surname> <given-names>JH</given-names></name><name><surname>Kwon</surname> <given-names>CH</given-names></name><name><surname>Lee</surname> <given-names>KW</given-names></name><name><surname>Lee</surname> <given-names>JH</given-names></name><name><surname>Park</surname> <given-names>CK</given-names></name><name><surname>Chung</surname> <given-names>WJ</given-names></name><name><surname>Hwang</surname> <given-names>JS</given-names></name><name><surname>Yan</surname> <given-names>JJ</given-names></name><name><surname>Song</surname> <given-names>DK</given-names></name><name><surname>Tsujimoto</surname> <given-names>Y</given-names></name><name><surname>Lee</surname> <given-names>MS</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Lysophosphatidylcholine as a death effector in the lipoapoptosis of hepatocytes</article-title><source>Journal of Lipid Research</source><volume>49</volume><fpage>84</fpage><lpage>97</lpage><pub-id pub-id-type="doi">10.1194/jlr.M700184-JLR200</pub-id><pub-id pub-id-type="pmid">17951222</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harbauer</surname> <given-names>AB</given-names></name><name><surname>Opalińska</surname> <given-names>M</given-names></name><name><surname>Gerbeth</surname> <given-names>C</given-names></name><name><surname>Herman</surname> <given-names>JS</given-names></name><name><surname>Rao</surname> <given-names>S</given-names></name><name><surname>Schönfisch</surname> <given-names>B</given-names></name><name><surname>Guiard</surname> <given-names>B</given-names></name><name><surname>Schmidt</surname> <given-names>O</given-names></name><name><surname>Pfanner</surname> <given-names>N</given-names></name><name><surname>Meisinger</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Mitochondria cell cycle-dependent regulation of mitochondrial preprotein translocase</article-title><source>Science</source><volume>346</volume><fpage>1109</fpage><lpage>1113</lpage><pub-id pub-id-type="doi">10.1126/science.1261253</pub-id><pub-id pub-id-type="pmid">25378463</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hennig</surname> <given-names>EE</given-names></name><name><surname>Mikula</surname> <given-names>M</given-names></name><name><surname>Goryca</surname> <given-names>K</given-names></name><name><surname>Paziewska</surname> <given-names>A</given-names></name><name><surname>Ledwon</surname> <given-names>J</given-names></name><name><surname>Nesteruk</surname> <given-names>M</given-names></name><name><surname>Woszczynski</surname> <given-names>M</given-names></name><name><surname>Walewska-Zielecka</surname> <given-names>B</given-names></name><name><surname>Pysniak</surname> <given-names>K</given-names></name><name><surname>Ostrowski</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Extracellular matrix and cytochrome P450 gene expression can distinguish steatohepatitis from steatosis in mice</article-title><source>Journal of Cellular and Molecular Medicine</source><volume>18</volume><fpage>1762</fpage><lpage>1772</lpage><pub-id pub-id-type="doi">10.1111/jcmm.12328</pub-id><pub-id pub-id-type="pmid">24913135</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Herbig</surname> <given-names>U</given-names></name><name><surname>Wei</surname> <given-names>W</given-names></name><name><surname>Dutriaux</surname> <given-names>A</given-names></name><name><surname>Jobling</surname> <given-names>WA</given-names></name><name><surname>Sedivy</surname> <given-names>JM</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Real-time imaging of transcriptional activation in live cells reveals rapid up-regulation of the cyclin-dependent kinase inhibitor gene CDKN1A in replicative cellular senescence</article-title><source>Aging Cell</source><volume>2</volume><fpage>295</fpage><lpage>304</lpage><pub-id pub-id-type="doi">10.1046/j.1474-9728.2003.00067.x</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hou</surname> <given-names>C</given-names></name><name><surname>Feng</surname> <given-names>W</given-names></name><name><surname>Wei</surname> <given-names>S</given-names></name><name><surname>Wang</surname> <given-names>Y</given-names></name><name><surname>Xu</surname> <given-names>X</given-names></name><name><surname>Wei</surname> <given-names>J</given-names></name><name><surname>Ma</surname> <given-names>Z</given-names></name><name><surname>Du</surname> <given-names>Y</given-names></name><name><surname>Guo</surname> <given-names>J</given-names></name><name><surname>He</surname> <given-names>Y</given-names></name><name><surname>Kong</surname> <given-names>F</given-names></name><name><surname>Tang</surname> <given-names>R</given-names></name><name><surname>Zheng</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Bioinformatics analysis of key differentially expressed genes in nonalcoholic fatty liver disease mice models</article-title><source>Gene Expression</source><volume>19</volume><fpage>25</fpage><lpage>35</lpage><pub-id pub-id-type="doi">10.3727/105221618X15341831737687</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Houten</surname> <given-names>SM</given-names></name><name><surname>Violante</surname> <given-names>S</given-names></name><name><surname>Ventura</surname> <given-names>FV</given-names></name><name><surname>Wanders</surname> <given-names>RJ</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The biochemistry and physiology of mitochondrial fatty acid β-Oxidation and its genetic disorders</article-title><source>Annual Review of Physiology</source><volume>78</volume><fpage>23</fpage><lpage>44</lpage><pub-id pub-id-type="doi">10.1146/annurev-physiol-021115-105045</pub-id><pub-id pub-id-type="pmid">26474213</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname> <given-names>S</given-names></name><name><surname>Sun</surname> <given-names>C</given-names></name><name><surname>Hou</surname> <given-names>Y</given-names></name><name><surname>Tang</surname> <given-names>Y</given-names></name><name><surname>Zhu</surname> <given-names>Z</given-names></name><name><surname>Zhang</surname> <given-names>Z</given-names></name><name><surname>Zhang</surname> <given-names>Y</given-names></name><name><surname>Wang</surname> <given-names>L</given-names></name><name><surname>Zhao</surname> <given-names>Q</given-names></name><name><surname>Chen</surname> <given-names>MG</given-names></name><name><surname>Guo</surname> <given-names>Z</given-names></name><name><surname>Wang</surname> <given-names>D</given-names></name><name><surname>Ju</surname> <given-names>W</given-names></name><name><surname>Zhou</surname> <given-names>Q</given-names></name><name><surname>Wu</surname> <given-names>L</given-names></name><name><surname>He</surname> <given-names>X</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>A comprehensive bioinformatics analysis on multiple gene expression omnibus datasets of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis</article-title><source>Scientific Reports</source><volume>8</volume><elocation-id>7630</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-018-25658-4</pub-id><pub-id pub-id-type="pmid">29769552</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ieronymaki</surname> <given-names>E</given-names></name><name><surname>Theodorakis</surname> <given-names>EM</given-names></name><name><surname>Lyroni</surname> <given-names>K</given-names></name><name><surname>Vergadi</surname> <given-names>E</given-names></name><name><surname>Lagoudaki</surname> <given-names>E</given-names></name><name><surname>Al-Qahtani</surname> <given-names>A</given-names></name><name><surname>Aznaourova</surname> <given-names>M</given-names></name><name><surname>Neofotistou-Themeli</surname> <given-names>E</given-names></name><name><surname>Eliopoulos</surname> <given-names>AG</given-names></name><name><surname>Vaporidi</surname> <given-names>K</given-names></name><name><surname>Tsatsanis</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Insulin resistance in macrophages alters their metabolism and promotes an M2-Like phenotype</article-title><source>The Journal of Immunology</source><volume>202</volume><fpage>1786</fpage><lpage>1797</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1800065</pub-id><pub-id pub-id-type="pmid">30718296</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Itoh</surname> <given-names>Y</given-names></name><name><surname>Kawamata</surname> <given-names>Y</given-names></name><name><surname>Harada</surname> <given-names>M</given-names></name><name><surname>Kobayashi</surname> <given-names>M</given-names></name><name><surname>Fujii</surname> <given-names>R</given-names></name><name><surname>Fukusumi</surname> <given-names>S</given-names></name><name><surname>Ogi</surname> <given-names>K</given-names></name><name><surname>Hosoya</surname> <given-names>M</given-names></name><name><surname>Tanaka</surname> <given-names>Y</given-names></name><name><surname>Uejima</surname> <given-names>H</given-names></name><name><surname>Tanaka</surname> <given-names>H</given-names></name><name><surname>Maruyama</surname> <given-names>M</given-names></name><name><surname>Satoh</surname> <given-names>R</given-names></name><name><surname>Okubo</surname> <given-names>S</given-names></name><name><surname>Kizawa</surname> <given-names>H</given-names></name><name><surname>Komatsu</surname> <given-names>H</given-names></name><name><surname>Matsumura</surname> <given-names>F</given-names></name><name><surname>Noguchi</surname> <given-names>Y</given-names></name><name><surname>Shinohara</surname> <given-names>T</given-names></name><name><surname>Hinuma</surname> <given-names>S</given-names></name><name><surname>Fujisawa</surname> <given-names>Y</given-names></name><name><surname>Fujino</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Free fatty acids regulate insulin secretion from pancreatic beta cells through GPR40</article-title><source>Nature</source><volume>422</volume><fpage>173</fpage><lpage>176</lpage><pub-id pub-id-type="doi">10.1038/nature01478</pub-id><pub-id pub-id-type="pmid">12629551</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Itzhaki</surname> <given-names>JE</given-names></name><name><surname>Gilbert</surname> <given-names>CS</given-names></name><name><surname>Porter</surname> <given-names>ACG</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Construction by gene targeting in human cells of a ‘conditional’ CDC2 mutant that rereplicates its DNA</article-title><source>Nature Genetics</source><volume>15</volume><fpage>258</fpage><lpage>265</lpage><pub-id pub-id-type="doi">10.1038/ng0397-258</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jensen</surname> <given-names>T</given-names></name><name><surname>Niwa</surname> <given-names>K</given-names></name><name><surname>Hisatome</surname> <given-names>I</given-names></name><name><surname>Kanbay</surname> <given-names>M</given-names></name><name><surname>Andres-Hernando</surname> <given-names>A</given-names></name><name><surname>Roncal-Jimenez</surname> <given-names>CA</given-names></name><name><surname>Sato</surname> <given-names>Y</given-names></name><name><surname>Garcia</surname> <given-names>G</given-names></name><name><surname>Ohno</surname> <given-names>M</given-names></name><name><surname>Lanaspa</surname> <given-names>MA</given-names></name><name><surname>Johnson</surname> <given-names>RJ</given-names></name><name><surname>Kuwabara</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Increased serum uric acid over five years is a risk factor for developing fatty liver</article-title><source>Scientific Reports</source><volume>8</volume><elocation-id>11735</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-018-30267-2</pub-id><pub-id pub-id-type="pmid">30082907</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname> <given-names>Y</given-names></name><name><surname>Lu</surname> <given-names>L</given-names></name><name><surname>Hu</surname> <given-names>Y</given-names></name><name><surname>Li</surname> <given-names>Q</given-names></name><name><surname>An</surname> <given-names>C</given-names></name><name><surname>Yu</surname> <given-names>X</given-names></name><name><surname>Shu</surname> <given-names>L</given-names></name><name><surname>Chen</surname> <given-names>A</given-names></name><name><surname>Niu</surname> <given-names>C</given-names></name><name><surname>Zhou</surname> <given-names>L</given-names></name><name><surname>Yang</surname> <given-names>Z</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Resistin induces hypertension and insulin resistance in mice via a TLR4-Dependent pathway</article-title><source>Scientific Reports</source><volume>6</volume><elocation-id>22193</elocation-id><pub-id pub-id-type="doi">10.1038/srep22193</pub-id><pub-id pub-id-type="pmid">26917360</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname> <given-names>ZG</given-names></name><name><surname>Sandhu</surname> <given-names>B</given-names></name><name><surname>Feldbrügge</surname> <given-names>L</given-names></name><name><surname>Yee</surname> <given-names>EU</given-names></name><name><surname>Csizmadia</surname> <given-names>E</given-names></name><name><surname>Mitsuhashi</surname> <given-names>S</given-names></name><name><surname>Huang</surname> <given-names>J</given-names></name><name><surname>Afdhal</surname> <given-names>NH</given-names></name><name><surname>Robson</surname> <given-names>SC</given-names></name><name><surname>Lai</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Serum activity of Macrophage-Derived adenosine deaminase 2 is associated with liver fibrosis in nonalcoholic fatty liver disease</article-title><source>Clinical Gastroenterology and Hepatology</source><volume>16</volume><fpage>1170</fpage><lpage>1172</lpage><pub-id pub-id-type="doi">10.1016/j.cgh.2017.11.028</pub-id><pub-id pub-id-type="pmid">29170098</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kadowaki</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome</article-title><source>Journal of Clinical Investigation</source><volume>116</volume><fpage>1784</fpage><lpage>1792</lpage><pub-id pub-id-type="doi">10.1172/JCI29126</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kelley</surname> <given-names>EE</given-names></name><name><surname>Khoo</surname> <given-names>NK</given-names></name><name><surname>Hundley</surname> <given-names>NJ</given-names></name><name><surname>Malik</surname> <given-names>UZ</given-names></name><name><surname>Freeman</surname> <given-names>BA</given-names></name><name><surname>Tarpey</surname> <given-names>MM</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Hydrogen peroxide is the major oxidant product of xanthine oxidase</article-title><source>Free Radical Biology and Medicine</source><volume>48</volume><fpage>493</fpage><lpage>498</lpage><pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2009.11.012</pub-id><pub-id pub-id-type="pmid">19941951</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kitada</surname> <given-names>T</given-names></name><name><surname>Seki</surname> <given-names>S</given-names></name><name><surname>Kawakita</surname> <given-names>N</given-names></name><name><surname>Kuroki</surname> <given-names>T</given-names></name><name><surname>Monna</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>Telomere shortening in chronic liver diseases</article-title><source>Biochemical and Biophysical Research Communications</source><volume>211</volume><fpage>33</fpage><lpage>39</lpage><pub-id pub-id-type="doi">10.1006/bbrc.1995.1774</pub-id><pub-id pub-id-type="pmid">7779103</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klotz</surname> <given-names>LO</given-names></name><name><surname>Sánchez-Ramos</surname> <given-names>C</given-names></name><name><surname>Prieto-Arroyo</surname> <given-names>I</given-names></name><name><surname>Urbánek</surname> <given-names>P</given-names></name><name><surname>Steinbrenner</surname> <given-names>H</given-names></name><name><surname>Monsalve</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Redox regulation of FoxO transcription factors</article-title><source>Redox Biology</source><volume>6</volume><fpage>51</fpage><lpage>72</lpage><pub-id pub-id-type="doi">10.1016/j.redox.2015.06.019</pub-id><pub-id pub-id-type="pmid">26184557</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Knuever</surname> <given-names>J</given-names></name><name><surname>Willenborg</surname> <given-names>S</given-names></name><name><surname>Ding</surname> <given-names>X</given-names></name><name><surname>Akyüz</surname> <given-names>MD</given-names></name><name><surname>Partridge</surname> <given-names>L</given-names></name><name><surname>Niessen</surname> <given-names>CM</given-names></name><name><surname>Brüning</surname> <given-names>JC</given-names></name><name><surname>Eming</surname> <given-names>SA</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Myeloid Cell-Restricted insulin/IGF-1 receptor deficiency protects against skin inflammation</article-title><source>The Journal of Immunology</source><volume>195</volume><fpage>5296</fpage><lpage>5308</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1501237</pub-id><pub-id pub-id-type="pmid">26519530</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuehne</surname> <given-names>A</given-names></name><name><surname>Emmert</surname> <given-names>H</given-names></name><name><surname>Soehle</surname> <given-names>J</given-names></name><name><surname>Winnefeld</surname> <given-names>M</given-names></name><name><surname>Fischer</surname> <given-names>F</given-names></name><name><surname>Wenck</surname> <given-names>H</given-names></name><name><surname>Gallinat</surname> <given-names>S</given-names></name><name><surname>Terstegen</surname> <given-names>L</given-names></name><name><surname>Lucius</surname> <given-names>R</given-names></name><name><surname>Hildebrand</surname> <given-names>J</given-names></name><name><surname>Zamboni</surname> <given-names>N</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Acute activation of oxidative pentose phosphate pathway as First-Line response to oxidative stress in human skin cells</article-title><source>Molecular Cell</source><volume>59</volume><fpage>359</fpage><lpage>371</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2015.06.017</pub-id><pub-id pub-id-type="pmid">26190262</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuleshov</surname> <given-names>MV</given-names></name><name><surname>Jones</surname> <given-names>MR</given-names></name><name><surname>Rouillard</surname> <given-names>AD</given-names></name><name><surname>Fernandez</surname> <given-names>NF</given-names></name><name><surname>Duan</surname> <given-names>Q</given-names></name><name><surname>Wang</surname> <given-names>Z</given-names></name><name><surname>Koplev</surname> <given-names>S</given-names></name><name><surname>Jenkins</surname> <given-names>SL</given-names></name><name><surname>Jagodnik</surname> <given-names>KM</given-names></name><name><surname>Lachmann</surname> <given-names>A</given-names></name><name><surname>McDermott</surname> <given-names>MG</given-names></name><name><surname>Monteiro</surname> <given-names>CD</given-names></name><name><surname>Gundersen</surname> <given-names>GW</given-names></name><name><surname>Ma'ayan</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Enrichr: a comprehensive gene set enrichment analysis web server 2016 update</article-title><source>Nucleic Acids Research</source><volume>44</volume><fpage>W90</fpage><lpage>W97</lpage><pub-id pub-id-type="doi">10.1093/nar/gkw377</pub-id><pub-id pub-id-type="pmid">27141961</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kurauti</surname> <given-names>MA</given-names></name><name><surname>Ferreira</surname> <given-names>SM</given-names></name><name><surname>Soares</surname> <given-names>GM</given-names></name><name><surname>Vettorazzi</surname> <given-names>JF</given-names></name><name><surname>Carneiro</surname> <given-names>EM</given-names></name><name><surname>Boschero</surname> <given-names>AC</given-names></name><name><surname>Costa-Júnior</surname> <given-names>JM</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Hyperinsulinemia is associated with increasing insulin secretion but not with decreasing insulin clearance in an age-related metabolic dysfunction mice model</article-title><source>Journal of Cellular Physiology</source><volume>234</volume><fpage>9802</fpage><lpage>9809</lpage><pub-id pub-id-type="doi">10.1002/jcp.27667</pub-id><pub-id pub-id-type="pmid">30370604</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kurtul</surname> <given-names>N</given-names></name><name><surname>Pençe</surname> <given-names>S</given-names></name><name><surname>Akarsu</surname> <given-names>E</given-names></name><name><surname>Koçoğlu</surname> <given-names>H</given-names></name><name><surname>Aksoy</surname> <given-names>Y</given-names></name><name><surname>Aksoy</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Adenosine deaminase activity in the serum of type 2 diabetic patients</article-title><source>Acta Medica</source><volume>47</volume><fpage>33</fpage><lpage>35</lpage><pub-id pub-id-type="doi">10.14712/18059694.2018.63</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kwon</surname> <given-names>HS</given-names></name><name><surname>Huang</surname> <given-names>B</given-names></name><name><surname>Unterman</surname> <given-names>TG</given-names></name><name><surname>Harris</surname> <given-names>RA</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Protein kinase B-alpha inhibits human pyruvate dehydrogenase kinase-4 gene induction by dexamethasone through inactivation of FOXO transcription factors</article-title><source>Diabetes</source><volume>53</volume><fpage>899</fpage><lpage>910</lpage><pub-id pub-id-type="doi">10.2337/diabetes.53.4.899</pub-id><pub-id pub-id-type="pmid">15047604</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lackner</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Hepatocellular ballooning in nonalcoholic steatohepatitis: the pathologist’s perspective</article-title><source>Expert Review of Gastroenterology &amp; Hepatology</source><volume>5</volume><fpage>223</fpage><lpage>231</lpage><pub-id pub-id-type="doi">10.1586/egh.11.8</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname> <given-names>J</given-names></name><name><surname>Choi</surname> <given-names>J</given-names></name><name><surname>Scafidi</surname> <given-names>S</given-names></name><name><surname>Wolfgang</surname> <given-names>MJ</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Hepatic fatty acid oxidation restrains systemic catabolism during starvation</article-title><source>Cell Reports</source><volume>16</volume><fpage>201</fpage><lpage>212</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2016.05.062</pub-id><pub-id pub-id-type="pmid">27320917</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname> <given-names>Y-S</given-names></name><name><surname>Jeong</surname> <given-names>W-I</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Retinoic acids and hepatic stellate cells in liver disease</article-title><source>Journal of Gastroenterology and Hepatology</source><volume>27</volume><fpage>75</fpage><lpage>79</lpage><pub-id pub-id-type="doi">10.1111/j.1440-1746.2011.07007.x</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lettieri Barbato</surname> <given-names>D</given-names></name><name><surname>Aquilano</surname> <given-names>K</given-names></name><name><surname>Baldelli</surname> <given-names>S</given-names></name><name><surname>Cannata</surname> <given-names>SM</given-names></name><name><surname>Bernardini</surname> <given-names>S</given-names></name><name><surname>Rotilio</surname> <given-names>G</given-names></name><name><surname>Ciriolo</surname> <given-names>MR</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Proline oxidase-adipose triglyceride lipase pathway restrains adipose cell death and tissue inflammation</article-title><source>Cell Death &amp; Differentiation</source><volume>21</volume><fpage>113</fpage><lpage>123</lpage><pub-id pub-id-type="doi">10.1038/cdd.2013.137</pub-id><pub-id pub-id-type="pmid">24096872</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>Y</given-names></name><name><surname>Yu</surname> <given-names>J</given-names></name><name><surname>Du</surname> <given-names>D</given-names></name><name><surname>Fu</surname> <given-names>S</given-names></name><name><surname>Chen</surname> <given-names>Y</given-names></name><name><surname>Yu</surname> <given-names>F</given-names></name><name><surname>Gao</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Involvement of post-transcriptional regulation of FOXO1 by HuR in 5-FU-induced apoptosis in breast Cancer cells</article-title><source>Oncology Letters</source><volume>6</volume><fpage>156</fpage><lpage>160</lpage><pub-id pub-id-type="doi">10.3892/ol.2013.1352</pub-id><pub-id pub-id-type="pmid">23946796</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>B</given-names></name><name><surname>Dewey</surname> <given-names>CN</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome</article-title><source>BMC Bioinformatics</source><volume>12</volume><elocation-id>323</elocation-id><pub-id pub-id-type="doi">10.1186/1471-2105-12-323</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>L</given-names></name><name><surname>Xie</surname> <given-names>B</given-names></name><name><surname>Fan</surname> <given-names>M</given-names></name><name><surname>Candas-Green</surname> <given-names>D</given-names></name><name><surname>Jiang</surname> <given-names>JX</given-names></name><name><surname>Wei</surname> <given-names>R</given-names></name><name><surname>Wang</surname> <given-names>Y</given-names></name><name><surname>Chen</surname> <given-names>HW</given-names></name><name><surname>Hu</surname> <given-names>Y</given-names></name><name><surname>Li</surname> <given-names>JJ</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Low-Level saturated fatty acid palmitate benefits liver cells by boosting mitochondrial metabolism via CDK1-SIRT3-CPT2 cascade</article-title><source>Developmental Cell</source><volume>52</volume><fpage>196</fpage><lpage>209</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2019.11.012</pub-id><pub-id pub-id-type="pmid">31866205</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Livak</surname> <given-names>KJ</given-names></name><name><surname>Schmittgen</surname> <given-names>TD</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta delta C(T)) Method</article-title><source>Methods</source><volume>25</volume><fpage>402</fpage><lpage>408</lpage><pub-id pub-id-type="doi">10.1006/meth.2001.1262</pub-id><pub-id pub-id-type="pmid">11846609</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lohka</surname> <given-names>MJ</given-names></name><name><surname>Hayes</surname> <given-names>MK</given-names></name><name><surname>Maller</surname> <given-names>JL</given-names></name></person-group><year iso-8601-date="1988">1988</year><article-title>Purification of maturation-promoting factor, an intracellular regulator of early mitotic events</article-title><source>PNAS</source><volume>85</volume><fpage>3009</fpage><lpage>3013</lpage><pub-id pub-id-type="doi">10.1073/pnas.85.9.3009</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname> <given-names>M</given-names></name><name><surname>Wan</surname> <given-names>M</given-names></name><name><surname>Leavens</surname> <given-names>KF</given-names></name><name><surname>Chu</surname> <given-names>Q</given-names></name><name><surname>Monks</surname> <given-names>BR</given-names></name><name><surname>Fernandez</surname> <given-names>S</given-names></name><name><surname>Ahima</surname> <given-names>RS</given-names></name><name><surname>Ueki</surname> <given-names>K</given-names></name><name><surname>Kahn</surname> <given-names>CR</given-names></name><name><surname>Birnbaum</surname> <given-names>MJ</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Insulin regulates liver metabolism in vivo in the absence of hepatic akt and Foxo1</article-title><source>Nature Medicine</source><volume>18</volume><fpage>388</fpage><lpage>395</lpage><pub-id pub-id-type="doi">10.1038/nm.2686</pub-id><pub-id pub-id-type="pmid">22344295</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Macdonald</surname> <given-names>RA</given-names></name></person-group><year iso-8601-date="1961">1961</year><article-title>&quot;Lifespan&quot; of liver cells Autoradio-graphic study using tritiated thymidine in normal, cirrhotic, and partially hepatectomized rats</article-title><source>Archives of Internal Medicine</source><volume>107</volume><fpage>335</fpage><lpage>343</lpage><pub-id pub-id-type="doi">10.1001/archinte.1961.03620030023003</pub-id><pub-id pub-id-type="pmid">13764742</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mandal</surname> <given-names>AK</given-names></name><name><surname>Mount</surname> <given-names>DB</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>The molecular physiology of uric acid homeostasis</article-title><source>Annual Review of Physiology</source><volume>77</volume><fpage>323</fpage><lpage>345</lpage><pub-id pub-id-type="doi">10.1146/annurev-physiol-021113-170343</pub-id><pub-id pub-id-type="pmid">25422986</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manoli</surname> <given-names>I</given-names></name><name><surname>Sysol</surname> <given-names>JR</given-names></name><name><surname>Epping</surname> <given-names>MW</given-names></name><name><surname>Li</surname> <given-names>L</given-names></name><name><surname>Wang</surname> <given-names>C</given-names></name><name><surname>Sloan</surname> <given-names>JL</given-names></name><name><surname>Pass</surname> <given-names>A</given-names></name><name><surname>Gagné</surname> <given-names>J</given-names></name><name><surname>Ktena</surname> <given-names>YP</given-names></name><name><surname>Li</surname> <given-names>L</given-names></name><name><surname>Trivedi</surname> <given-names>NS</given-names></name><name><surname>Ouattara</surname> <given-names>B</given-names></name><name><surname>Zerfas</surname> <given-names>PM</given-names></name><name><surname>Hoffmann</surname> <given-names>V</given-names></name><name><surname>Abu-Asab</surname> <given-names>M</given-names></name><name><surname>Tsokos</surname> <given-names>MG</given-names></name><name><surname>Kleiner</surname> <given-names>DE</given-names></name><name><surname>Garone</surname> <given-names>C</given-names></name><name><surname>Cusmano-Ozog</surname> <given-names>K</given-names></name><name><surname>Enns</surname> <given-names>GM</given-names></name><name><surname>Vernon</surname> <given-names>HJ</given-names></name><name><surname>Andersson</surname> <given-names>HC</given-names></name><name><surname>Grunewald</surname> <given-names>S</given-names></name><name><surname>Elkahloun</surname> <given-names>AG</given-names></name><name><surname>Girard</surname> <given-names>CL</given-names></name><name><surname>Schnermann</surname> <given-names>J</given-names></name><name><surname>DiMauro</surname> <given-names>S</given-names></name><name><surname>Andres-Mateos</surname> <given-names>E</given-names></name><name><surname>Vandenberghe</surname> <given-names>LH</given-names></name><name><surname>Chandler</surname> <given-names>RJ</given-names></name><name><surname>Venditti</surname> <given-names>CP</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>FGF21 underlies a hormetic response to metabolic stress in methylmalonic acidemia</article-title><source>JCI Insight</source><volume>3</volume><elocation-id>124351</elocation-id><pub-id pub-id-type="doi">10.1172/jci.insight.124351</pub-id><pub-id pub-id-type="pmid">30518688</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marín-Juez</surname> <given-names>R</given-names></name><name><surname>Jong-Raadsen</surname> <given-names>S</given-names></name><name><surname>Yang</surname> <given-names>S</given-names></name><name><surname>Spaink</surname> <given-names>HP</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Hyperinsulinemia induces insulin resistance and immune suppression via Ptpn6/Shp1 in zebrafish</article-title><source>Journal of Endocrinology</source><volume>222</volume><fpage>229</fpage><lpage>241</lpage><pub-id pub-id-type="doi">10.1530/JOE-14-0178</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McConnell</surname> <given-names>BB</given-names></name><name><surname>Starborg</surname> <given-names>M</given-names></name><name><surname>Brookes</surname> <given-names>S</given-names></name><name><surname>Peters</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Inhibitors of cyclin-dependent kinases induce features of replicative senescence in early passage human diploid fibroblasts</article-title><source>Current Biology</source><volume>8</volume><fpage>351</fpage><lpage>354</lpage><pub-id pub-id-type="doi">10.1016/S0960-9822(98)70137-X</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meng</surname> <given-names>X</given-names></name><name><surname>Nikolic-Paterson</surname> <given-names>DJ</given-names></name><name><surname>Lan</surname> <given-names>HY</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>TGF-β: the master regulator of fibrosis</article-title><source>Nature Reviews Nephrology</source><volume>12</volume><fpage>325</fpage><lpage>338</lpage><pub-id pub-id-type="doi">10.1038/nrneph.2016.48</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Metsalu</surname> <given-names>T</given-names></name><name><surname>Vilo</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>ClustVis: a web tool for visualizing clustering of multivariate data using Principal Component Analysis and heatmap</article-title><source>Nucleic Acids Research</source><volume>43</volume><fpage>W566</fpage><lpage>W570</lpage><pub-id pub-id-type="doi">10.1093/nar/gkv468</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miettinen</surname> <given-names>TP</given-names></name><name><surname>Pessa</surname> <given-names>HK</given-names></name><name><surname>Caldez</surname> <given-names>MJ</given-names></name><name><surname>Fuhrer</surname> <given-names>T</given-names></name><name><surname>Diril</surname> <given-names>MK</given-names></name><name><surname>Sauer</surname> <given-names>U</given-names></name><name><surname>Kaldis</surname> <given-names>P</given-names></name><name><surname>Björklund</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Identification of transcriptional and metabolic programs related to mammalian cell size</article-title><source>Current Biology</source><volume>24</volume><fpage>598</fpage><lpage>608</lpage><pub-id pub-id-type="doi">10.1016/j.cub.2014.01.071</pub-id><pub-id pub-id-type="pmid">24613310</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mitro</surname> <given-names>N</given-names></name><name><surname>Mak</surname> <given-names>PA</given-names></name><name><surname>Vargas</surname> <given-names>L</given-names></name><name><surname>Godio</surname> <given-names>C</given-names></name><name><surname>Hampton</surname> <given-names>E</given-names></name><name><surname>Molteni</surname> <given-names>V</given-names></name><name><surname>Kreusch</surname> <given-names>A</given-names></name><name><surname>Saez</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>The nuclear receptor LXR is a glucose sensor</article-title><source>Nature</source><volume>445</volume><fpage>219</fpage><lpage>223</lpage><pub-id pub-id-type="doi">10.1038/nature05449</pub-id><pub-id pub-id-type="pmid">17187055</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miyaoka</surname> <given-names>Y</given-names></name><name><surname>Miyajima</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>To divide or not to divide: revisiting liver regeneration</article-title><source>Cell Division</source><volume>8</volume><elocation-id>8</elocation-id><pub-id pub-id-type="doi">10.1186/1747-1028-8-8</pub-id><pub-id pub-id-type="pmid">23786799</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miyoshi</surname> <given-names>H</given-names></name><name><surname>Perfield</surname> <given-names>JW</given-names></name><name><surname>Souza</surname> <given-names>SC</given-names></name><name><surname>Shen</surname> <given-names>W-J</given-names></name><name><surname>Zhang</surname> <given-names>H-H</given-names></name><name><surname>Stancheva</surname> <given-names>ZS</given-names></name><name><surname>Kraemer</surname> <given-names>FB</given-names></name><name><surname>Obin</surname> <given-names>MS</given-names></name><name><surname>Greenberg</surname> <given-names>AS</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Control of adipose triglyceride lipase action by serine 517 of perilipin A globally regulates protein kinase A-stimulated lipolysis in adipocytes</article-title><source>Journal of Biological Chemistry</source><volume>282</volume><fpage>996</fpage><lpage>1002</lpage><pub-id pub-id-type="doi">10.1074/jbc.M605770200</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moffat</surname> <given-names>J</given-names></name><name><surname>Grueneberg</surname> <given-names>DA</given-names></name><name><surname>Yang</surname> <given-names>X</given-names></name><name><surname>Kim</surname> <given-names>SY</given-names></name><name><surname>Kloepfer</surname> <given-names>AM</given-names></name><name><surname>Hinkle</surname> <given-names>G</given-names></name><name><surname>Piqani</surname> <given-names>B</given-names></name><name><surname>Eisenhaure</surname> <given-names>TM</given-names></name><name><surname>Luo</surname> <given-names>B</given-names></name><name><surname>Grenier</surname> <given-names>JK</given-names></name><name><surname>Carpenter</surname> <given-names>AE</given-names></name><name><surname>Foo</surname> <given-names>SY</given-names></name><name><surname>Stewart</surname> <given-names>SA</given-names></name><name><surname>Stockwell</surname> <given-names>BR</given-names></name><name><surname>Hacohen</surname> <given-names>N</given-names></name><name><surname>Hahn</surname> <given-names>WC</given-names></name><name><surname>Lander</surname> <given-names>ES</given-names></name><name><surname>Sabatini</surname> <given-names>DM</given-names></name><name><surname>Root</surname> <given-names>DE</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen</article-title><source>Cell</source><volume>124</volume><fpage>1283</fpage><lpage>1298</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2006.01.040</pub-id><pub-id pub-id-type="pmid">16564017</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morita</surname> <given-names>I</given-names></name><name><surname>Tanimoto</surname> <given-names>K</given-names></name><name><surname>Akiyama</surname> <given-names>N</given-names></name><name><surname>Naya</surname> <given-names>N</given-names></name><name><surname>Fujieda</surname> <given-names>K</given-names></name><name><surname>Iwasaki</surname> <given-names>T</given-names></name><name><surname>Yukioka</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Chronic hyperinsulinemia contributes to insulin resistance under dietary restriction in association with altered lipid metabolism in Zucker diabetic fatty rats</article-title><source>American Journal of Physiology-Endocrinology and Metabolism</source><volume>312</volume><fpage>E264</fpage><lpage>E272</lpage><pub-id pub-id-type="doi">10.1152/ajpendo.00342.2016</pub-id><pub-id pub-id-type="pmid">28143857</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moylan</surname> <given-names>CA</given-names></name><name><surname>Pang</surname> <given-names>H</given-names></name><name><surname>Dellinger</surname> <given-names>A</given-names></name><name><surname>Suzuki</surname> <given-names>A</given-names></name><name><surname>Garrett</surname> <given-names>ME</given-names></name><name><surname>Guy</surname> <given-names>CD</given-names></name><name><surname>Murphy</surname> <given-names>SK</given-names></name><name><surname>Ashley-Koch</surname> <given-names>AE</given-names></name><name><surname>Choi</surname> <given-names>SS</given-names></name><name><surname>Michelotti</surname> <given-names>GA</given-names></name><name><surname>Hampton</surname> <given-names>DD</given-names></name><name><surname>Chen</surname> <given-names>Y</given-names></name><name><surname>Tillmann</surname> <given-names>HL</given-names></name><name><surname>Hauser</surname> <given-names>MA</given-names></name><name><surname>Abdelmalek</surname> <given-names>MF</given-names></name><name><surname>Diehl</surname> <given-names>AM</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Hepatic gene expression profiles differentiate presymptomatic patients with mild versus severe nonalcoholic fatty liver disease</article-title><source>Hepatology</source><volume>59</volume><fpage>471</fpage><lpage>482</lpage><pub-id pub-id-type="doi">10.1002/hep.26661</pub-id><pub-id pub-id-type="pmid">23913408</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Narayanaswamy</surname> <given-names>P</given-names></name><name><surname>Teo</surname> <given-names>G</given-names></name><name><surname>Ow</surname> <given-names>JR</given-names></name><name><surname>Lau</surname> <given-names>A</given-names></name><name><surname>Kaldis</surname> <given-names>P</given-names></name><name><surname>Tate</surname> <given-names>S</given-names></name><name><surname>Choi</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>MetaboKit: a comprehensive data extraction tool for untargeted metabolomics</article-title><source>Molecular Omics</source><volume>16</volume><fpage>436</fpage><lpage>447</lpage><pub-id pub-id-type="doi">10.1039/D0MO00030B</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Niska-Blakie</surname> <given-names>J</given-names></name><name><surname>Gopinathan</surname> <given-names>L</given-names></name><name><surname>Low</surname> <given-names>KN</given-names></name><name><surname>Kien</surname> <given-names>YL</given-names></name><name><surname>Goh</surname> <given-names>CMF</given-names></name><name><surname>Caldez</surname> <given-names>MJ</given-names></name><name><surname>Pfeiffenberger</surname> <given-names>E</given-names></name><name><surname>Jones</surname> <given-names>OS</given-names></name><name><surname>Ong</surname> <given-names>CB</given-names></name><name><surname>Kurochkin</surname> <given-names>IV</given-names></name><name><surname>Coppola</surname> <given-names>V</given-names></name><name><surname>Tessarollo</surname> <given-names>L</given-names></name><name><surname>Choi</surname> <given-names>H</given-names></name><name><surname>Kanagasundaram</surname> <given-names>Y</given-names></name><name><surname>Eisenhaber</surname> <given-names>F</given-names></name><name><surname>Maurer-Stroh</surname> <given-names>S</given-names></name><name><surname>Kaldis</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Knockout of the non-essential gene SUGCT creates diet-linked, age-related microbiome disbalance with a diabetes-like metabolic syndrome phenotype</article-title><source>Cellular and Molecular Life Sciences</source><volume>77</volume><fpage>3423</fpage><lpage>3439</lpage><pub-id pub-id-type="doi">10.1007/s00018-019-03359-z</pub-id><pub-id pub-id-type="pmid">31722069</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ogrodnik</surname> <given-names>M</given-names></name><name><surname>Miwa</surname> <given-names>S</given-names></name><name><surname>Tchkonia</surname> <given-names>T</given-names></name><name><surname>Tiniakos</surname> <given-names>D</given-names></name><name><surname>Wilson</surname> <given-names>CL</given-names></name><name><surname>Lahat</surname> <given-names>A</given-names></name><name><surname>Day</surname> <given-names>CP</given-names></name><name><surname>Burt</surname> <given-names>A</given-names></name><name><surname>Palmer</surname> <given-names>A</given-names></name><name><surname>Anstee</surname> <given-names>QM</given-names></name><name><surname>Grellscheid</surname> <given-names>SN</given-names></name><name><surname>Hoeijmakers</surname> <given-names>JHJ</given-names></name><name><surname>Barnhoorn</surname> <given-names>S</given-names></name><name><surname>Mann</surname> <given-names>DA</given-names></name><name><surname>Bird</surname> <given-names>TG</given-names></name><name><surname>Vermeij</surname> <given-names>WP</given-names></name><name><surname>Kirkland</surname> <given-names>JL</given-names></name><name><surname>Passos</surname> <given-names>JF</given-names></name><name><surname>von Zglinicki</surname> <given-names>T</given-names></name><name><surname>Jurk</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Cellular senescence drives age-dependent hepatic steatosis</article-title><source>Nature Communications</source><volume>8</volume><elocation-id>15691</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms15691</pub-id><pub-id pub-id-type="pmid">28608850</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Omori</surname> <given-names>S</given-names></name><name><surname>Wang</surname> <given-names>TW</given-names></name><name><surname>Johmura</surname> <given-names>Y</given-names></name><name><surname>Kanai</surname> <given-names>T</given-names></name><name><surname>Nakano</surname> <given-names>Y</given-names></name><name><surname>Kido</surname> <given-names>T</given-names></name><name><surname>Susaki</surname> <given-names>EA</given-names></name><name><surname>Nakajima</surname> <given-names>T</given-names></name><name><surname>Shichino</surname> <given-names>S</given-names></name><name><surname>Ueha</surname> <given-names>S</given-names></name><name><surname>Ozawa</surname> <given-names>M</given-names></name><name><surname>Yokote</surname> <given-names>K</given-names></name><name><surname>Kumamoto</surname> <given-names>S</given-names></name><name><surname>Nishiyama</surname> <given-names>A</given-names></name><name><surname>Sakamoto</surname> <given-names>T</given-names></name><name><surname>Yamaguchi</surname> <given-names>K</given-names></name><name><surname>Hatakeyama</surname> <given-names>S</given-names></name><name><surname>Shimizu</surname> <given-names>E</given-names></name><name><surname>Katayama</surname> <given-names>K</given-names></name><name><surname>Yamada</surname> <given-names>Y</given-names></name><name><surname>Yamazaki</surname> <given-names>S</given-names></name><name><surname>Iwasaki</surname> <given-names>K</given-names></name><name><surname>Miyoshi</surname> <given-names>C</given-names></name><name><surname>Funato</surname> <given-names>H</given-names></name><name><surname>Yanagisawa</surname> <given-names>M</given-names></name><name><surname>Ueno</surname> <given-names>H</given-names></name><name><surname>Imoto</surname> <given-names>S</given-names></name><name><surname>Furukawa</surname> <given-names>Y</given-names></name><name><surname>Yoshida</surname> <given-names>N</given-names></name><name><surname>Matsushima</surname> <given-names>K</given-names></name><name><surname>Ueda</surname> <given-names>HR</given-names></name><name><surname>Miyajima</surname> <given-names>A</given-names></name><name><surname>Nakanishi</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Generation of a p16 reporter mouse and its use to characterize and target p16high Cells In Vivo</article-title><source>Cell Metabolism</source><volume>32</volume><fpage>814</fpage><lpage>828</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2020.09.006</pub-id><pub-id pub-id-type="pmid">32949498</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Palsgaard</surname> <given-names>J</given-names></name><name><surname>Brøns</surname> <given-names>C</given-names></name><name><surname>Friedrichsen</surname> <given-names>M</given-names></name><name><surname>Dominguez</surname> <given-names>H</given-names></name><name><surname>Jensen</surname> <given-names>M</given-names></name><name><surname>Storgaard</surname> <given-names>H</given-names></name><name><surname>Spohr</surname> <given-names>C</given-names></name><name><surname>Torp-Pedersen</surname> <given-names>C</given-names></name><name><surname>Borup</surname> <given-names>R</given-names></name><name><surname>De Meyts</surname> <given-names>P</given-names></name><name><surname>Vaag</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Gene expression in skeletal muscle biopsies from people with type 2 diabetes and relatives: differential regulation of insulin signaling pathways</article-title><source>PLOS ONE</source><volume>4</volume><elocation-id>e6575</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0006575</pub-id><pub-id pub-id-type="pmid">19668377</pub-id></element-citation></ref><ref id="bib84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Papandreou</surname> <given-names>C</given-names></name><name><surname>Li</surname> <given-names>J</given-names></name><name><surname>Liang</surname> <given-names>L</given-names></name><name><surname>Bulló</surname> <given-names>M</given-names></name><name><surname>Zheng</surname> <given-names>Y</given-names></name><name><surname>Ruiz-Canela</surname> <given-names>M</given-names></name><name><surname>Yu</surname> <given-names>E</given-names></name><name><surname>Guasch-Ferré</surname> <given-names>M</given-names></name><name><surname>Razquin</surname> <given-names>C</given-names></name><name><surname>Clish</surname> <given-names>C</given-names></name><name><surname>Corella</surname> <given-names>D</given-names></name><name><surname>Estruch</surname> <given-names>R</given-names></name><name><surname>Ros</surname> <given-names>E</given-names></name><name><surname>Fitó</surname> <given-names>M</given-names></name><name><surname>Arós</surname> <given-names>F</given-names></name><name><surname>Serra-Majem</surname> <given-names>L</given-names></name><name><surname>Rosique</surname> <given-names>N</given-names></name><name><surname>Martínez-González</surname> <given-names>MA</given-names></name><name><surname>Hu</surname> <given-names>FB</given-names></name><name><surname>Salas-Salvadó</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Metabolites related to purine catabolism and risk of type 2 diabetes incidence; modifying effects of the TCF7L2-rs7903146 polymorphism</article-title><source>Scientific Reports</source><volume>9</volume><elocation-id>2892</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-019-39441-6</pub-id><pub-id pub-id-type="pmid">30814579</pub-id></element-citation></ref><ref id="bib85"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Papatheodoridi</surname> <given-names>AM</given-names></name><name><surname>Chrysavgis</surname> <given-names>L</given-names></name><name><surname>Koutsilieris</surname> <given-names>M</given-names></name><name><surname>Chatzigeorgiou</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>The role of senescence in the development of nonalcoholic fatty liver disease and progression to nonalcoholic steatohepatitis</article-title><source>Hepatology</source><volume>71</volume><fpage>363</fpage><lpage>374</lpage><pub-id pub-id-type="doi">10.1002/hep.30834</pub-id><pub-id pub-id-type="pmid">31230380</pub-id></element-citation></ref><ref id="bib86"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patel</surname> <given-names>S</given-names></name><name><surname>Alvarez-Guaita</surname> <given-names>A</given-names></name><name><surname>Melvin</surname> <given-names>A</given-names></name><name><surname>Rimmington</surname> <given-names>D</given-names></name><name><surname>Dattilo</surname> <given-names>A</given-names></name><name><surname>Miedzybrodzka</surname> <given-names>EL</given-names></name><name><surname>Cimino</surname> <given-names>I</given-names></name><name><surname>Maurin</surname> <given-names>AC</given-names></name><name><surname>Roberts</surname> <given-names>GP</given-names></name><name><surname>Meek</surname> <given-names>CL</given-names></name><name><surname>Virtue</surname> <given-names>S</given-names></name><name><surname>Sparks</surname> <given-names>LM</given-names></name><name><surname>Parsons</surname> <given-names>SA</given-names></name><name><surname>Redman</surname> <given-names>LM</given-names></name><name><surname>Bray</surname> <given-names>GA</given-names></name><name><surname>Liou</surname> <given-names>AP</given-names></name><name><surname>Woods</surname> <given-names>RM</given-names></name><name><surname>Parry</surname> <given-names>SA</given-names></name><name><surname>Jeppesen</surname> <given-names>PB</given-names></name><name><surname>Kolnes</surname> <given-names>AJ</given-names></name><name><surname>Harding</surname> <given-names>HP</given-names></name><name><surname>Ron</surname> <given-names>D</given-names></name><name><surname>Vidal-Puig</surname> <given-names>A</given-names></name><name><surname>Reimann</surname> <given-names>F</given-names></name><name><surname>Gribble</surname> <given-names>FM</given-names></name><name><surname>Hulston</surname> <given-names>CJ</given-names></name><name><surname>Farooqi</surname> <given-names>IS</given-names></name><name><surname>Fafournoux</surname> <given-names>P</given-names></name><name><surname>Smith</surname> <given-names>SR</given-names></name><name><surname>Jensen</surname> <given-names>J</given-names></name><name><surname>Breen</surname> <given-names>D</given-names></name><name><surname>Wu</surname> <given-names>Z</given-names></name><name><surname>Zhang</surname> <given-names>BB</given-names></name><name><surname>Coll</surname> <given-names>AP</given-names></name><name><surname>Savage</surname> <given-names>DB</given-names></name><name><surname>O'Rahilly</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>GDF15 provides an endocrine signal of nutritional stress in mice and humans</article-title><source>Cell Metabolism</source><volume>29</volume><fpage>707</fpage><lpage>718</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2018.12.016</pub-id><pub-id pub-id-type="pmid">30639358</pub-id></element-citation></ref><ref id="bib87"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petersen</surname> <given-names>MC</given-names></name><name><surname>Shulman</surname> <given-names>GI</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Mechanisms of insulin action and insulin resistance</article-title><source>Physiological Reviews</source><volume>98</volume><fpage>2133</fpage><lpage>2223</lpage><pub-id pub-id-type="doi">10.1152/physrev.00063.2017</pub-id><pub-id pub-id-type="pmid">30067154</pub-id></element-citation></ref><ref id="bib88"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ponugoti</surname> <given-names>B</given-names></name><name><surname>Kim</surname> <given-names>D-H</given-names></name><name><surname>Xiao</surname> <given-names>Z</given-names></name><name><surname>Smith</surname> <given-names>Z</given-names></name><name><surname>Miao</surname> <given-names>J</given-names></name><name><surname>Zang</surname> <given-names>M</given-names></name><name><surname>Wu</surname> <given-names>S-Y</given-names></name><name><surname>Chiang</surname> <given-names>C-M</given-names></name><name><surname>Veenstra</surname> <given-names>TD</given-names></name><name><surname>Kemper</surname> <given-names>JK</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>SIRT1 deacetylates and inhibits SREBP-1C activity in regulation of hepatic lipid metabolism</article-title><source>Journal of Biological Chemistry</source><volume>285</volume><fpage>33959</fpage><lpage>33970</lpage><pub-id pub-id-type="doi">10.1074/jbc.M110.122978</pub-id></element-citation></ref><ref id="bib89"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Postic</surname> <given-names>C</given-names></name><name><surname>Magnuson</surname> <given-names>MA</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>DNA excision in liver by an albumin-Cre transgene occurs progressively with age</article-title><source>Genesis</source><volume>26</volume><fpage>149</fpage><lpage>150</lpage><pub-id pub-id-type="doi">10.1002/(SICI)1526-968X(200002)26:2&lt;149::AID-GENE16&gt;3.0.CO;2-V</pub-id></element-citation></ref><ref id="bib90"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prozorovski</surname> <given-names>T</given-names></name><name><surname>Schulze-Topphoff</surname> <given-names>U</given-names></name><name><surname>Glumm</surname> <given-names>R</given-names></name><name><surname>Baumgart</surname> <given-names>J</given-names></name><name><surname>Schröter</surname> <given-names>F</given-names></name><name><surname>Ninnemann</surname> <given-names>O</given-names></name><name><surname>Siegert</surname> <given-names>E</given-names></name><name><surname>Bendix</surname> <given-names>I</given-names></name><name><surname>Brüstle</surname> <given-names>O</given-names></name><name><surname>Nitsch</surname> <given-names>R</given-names></name><name><surname>Zipp</surname> <given-names>F</given-names></name><name><surname>Aktas</surname> <given-names>O</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Sirt1 contributes critically to the redox-dependent fate of neural progenitors</article-title><source>Nature Cell Biology</source><volume>10</volume><fpage>385</fpage><lpage>394</lpage><pub-id pub-id-type="doi">10.1038/ncb1700</pub-id><pub-id pub-id-type="pmid">18344989</pub-id></element-citation></ref><ref id="bib91"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quadri</surname> <given-names>RA</given-names></name><name><surname>Arbogast</surname> <given-names>A</given-names></name><name><surname>Phelouzat</surname> <given-names>MA</given-names></name><name><surname>Boutet</surname> <given-names>S</given-names></name><name><surname>Plastre</surname> <given-names>O</given-names></name><name><surname>Proust</surname> <given-names>JJ</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Age-associated decline in cdk1 activity delays cell cycle progression of human T lymphocytes</article-title><source>Journal of Immunology</source><volume>161</volume><fpage>5203</fpage><lpage>5209</lpage><pub-id pub-id-type="pmid">9820491</pub-id></element-citation></ref><ref id="bib92"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reid</surname> <given-names>BN</given-names></name><name><surname>Ables</surname> <given-names>GP</given-names></name><name><surname>Otlivanchik</surname> <given-names>OA</given-names></name><name><surname>Schoiswohl</surname> <given-names>G</given-names></name><name><surname>Zechner</surname> <given-names>R</given-names></name><name><surname>Blaner</surname> <given-names>WS</given-names></name><name><surname>Goldberg</surname> <given-names>IJ</given-names></name><name><surname>Schwabe</surname> <given-names>RF</given-names></name><name><surname>Chua</surname> <given-names>SC</given-names></name><name><surname>Huang</surname> <given-names>L-S</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Hepatic overexpression of Hormone-sensitive lipase and adipose triglyceride lipase promotes fatty acid oxidation, stimulates direct release of free fatty acids, and ameliorates steatosis</article-title><source>Journal of Biological Chemistry</source><volume>283</volume><fpage>13087</fpage><lpage>13099</lpage><pub-id pub-id-type="doi">10.1074/jbc.M800533200</pub-id></element-citation></ref><ref id="bib93"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Repa</surname> <given-names>JJ</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRalpha and LXRbeta</article-title><source>Genes &amp; Development</source><volume>14</volume><fpage>2819</fpage><lpage>2830</lpage><pub-id pub-id-type="doi">10.1101/gad.844900</pub-id></element-citation></ref><ref id="bib94"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ritschka</surname> <given-names>B</given-names></name><name><surname>Knauer-Meyer</surname> <given-names>T</given-names></name><name><surname>Gonçalves</surname> <given-names>DS</given-names></name><name><surname>Mas</surname> <given-names>A</given-names></name><name><surname>Plassat</surname> <given-names>JL</given-names></name><name><surname>Durik</surname> <given-names>M</given-names></name><name><surname>Jacobs</surname> <given-names>H</given-names></name><name><surname>Pedone</surname> <given-names>E</given-names></name><name><surname>Di Vicino</surname> <given-names>U</given-names></name><name><surname>Cosma</surname> <given-names>MP</given-names></name><name><surname>Keyes</surname> <given-names>WM</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>The senotherapeutic drug ABT-737 disrupts aberrant p21 expression to restore liver regeneration in adult mice</article-title><source>Genes &amp; Development</source><volume>34</volume><fpage>489</fpage><lpage>494</lpage><pub-id pub-id-type="doi">10.1101/gad.332643.119</pub-id><pub-id pub-id-type="pmid">32139422</pub-id></element-citation></ref><ref id="bib95"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roden</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Mechanisms of Disease: hepatic steatosis in type 2 diabetes—pathogenesis and clinical relevance</article-title><source>Nature Clinical Practice Endocrinology &amp; Metabolism</source><volume>2</volume><fpage>335</fpage><lpage>348</lpage><pub-id pub-id-type="doi">10.1038/ncpendmet0190</pub-id></element-citation></ref><ref id="bib96"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ronnett</surname> <given-names>GV</given-names></name><name><surname>Knutson</surname> <given-names>VP</given-names></name><name><surname>Lane</surname> <given-names>MD</given-names></name></person-group><year iso-8601-date="1982">1982</year><article-title>Insulin-induced down-regulation of insulin receptors in 3T3-L1 adipocytes altered rate of receptor inactivation</article-title><source>The Journal of Biological Chemistry</source><volume>257</volume><fpage>4285</fpage><lpage>4291</lpage><pub-id pub-id-type="pmid">7040381</pub-id></element-citation></ref><ref id="bib97"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rorsman</surname> <given-names>P</given-names></name><name><surname>Ashcroft</surname> <given-names>FM</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Pancreatic β-Cell Electrical Activity and Insulin Secretion: Of Mice and Men</article-title><source>Physiological Reviews</source><volume>98</volume><fpage>117</fpage><lpage>214</lpage><pub-id pub-id-type="doi">10.1152/physrev.00008.2017</pub-id></element-citation></ref><ref id="bib98"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ryaboshapkina</surname> <given-names>M</given-names></name><name><surname>Hammar</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Human hepatic gene expression signature of non-alcoholic fatty liver disease progression, a meta-analysis</article-title><source>Scientific Reports</source><volume>7</volume><elocation-id>12361</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-017-10930-w</pub-id></element-citation></ref><ref id="bib99"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scaglia</surname> <given-names>N</given-names></name><name><surname>Tyekucheva</surname> <given-names>S</given-names></name><name><surname>Zadra</surname> <given-names>G</given-names></name><name><surname>Photopoulos</surname> <given-names>C</given-names></name><name><surname>Loda</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>De novo fatty acid synthesis at the mitotic exit is required to complete cellular division</article-title><source>Cell Cycle</source><volume>13</volume><fpage>859</fpage><lpage>868</lpage><pub-id pub-id-type="doi">10.4161/cc.27767</pub-id></element-citation></ref><ref id="bib100"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schindelin</surname> <given-names>J</given-names></name><name><surname>Arganda-Carreras</surname> <given-names>I</given-names></name><name><surname>Frise</surname> <given-names>E</given-names></name><name><surname>Kaynig</surname> <given-names>V</given-names></name><name><surname>Longair</surname> <given-names>M</given-names></name><name><surname>Pietzsch</surname> <given-names>T</given-names></name><name><surname>Preibisch</surname> <given-names>S</given-names></name><name><surname>Rueden</surname> <given-names>C</given-names></name><name><surname>Saalfeld</surname> <given-names>S</given-names></name><name><surname>Schmid</surname> <given-names>B</given-names></name><name><surname>Tinevez</surname> <given-names>JY</given-names></name><name><surname>White</surname> <given-names>DJ</given-names></name><name><surname>Hartenstein</surname> <given-names>V</given-names></name><name><surname>Eliceiri</surname> <given-names>K</given-names></name><name><surname>Tomancak</surname> <given-names>P</given-names></name><name><surname>Cardona</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Fiji: an open-source platform for biological-image analysis</article-title><source>Nature Methods</source><volume>9</volume><fpage>676</fpage><lpage>682</lpage><pub-id pub-id-type="doi">10.1038/nmeth.2019</pub-id><pub-id pub-id-type="pmid">22743772</pub-id></element-citation></ref><ref id="bib101"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmucker</surname> <given-names>DL</given-names></name><name><surname>Sanchez</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Liver regeneration and aging: a current perspective</article-title><source>Current Gerontology and Geriatrics Research</source><volume>2011</volume><fpage>1</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1155/2011/526379</pub-id></element-citation></ref><ref id="bib102"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sekiya</surname> <given-names>M</given-names></name><name><surname>Hiraishi</surname> <given-names>A</given-names></name><name><surname>Touyama</surname> <given-names>M</given-names></name><name><surname>Sakamoto</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Oxidative stress induced lipid accumulation via SREBP1c activation in HepG2 cells</article-title><source>Biochemical and Biophysical Research Communications</source><volume>375</volume><fpage>602</fpage><lpage>607</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2008.08.068</pub-id></element-citation></ref><ref id="bib103"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Senokuchi</surname> <given-names>T</given-names></name><name><surname>Liang</surname> <given-names>CP</given-names></name><name><surname>Seimon</surname> <given-names>TA</given-names></name><name><surname>Han</surname> <given-names>S</given-names></name><name><surname>Matsumoto</surname> <given-names>M</given-names></name><name><surname>Banks</surname> <given-names>AS</given-names></name><name><surname>Paik</surname> <given-names>JH</given-names></name><name><surname>DePinho</surname> <given-names>RA</given-names></name><name><surname>Accili</surname> <given-names>D</given-names></name><name><surname>Tabas</surname> <given-names>I</given-names></name><name><surname>Tall</surname> <given-names>AR</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Forkhead transcription factors (FoxOs) promote apoptosis of insulin-resistant macrophages during cholesterol-induced endoplasmic reticulum stress</article-title><source>Diabetes</source><volume>57</volume><fpage>2967</fpage><lpage>2976</lpage><pub-id pub-id-type="doi">10.2337/db08-0520</pub-id><pub-id pub-id-type="pmid">18728232</pub-id></element-citation></ref><ref id="bib104"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shackelford</surname> <given-names>C</given-names></name><name><surname>Long</surname> <given-names>G</given-names></name><name><surname>Wolf</surname> <given-names>J</given-names></name><name><surname>Okerberg</surname> <given-names>C</given-names></name><name><surname>Herbert</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Qualitative and quantitative analysis of nonneoplastic lesions in toxicology studies</article-title><source>Toxicologic Pathology</source><volume>30</volume><fpage>93</fpage><lpage>96</lpage><pub-id pub-id-type="doi">10.1080/01926230252824761</pub-id><pub-id pub-id-type="pmid">11890482</pub-id></element-citation></ref><ref id="bib105"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shang</surname> <given-names>Y</given-names></name><name><surname>Myers</surname> <given-names>M</given-names></name><name><surname>Brown</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Formation of the androgen receptor transcription complex</article-title><source>Molecular Cell</source><volume>9</volume><fpage>601</fpage><lpage>610</lpage><pub-id pub-id-type="doi">10.1016/S1097-2765(02)00471-9</pub-id><pub-id pub-id-type="pmid">11931767</pub-id></element-citation></ref><ref id="bib106"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shillabeer</surname> <given-names>G</given-names></name><name><surname>Hornford</surname> <given-names>J</given-names></name><name><surname>Forden</surname> <given-names>JM</given-names></name><name><surname>Wong</surname> <given-names>NC</given-names></name><name><surname>Lau</surname> <given-names>DC</given-names></name></person-group><year iso-8601-date="1990">1990</year><article-title>Hepatic and adipose tissue lipogenic enzyme mRNA levels are suppressed by high fat diets in the rat</article-title><source>Journal of Lipid Research</source><volume>31</volume><fpage>623</fpage><lpage>631</lpage><pub-id pub-id-type="pmid">2191066</pub-id></element-citation></ref><ref id="bib107"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Srivastava</surname> <given-names>A</given-names></name><name><surname>Shankar</surname> <given-names>K</given-names></name><name><surname>Beg</surname> <given-names>M</given-names></name><name><surname>Rajan</surname> <given-names>S</given-names></name><name><surname>Gupta</surname> <given-names>A</given-names></name><name><surname>Varshney</surname> <given-names>S</given-names></name><name><surname>Kumar</surname> <given-names>D</given-names></name><name><surname>Gupta</surname> <given-names>S</given-names></name><name><surname>Mishra</surname> <given-names>RK</given-names></name><name><surname>Gaikwad</surname> <given-names>AN</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Chronic hyperinsulinemia induced miR-27b is linked to adipocyte insulin resistance by targeting insulin receptor</article-title><source>Journal of Molecular Medicine</source><volume>96</volume><fpage>315</fpage><lpage>331</lpage><pub-id pub-id-type="doi">10.1007/s00109-018-1623-z</pub-id><pub-id pub-id-type="pmid">29455245</pub-id></element-citation></ref><ref id="bib108"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stein</surname> <given-names>GH</given-names></name><name><surname>Drullinger</surname> <given-names>LF</given-names></name><name><surname>Robetorye</surname> <given-names>RS</given-names></name><name><surname>Pereira-Smith</surname> <given-names>OM</given-names></name><name><surname>Smith</surname> <given-names>JR</given-names></name></person-group><year iso-8601-date="1991">1991</year><article-title>Senescent cells fail to express cdc2, cycA, and cycB in response to mitogen stimulation</article-title><source>PNAS</source><volume>88</volume><fpage>11012</fpage><lpage>11016</lpage><pub-id pub-id-type="doi">10.1073/pnas.88.24.11012</pub-id></element-citation></ref><ref id="bib109"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Storey</surname> <given-names>JD</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>A direct approach to false discovery rates</article-title><source>Journal of the Royal Statistical Society: Series B</source><volume>64</volume><fpage>479</fpage><lpage>498</lpage><pub-id pub-id-type="doi">10.1111/1467-9868.00346</pub-id></element-citation></ref><ref id="bib110"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname> <given-names>L</given-names></name><name><surname>Liu</surname> <given-names>T</given-names></name><name><surname>Zhang</surname> <given-names>S</given-names></name><name><surname>Guo</surname> <given-names>K</given-names></name><name><surname>Liu</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Oct4 induces EMT through LEF1/β-catenin dependent WNT signaling pathway in hepatocellular carcinoma</article-title><source>Oncology Letters</source><volume>13</volume><fpage>2599</fpage><lpage>2606</lpage><pub-id pub-id-type="doi">10.3892/ol.2017.5788</pub-id></element-citation></ref><ref id="bib111"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taddeo</surname> <given-names>EP</given-names></name><name><surname>Alsabeeh</surname> <given-names>N</given-names></name><name><surname>Baghdasarian</surname> <given-names>S</given-names></name><name><surname>Wikstrom</surname> <given-names>JD</given-names></name><name><surname>Ritou</surname> <given-names>E</given-names></name><name><surname>Sereda</surname> <given-names>S</given-names></name><name><surname>Erion</surname> <given-names>K</given-names></name><name><surname>Li</surname> <given-names>J</given-names></name><name><surname>Stiles</surname> <given-names>L</given-names></name><name><surname>Abdulla</surname> <given-names>M</given-names></name><name><surname>Swanson</surname> <given-names>Z</given-names></name><name><surname>Wilhelm</surname> <given-names>JJ</given-names></name><name><surname>Bellin</surname> <given-names>MD</given-names></name><name><surname>Kibbey</surname> <given-names>RG</given-names></name><name><surname>Liesa</surname> <given-names>M</given-names></name><name><surname>Shirihai</surname> <given-names>OS</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Mitochondrial proton leak regulated by cyclophilin D elevates insulin secretion in islets at Nonstimulatory glucose levels</article-title><source>Diabetes</source><volume>69</volume><fpage>131</fpage><lpage>145</lpage><pub-id pub-id-type="doi">10.2337/db19-0379</pub-id><pub-id pub-id-type="pmid">31740442</pub-id></element-citation></ref><ref id="bib112"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tercé</surname> <given-names>F</given-names></name><name><surname>Brun</surname> <given-names>H</given-names></name><name><surname>Vance</surname> <given-names>DE</given-names></name></person-group><year iso-8601-date="1994">1994</year><article-title>Requirement of phosphatidylcholine for normal progression through the cell cycle in C3H/10T1/2 fibroblasts</article-title><source>Journal of Lipid Research</source><volume>35</volume><fpage>2130</fpage><lpage>2142</lpage><pub-id pub-id-type="pmid">7897311</pub-id></element-citation></ref><ref id="bib113"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tovar</surname> <given-names>AR</given-names></name><name><surname>Díaz-Villaseñor</surname> <given-names>A</given-names></name><name><surname>Cruz-Salazar</surname> <given-names>N</given-names></name><name><surname>Ordáz</surname> <given-names>G</given-names></name><name><surname>Granados</surname> <given-names>O</given-names></name><name><surname>Palacios-González</surname> <given-names>B</given-names></name><name><surname>Tovar-Palacio</surname> <given-names>C</given-names></name><name><surname>López</surname> <given-names>P</given-names></name><name><surname>Torres</surname> <given-names>N</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Dietary type and amount of fat modulate lipid metabolism gene expression in liver and in adipose tissue in high-fat diet-fed rats</article-title><source>Archives of Medical Research</source><volume>42</volume><fpage>540</fpage><lpage>553</lpage><pub-id pub-id-type="doi">10.1016/j.arcmed.2011.10.004</pub-id><pub-id pub-id-type="pmid">22023986</pub-id></element-citation></ref><ref id="bib114"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Usui</surname> <given-names>R</given-names></name><name><surname>Yabe</surname> <given-names>D</given-names></name><name><surname>Fauzi</surname> <given-names>M</given-names></name><name><surname>Goto</surname> <given-names>H</given-names></name><name><surname>Botagarova</surname> <given-names>A</given-names></name><name><surname>Tokumoto</surname> <given-names>S</given-names></name><name><surname>Tatsuoka</surname> <given-names>H</given-names></name><name><surname>Tahara</surname> <given-names>Y</given-names></name><name><surname>Kobayashi</surname> <given-names>S</given-names></name><name><surname>Manabe</surname> <given-names>T</given-names></name><name><surname>Baba</surname> <given-names>Y</given-names></name><name><surname>Kurosaki</surname> <given-names>T</given-names></name><name><surname>Herrera</surname> <given-names>PL</given-names></name><name><surname>Ogura</surname> <given-names>M</given-names></name><name><surname>Nagashima</surname> <given-names>K</given-names></name><name><surname>Inagaki</surname> <given-names>N</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>GPR40 activation initiates store-operated Ca<sup>2+</sup> entry and potentiates insulin secretion via the IP3R1/STIM1/Orai1 pathway in pancreatic β-cells</article-title><source>Scientific Reports</source><volume>9</volume><elocation-id>15562</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-019-52048-1</pub-id><pub-id pub-id-type="pmid">31664108</pub-id></element-citation></ref><ref id="bib115"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Koppen</surname> <given-names>A</given-names></name><name><surname>Verschuren</surname> <given-names>L</given-names></name><name><surname>van den Hoek</surname> <given-names>AM</given-names></name><name><surname>Verheij</surname> <given-names>J</given-names></name><name><surname>Morrison</surname> <given-names>MC</given-names></name><name><surname>Li</surname> <given-names>K</given-names></name><name><surname>Nagabukuro</surname> <given-names>H</given-names></name><name><surname>Costessi</surname> <given-names>A</given-names></name><name><surname>Caspers</surname> <given-names>MPM</given-names></name><name><surname>van den Broek</surname> <given-names>TJ</given-names></name><name><surname>Sagartz</surname> <given-names>J</given-names></name><name><surname>Kluft</surname> <given-names>C</given-names></name><name><surname>Beysen</surname> <given-names>C</given-names></name><name><surname>Emson</surname> <given-names>C</given-names></name><name><surname>van Gool</surname> <given-names>AJ</given-names></name><name><surname>Goldschmeding</surname> <given-names>R</given-names></name><name><surname>Stoop</surname> <given-names>R</given-names></name><name><surname>Bobeldijk-Pastorova</surname> <given-names>I</given-names></name><name><surname>Turner</surname> <given-names>SM</given-names></name><name><surname>Hanauer</surname> <given-names>G</given-names></name><name><surname>Hanemaaijer</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Uncovering a predictive molecular signature for the onset of NASH-Related fibrosis in a translational NASH mouse model</article-title><source>Cellular and Molecular Gastroenterology and Hepatology</source><volume>5</volume><fpage>83</fpage><lpage>98</lpage><pub-id pub-id-type="doi">10.1016/j.jcmgh.2017.10.001</pub-id><pub-id pub-id-type="pmid">29276754</pub-id></element-citation></ref><ref id="bib116"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Varadaiah</surname> <given-names>YGC</given-names></name><name><surname>Sivanesan</surname> <given-names>S</given-names></name><name><surname>Nayak</surname> <given-names>SB</given-names></name><name><surname>Thirumalarao</surname> <given-names>KR</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Purine metabolites can indicate diabetes progression</article-title><source>Archives of Physiology and Biochemistry</source><volume>8</volume><fpage>1</fpage><lpage>5</lpage><pub-id pub-id-type="doi">10.1080/13813455.2019.1663219</pub-id></element-citation></ref><ref id="bib117"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Veteläinen</surname> <given-names>R</given-names></name><name><surname>van Vliet</surname> <given-names>AK</given-names></name><name><surname>van Gulik</surname> <given-names>TM</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Severe steatosis increases hepatocellular injury and impairs liver regeneration in a rat model of partial hepatectomy</article-title><source>Annals of Surgery</source><volume>245</volume><fpage>44</fpage><lpage>50</lpage><pub-id pub-id-type="doi">10.1097/01.sla.0000225253.84501.0e</pub-id><pub-id pub-id-type="pmid">17197964</pub-id></element-citation></ref><ref id="bib118"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wiemann</surname> <given-names>SU</given-names></name><name><surname>Satyanarayana</surname> <given-names>A</given-names></name><name><surname>Tsahuridu</surname> <given-names>M</given-names></name><name><surname>Tillmann</surname> <given-names>HL</given-names></name><name><surname>Zender</surname> <given-names>L</given-names></name><name><surname>Klempnauer</surname> <given-names>J</given-names></name><name><surname>Flemming</surname> <given-names>P</given-names></name><name><surname>Franco</surname> <given-names>S</given-names></name><name><surname>Blasco</surname> <given-names>MA</given-names></name><name><surname>Manns</surname> <given-names>MP</given-names></name><name><surname>Rudolph</surname> <given-names>KL</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Hepatocyte telomere shortening and senescence are general markers of human liver cirrhosis</article-title><source>The FASEB Journal</source><volume>16</volume><fpage>935</fpage><lpage>942</lpage><pub-id pub-id-type="doi">10.1096/fj.01-0977com</pub-id><pub-id pub-id-type="pmid">12087054</pub-id></element-citation></ref><ref id="bib119"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Willy</surname> <given-names>PJ</given-names></name><name><surname>Umesono</surname> <given-names>K</given-names></name><name><surname>Ong</surname> <given-names>ES</given-names></name><name><surname>Evans</surname> <given-names>RM</given-names></name><name><surname>Heyman</surname> <given-names>RA</given-names></name><name><surname>Mangelsdorf</surname> <given-names>DJ</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>LXR, a nuclear receptor that defines a distinct retinoid response pathway</article-title><source>Genes &amp; Development</source><volume>9</volume><fpage>1033</fpage><lpage>1045</lpage><pub-id pub-id-type="doi">10.1101/gad.9.9.1033</pub-id><pub-id pub-id-type="pmid">7744246</pub-id></element-citation></ref><ref id="bib120"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wobser</surname> <given-names>H</given-names></name><name><surname>Dorn</surname> <given-names>C</given-names></name><name><surname>Weiss</surname> <given-names>TS</given-names></name><name><surname>Amann</surname> <given-names>T</given-names></name><name><surname>Bollheimer</surname> <given-names>C</given-names></name><name><surname>Büttner</surname> <given-names>R</given-names></name><name><surname>Schölmerich</surname> <given-names>J</given-names></name><name><surname>Hellerbrand</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Lipid accumulation in hepatocytes induces fibrogenic activation of hepatic stellate cells</article-title><source>Cell Research</source><volume>19</volume><fpage>996</fpage><lpage>1005</lpage><pub-id pub-id-type="doi">10.1038/cr.2009.73</pub-id><pub-id pub-id-type="pmid">19546889</pub-id></element-citation></ref><ref id="bib121"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname> <given-names>H</given-names></name><name><surname>Riabowol</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>Differential CDK-inhibitor gene expression in aging human diploid fibroblasts</article-title><source>Experimental Gerontology</source><volume>31</volume><fpage>311</fpage><lpage>325</lpage><pub-id pub-id-type="doi">10.1016/0531-5565(95)00025-9</pub-id></element-citation></ref><ref id="bib122"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname> <given-names>C</given-names></name><name><surname>Wan</surname> <given-names>X</given-names></name><name><surname>Xu</surname> <given-names>L</given-names></name><name><surname>Weng</surname> <given-names>H</given-names></name><name><surname>Yan</surname> <given-names>M</given-names></name><name><surname>Miao</surname> <given-names>M</given-names></name><name><surname>Sun</surname> <given-names>Y</given-names></name><name><surname>Xu</surname> <given-names>G</given-names></name><name><surname>Dooley</surname> <given-names>S</given-names></name><name><surname>Li</surname> <given-names>Y</given-names></name><name><surname>Yu</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Xanthine oxidase in non-alcoholic fatty liver disease and hyperuricemia: one stone hits two birds</article-title><source>Journal of Hepatology</source><volume>62</volume><fpage>1412</fpage><lpage>1419</lpage><pub-id pub-id-type="doi">10.1016/j.jhep.2015.01.019</pub-id><pub-id pub-id-type="pmid">25623823</pub-id></element-citation></ref><ref id="bib123"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname> <given-names>G</given-names></name><name><surname>Ye</surname> <given-names>J</given-names></name><name><surname>Liu</surname> <given-names>XJ</given-names></name><name><surname>Zhang</surname> <given-names>NP</given-names></name><name><surname>Zhao</surname> <given-names>YM</given-names></name><name><surname>Fan</surname> <given-names>J</given-names></name><name><surname>Liu</surname> <given-names>XP</given-names></name><name><surname>Wu</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Activation of pluripotent genes in hepatic progenitor cells in the transition of nonalcoholic steatohepatitis to pre-malignant lesions</article-title><source>Laboratory Investigation</source><volume>97</volume><fpage>1201</fpage><lpage>1217</lpage><pub-id pub-id-type="doi">10.1038/labinvest.2017.84</pub-id><pub-id pub-id-type="pmid">28869588</pub-id></element-citation></ref><ref id="bib124"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamauchi</surname> <given-names>T</given-names></name><name><surname>Kamon</surname> <given-names>J</given-names></name><name><surname>Minokoshi</surname> <given-names>Y</given-names></name><name><surname>Ito</surname> <given-names>Y</given-names></name><name><surname>Waki</surname> <given-names>H</given-names></name><name><surname>Uchida</surname> <given-names>S</given-names></name><name><surname>Yamashita</surname> <given-names>S</given-names></name><name><surname>Noda</surname> <given-names>M</given-names></name><name><surname>Kita</surname> <given-names>S</given-names></name><name><surname>Ueki</surname> <given-names>K</given-names></name><name><surname>Eto</surname> <given-names>K</given-names></name><name><surname>Akanuma</surname> <given-names>Y</given-names></name><name><surname>Froguel</surname> <given-names>P</given-names></name><name><surname>Foufelle</surname> <given-names>F</given-names></name><name><surname>Ferre</surname> <given-names>P</given-names></name><name><surname>Carling</surname> <given-names>D</given-names></name><name><surname>Kimura</surname> <given-names>S</given-names></name><name><surname>Nagai</surname> <given-names>R</given-names></name><name><surname>Kahn</surname> <given-names>BB</given-names></name><name><surname>Kadowaki</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase</article-title><source>Nature Medicine</source><volume>8</volume><fpage>1288</fpage><lpage>1295</lpage><pub-id pub-id-type="doi">10.1038/nm788</pub-id><pub-id pub-id-type="pmid">12368907</pub-id></element-citation></ref><ref id="bib125"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname> <given-names>S</given-names></name><name><surname>Lin</surname> <given-names>HZ</given-names></name><name><surname>Mandal</surname> <given-names>AK</given-names></name><name><surname>Huang</surname> <given-names>J</given-names></name><name><surname>Diehl</surname> <given-names>AM</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Disrupted signaling and inhibited regeneration in obese mice with fatty livers: Implications for nonalcoholic fatty liver disease pathophysiology</article-title><source>Hepatology</source><volume>34</volume><fpage>694</fpage><lpage>706</lpage><pub-id pub-id-type="doi">10.1053/jhep.2001.28054</pub-id></element-citation></ref><ref id="bib126"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname> <given-names>Y</given-names></name><name><surname>Fu</surname> <given-names>W</given-names></name><name><surname>Chen</surname> <given-names>J</given-names></name><name><surname>Olashaw</surname> <given-names>N</given-names></name><name><surname>Zhang</surname> <given-names>X</given-names></name><name><surname>Nicosia</surname> <given-names>SV</given-names></name><name><surname>Bhalla</surname> <given-names>K</given-names></name><name><surname>Bai</surname> <given-names>W</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>SIRT1 sumoylation regulates its deacetylase activity and cellular response to genotoxic stress</article-title><source>Nature Cell Biology</source><volume>9</volume><fpage>1253</fpage><lpage>1262</lpage><pub-id pub-id-type="doi">10.1038/ncb1645</pub-id><pub-id pub-id-type="pmid">17934453</pub-id></element-citation></ref><ref id="bib127"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yin</surname> <given-names>X</given-names></name><name><surname>Zhang</surname> <given-names>BH</given-names></name><name><surname>Zheng</surname> <given-names>SS</given-names></name><name><surname>Gao</surname> <given-names>DM</given-names></name><name><surname>Qiu</surname> <given-names>SJ</given-names></name><name><surname>Wu</surname> <given-names>WZ</given-names></name><name><surname>Ren</surname> <given-names>ZG</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Coexpression of gene Oct4 and nanog initiates stem cell characteristics in hepatocellular carcinoma and promotes epithelial-mesenchymal transition through activation of Stat3/Snail signaling</article-title><source>Journal of Hematology &amp; Oncology</source><volume>8</volume><elocation-id>23</elocation-id><pub-id pub-id-type="doi">10.1186/s13045-015-0119-3</pub-id><pub-id pub-id-type="pmid">25879771</pub-id></element-citation></ref><ref id="bib128"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yokoo</surname> <given-names>T</given-names></name><name><surname>Kamimura</surname> <given-names>K</given-names></name><name><surname>Abe</surname> <given-names>H</given-names></name><name><surname>Kobayashi</surname> <given-names>Y</given-names></name><name><surname>Kanefuji</surname> <given-names>T</given-names></name><name><surname>Ogawa</surname> <given-names>K</given-names></name><name><surname>Goto</surname> <given-names>R</given-names></name><name><surname>Oda</surname> <given-names>M</given-names></name><name><surname>Suda</surname> <given-names>T</given-names></name><name><surname>Terai</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Liver-targeted hydrodynamic gene therapy: recent advances in the technique</article-title><source>World Journal of Gastroenterology</source><volume>22</volume><fpage>8862</fpage><lpage>8868</lpage><pub-id pub-id-type="doi">10.3748/wjg.v22.i40.8862</pub-id><pub-id pub-id-type="pmid">27833377</pub-id></element-citation></ref><ref id="bib129"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>W</given-names></name><name><surname>Bu</surname> <given-names>SY</given-names></name><name><surname>Mashek</surname> <given-names>MT</given-names></name><name><surname>O-Sullivan</surname> <given-names>I</given-names></name><name><surname>Sibai</surname> <given-names>Z</given-names></name><name><surname>Khan</surname> <given-names>SA</given-names></name><name><surname>Ilkayeva</surname> <given-names>O</given-names></name><name><surname>Newgard</surname> <given-names>CB</given-names></name><name><surname>Mashek</surname> <given-names>DG</given-names></name><name><surname>Unterman</surname> <given-names>TG</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Integrated regulation of hepatic lipid and glucose metabolism by adipose triacylglycerol lipase and FoxO proteins</article-title><source>Cell Reports</source><volume>15</volume><fpage>349</fpage><lpage>359</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2016.03.021</pub-id><pub-id pub-id-type="pmid">27050511</pub-id></element-citation></ref><ref id="bib130"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname> <given-names>G</given-names></name><name><surname>Nakano</surname> <given-names>K</given-names></name><name><surname>Chijiiwa</surname> <given-names>K</given-names></name><name><surname>Ueda</surname> <given-names>J</given-names></name><name><surname>Tanaka</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Inhibited activities in CCAAT/enhancer-binding protein, activating protein-1 and cyclins after hepatectomy in rats with thioacetamide-induced liver cirrhosis</article-title><source>Biochemical and Biophysical Research Communications</source><volume>292</volume><fpage>474</fpage><lpage>481</lpage><pub-id pub-id-type="doi">10.1006/bbrc.2002.6630</pub-id><pub-id pub-id-type="pmid">11906187</pub-id></element-citation></ref><ref id="bib131"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zimmermann</surname> <given-names>R</given-names></name><name><surname>Strauss</surname> <given-names>JG</given-names></name><name><surname>Haemmerle</surname> <given-names>G</given-names></name><name><surname>Schoiswohl</surname> <given-names>G</given-names></name><name><surname>Birner-Gruenberger</surname> <given-names>R</given-names></name><name><surname>Riederer</surname> <given-names>M</given-names></name><name><surname>Lass</surname> <given-names>A</given-names></name><name><surname>Neuberger</surname> <given-names>G</given-names></name><name><surname>Eisenhaber</surname> <given-names>F</given-names></name><name><surname>Hermetter</surname> <given-names>A</given-names></name><name><surname>Zechner</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Fat mobilization in adipose tissue is promoted by adipose triglyceride lipase</article-title><source>Science</source><volume>306</volume><fpage>1383</fpage><lpage>1386</lpage><pub-id pub-id-type="doi">10.1126/science.1100747</pub-id><pub-id pub-id-type="pmid">15550674</pub-id></element-citation></ref></ref-list></back><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.63835.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group><contrib contrib-type="editor"><name><surname>James</surname><given-names>David E</given-names></name><role>Reviewing Editor</role><aff><institution>The University of Sydney</institution><country>Australia</country></aff></contrib></contrib-group></front-stub><body><boxed-text><p>In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.</p></boxed-text><p>[Editors' note: this paper was reviewed by <ext-link ext-link-type="uri" xlink:href="https://www.reviewcommons.org/">Review Commons</ext-link>.]</p><p><bold>Acceptance summary:</bold></p><p>NAFLD while of profound physiological significance to human health remains somewhat mysterious in terms of its cause, which limits new therapeutic approaches. This paper links hepatocyte proliferation to dysregulation of lipid metabolism and proposes a new mechanism to explain the development of age-dependent NAFLD. It is an important paper for the field and should be of widespread interest- particularly researchers in the fields of liver disease, ageing and lipid metabolism.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.63835.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Your study provides impressive evidence linking CDK1 to hepatic steatosis and liver disease. All reviewers were highly impressed by the diverse array of techniques and approaches that you brought to bear on this interesting problem. I have read the reviewers comments and your response to each of these and it is my opinion that you should be able to respond to these comments within a reasonable period of time. Some of the points raised by Rev #2 are particularly important and you should try to address these in detail. One point that I felt was important to address was the issue of whether CDK1 is only involved in cell proliferation or does it control other aspects of liver function. This may require some softening of some of the claims and conclusions made throughout.</p></disp-quote><p>Thank you for these constructive comments. We have followed your and the reviewers’ suggestions and have addressed all the points that were raised. We added new data in Figure1I, 1J, 1L, 2K, and 9. In addition, we toned down several of our claims by providing alternative explanations. Overall, we have improved this revised version of our manuscript and hope it can be published in its current form.</p><disp-quote content-type="editor-comment"><p>Reviewer #1:</p><p>In liver disease like NAFLD or NASH, it is known that proliferation of hepatocytes is impaired. This is thought to be caused by lipid droplet accumulation in hepatocytes and therefore being a secondary effect. The decrease in hepatocyte proliferation is an aggravating factor in the disease since the repair of liver damage relies on self-renewal of hepatocytes. In this manuscript the authors investigate if blocking hepatocyte self-renewal (by knocking out CDK1) has any effects on lipid metabolism. Partly this is based on their previous work where they studied glucose metabolism. The authors find reduced triacylglycerides (TGs) in young animals, which is caused by oxidative stress activating the transcription factor FOXO1 to drive the expression of Pnpla2 (encoding the ATGL protein). They ChIP FOXO1 to the Pnpla2 promoter but more importantly silencing of Pnpla2 in the liver of mice, restores TGs to wild type levels. In addition, reducing oxidative stress using NAC has the same outcome than silencing Pnpla2. Furthermore, the authors detected impaired β-oxidation, reflected by increased acylcarnitines and reduced β-hydroxybutyrate, which led to high levels of free fatty acids in plasma that was transported to and stored in adipose tissue. Eventually, this increased insulin secretion. When the mice were aged, the hyperinsulinemia caused insulin resistance and hepatic steatosis, similarly as is observed in diabetic patients.</p><p>This is a highly significant manuscript with a lot of valuable data, which will be useful for a broad audience. The work presented here is a tour-de-force, where the authors use systems biology including animals, RNA sequencing, lipidomics, metabolomics, ChIP, histology, physiology, and biochemical approaches. It is also important that not only the liver was studied but also adipose tissue and skeletal muscle in addition to blood parameters. Overall, this study is well-rounded, investigates an important biological problem with clinical implications, and used state-of-the-art approaches.</p><p>The first important finding is the axis of loss of hepatocyte self-renewal/Cdk1-&gt;oxidative stress-&gt;FOXO1-&gt;Pnpla2. Especially since both NAC and silencing of Pnpla2 lead to the restoration of TGs. The second important point is how the impairment of hepatocytes affects other organs like adipose tissue and skeletal muscle. The authors have done a good job to provide a complete picture of the biology how these tissues interact in terms of lipid metabolism. The final important point is the investigations of the age mice both at 6 and 12 months, which provides a picture how the disease progresses and this resembles much more what happens in patients in the clinic.</p><p>In summary, the authors provide strong evidence that the loss of hepatocyte self-renewal causes changes in lipid metabolism that resemble those seen in patients with liver disease or diabetes.</p><p>There are a number of issues, which need to be addressed:</p><p>1) In the ChIP experiments (Figure 1M and 7G) some important negative controls are missing. The authors need to add these.</p></disp-quote><p>We have included the IgG isotype controls in the figures for the ChIP experiments (Figure 10 and Figure 7G) to prove that our experiments are well controlled.</p><disp-quote content-type="editor-comment"><p>2) Although the authors report the number of up/down-regulated genes in the RNA sequencing experiments, the total number of genes detected have not been reported.</p><p>3) In the lipidomics experiments, the authors state &quot;The majority of lipid species were unchanged&quot; but they need to mention how many lipid species they were able to detect reliably. This is important information.</p></disp-quote><p>We agree with point 2 and 3 and have incorporated into the text the total number of detected genes from the RNAseq and detected lipid species from the lipidomics data. We have also added the complete list of genes detected in Supplementary file 6, in addition to the list of differentially expressed genes that was already in Supplementary file 6.</p><disp-quote content-type="editor-comment"><p>4) Can the authors explain how oxidative stress induces FOXO1 in hepatocytes?</p></disp-quote><p>We have provided mechanisms on how oxidative stress might induce FOXO1 activity in the Discussion section.</p><disp-quote content-type="editor-comment"><p>5) The authors should speculate how it can come to a reversal of the phenotype when comparing young and old mice.</p></disp-quote><p>We thank the reviewer for bringing up this point. To be more explicit, we have described how we believe the development of insulin resistance can cause the reversal of hepatic lipid phenotype upon aging in the Discussion section.</p><disp-quote content-type="editor-comment"><p>6) Adiponectins are mentioned (Figure 5—figure supplement 1E) but how they contribute to the phenotype needs to be explained more carefully.</p></disp-quote><p>We have included a short description on how adiponectin may mechanistically contribute to insulin resistance in the text.</p><disp-quote content-type="editor-comment"><p>7) Using metabolomics, the authors identify the purine metabolism pathway but this finding needs to be explained more carefully and these findings need to be put in context.</p></disp-quote><p>We have provided a paragraph of Discussion on why purine metabolites might be increased in insulin resistance, especially in the context of the <italic>Cdk1</italic> cKO mice.</p><disp-quote content-type="editor-comment"><p>Significance:</p><p>This manuscript is of high significance due to its findings, its investigations of the molecular details, and the number of unbiased approaches used. It is an important finding that impairment of hepatocyte self-renewal leads to remodeling of lipid metabolism since the opposite was expected. For many years, lipid droplet accumulation in hepatocytes was thought to be the reason for impaired self-renewal. Therefore, it is possible that lipid droplet accumulation is not causally linked to hepatocyte self-renewal but this will need to be further investigated. In my opinion, this manuscript should be published in a high-quality journal.</p></disp-quote><p>We thank this reviewer for the support of our manuscript.</p><disp-quote content-type="editor-comment"><p>Reviewer #2:</p><p>Authors propose that loss of hepatocyte proliferation (achieved through specific deletion of CDK1 in hepatocytes) results in changes in lipid metabolism and with aging contributes to insulin resistance and hepatic steatosis. The authors show that CDK1-/- hepatocytes contain decreased level of triacylglycerides and decreased fatty acid oxidation- which results in elevated storage of FFA as triacylglycerides in WTA.</p><p>Major comments:</p><p>Data is of very high quality, well designed and performed and presented clearly. Authors used multiple approaches to investigate their hypotheses- including omics approaches (lipidomics, RNA-seq), molecular biology approaches and physiological assessments. In my view, the key conclusions are supported by the evidence and the model presented is plausible. I have some general comments- which in my view do not require extensive additional experimentation- but that the authors should consider if possible to address experimentally and/or discuss.</p><p>I wonder if hepatocyte proliferation is really an important factor here- hepatocyte proliferation occurs at very low frequency in uninjured liver (could the lipid metabolism phenotypes observed due to loss of CDK1 be uncoupled from the role of CDK1 in hepatocyte proliferation?).</p></disp-quote><p>This is an important point that the reviewer has brought up. We agree that the observed phenotypes might be due to a specific loss of CDK1 activity. As such, we have sought to bring forward the limitation of the <italic>Cdk1</italic> cKO mouse model as a generalization of the loss of hepatocyte proliferation in the Discussion. In general, we have toned this down and provided several alternative explanations.</p><disp-quote content-type="editor-comment"><p>Aged CDK1-/- mice (12 months old) showed increased blood glucose, insulin resistance, hepatic steatosis and liver fibrosis, which is a very interesting observation- I wonder if the authors could comment on the physiological relevance. Is Cdk1 expression decreased during natural aging in hepatocytes? Does it impact on hepatocyte proliferation during the aging process-in the absence of liver injury?</p></disp-quote><p>We have discussed how CDK1 activity is reduced during aging, both from reduced transcriptional induction and increased senescence, which makes aging a physiologically relevant context whereby findings from <italic>Cdk1</italic> cKO mice are applicable. As the reviewer has brought up, we believe it is also in part responsible for reduced proliferative capacity of aged hepatocytes. However, it is quite unlikely that aging occurs in the absence of accumulated liver injury, as the liver is constantly exposed to toxins for clearance, resulting in hepatocyte death and consistent need for hepatocytes to divide for homeostatic renewal.</p><disp-quote content-type="editor-comment"><p>IS decreased Cdk1 a feature of NASH?</p></disp-quote><p>Meta-analysis of transcriptomics data from NAFLD patient livers does not find a difference in CDK1 transcript levels, but we have also highlighted that senescence markers are higher in NAFLD liver, in which case Cdk1 activity is inhibited.</p><disp-quote content-type="editor-comment"><p>Authors show increased steatosis and fibrosis markers in aged CDK1-/- livers which are characteristic of NASH- what about inflammatory markers such as expression of pro-inflammatory genes and immune cell infiltrates?</p></disp-quote><p>We have highlighted the absence of immune infiltrates in the aged <italic>Cdk1</italic> cKO livers and have proposed that insulin resistance in the aged <italic>Cdk1</italic> cKO mice be immunosuppressive and prevent manifestation of inflammation in the aged liver.</p><disp-quote content-type="editor-comment"><p>As mentioned in the Introduction- there is plenty of evidence that hepatocyte cellular senescence is (i) observed during NAFLD; (ii) contributes causally to steatosis. Does deletion of CDK1 contribute to hepatocyte senescence?</p></disp-quote><p>We have performed senescence-associated β-galactosidase staining as well as qPCR analysis of senescent markers, both of which indicate increased presence of senescent cells in <italic>Cdk1</italic> cKO livers (Figure 9). As such, we have highlighted this as a potential limitation of the <italic>Cdk1</italic> cKO model.</p><disp-quote content-type="editor-comment"><p>Authors should cite very recent paper- by Omori S and colleagues (Cell metabolism)- which shows that elimination of p16ink4a cells ameliorates steatosis and inflammation in a NASH model.</p></disp-quote><p>We have cited the paper by Omori <italic>et al.</italic> in our Discussion on the involvement of senescence in the NAFLD phenotype.</p><disp-quote content-type="editor-comment"><p>Minor comments</p><p>Text and Figures are generally clear and accurate. In Figure 1 A- heat map of hepatic triacylglycerides should indicate the species otherwise it is not particularly informative.</p></disp-quote><p>We have included the lipid species in Figure 1A.</p><disp-quote content-type="editor-comment"><p>The fact that anti-oxidant enzymes are up-regulated at the mRNA level in CDK1-/- is evidence of increased oxidative stress (may be the opposite)- however, the carbonylation data is convincing in indicating increased oxidative stress.</p></disp-quote><p>We agree that the mRNA expression of oxidative stress genes can be interpreted both ways and therefore the protein carbonylation data is an important factor.</p><disp-quote content-type="editor-comment"><p>Significance</p><p>This paper links hepatocyte proliferation to dysregulation of lipid metabolism- and proposes a new mechanism to explain the development of age-dependent NAFLD. It is an important paper for the field and should be of widespread interest- particularly researchers in the fields of liver disease, aging and lipid metabolism.</p><p>I am expert in aging and age-related disease and the role of aging in lipid metabolism.</p><p>Reviewer’s cross-commenting</p><p>I have no additional comments. All points raised are valid and I am generally in agreement with the assessment from the other reviewers. This study is well designed and its findings significant.</p></disp-quote><p>We thank this reviewer for the constructive comments and the support of our manuscript.</p><disp-quote content-type="editor-comment"><p>Reviewer #3:</p><p>Cell proliferation and cell metabolism are intimately linked with well-described regulatory pathways involved in the coordinated control of these processes. As but one example, in order to ensure an adequate supply of essential building blocks required for membrane biosynthesis, changes in lipid uptake/synthesis/storage accompany proliferation. In the current study, Ow and colleagues take advantage of a mouse model of impaired hepatocyte proliferation (Cdk1Liv-/- mouse) to thoroughly examine the impact of proliferation on lipid metabolism and systemic physiology. In young mice, the authors report defects in lipolysis and fatty acid oxidation that increase adiposity and enhance insulin secretion. In aged mice, insulin resistance and hepatic steatosis is observed. In light of these results, the authors propose a previously uncharacterised role for impaired hepatocyte proliferation in liver disease.</p><p>This is an elegant study with a logical flow and high-quality data to support the hypotheses and conclusions. All experiments are adequately replicated and statistical analysis is appropriate. The Materials and methods are thorough, and all experiments could be reproduced by others in the field. As outlined below there are some minor experiments, that are neither time nor resource heavy, that would improve the study.</p><p>The authors conclude that the reduction in TGs in hepatocytes from Cdk1Liv-/- mice results from increased transcription of Pnpla2/ATGL. Ideally, in Figure 1K, the authors should demonstrate that ATGL protein expression is increased in Cdk1Liv-/- liver lysates. This will complement the mRNA expression data shown in Figure 1H.</p></disp-quote><p>We have performed immunoblot for ATGL on 8-week-old liver lysates and have found that ATGL protein level is increased, supporting the mRNA data. The data has been incorporated as Figure 1I-J.</p><disp-quote content-type="editor-comment"><p>In relation to Figure 2I/J, the authors refer to a study showing that CDK1 phosphorylates SIRT3 to promote CPT2 dimerization and fatty acid oxidation (Liu et al., 2020). Clearly SIRT3 phosphorylation is dramatically reduced in the CdkLiv-/- setting but the authors should also demonstrate changes in CPT2 acetylation or CPT2 enzyme activity in their model.</p></disp-quote><p>We have immunoprecipitated CPT2 and ran an immunoblot, probing for pan-acetylation. In agreement with our hypothesis that SIRT3 activity is reduced, there is an increase in acetylated residues on CPT2. The data is shown now in Figure 2K.</p><disp-quote content-type="editor-comment"><p>In Figure 7B, the authors demonstrate decreased expression of Foxq1 in Cdk1Liv-/- samples from aged mice. Given the association between FOXQ1 and FOXO1, is there any difference in FOXQ1 transcript or protein expression in Cdk1Liv-/- samples from young mice?</p></disp-quote><p>We have performed qPCR for <italic>Foxq1</italic> and do not observe significant differences at the mRNA level. The data has been included in Figure 1L. We also discuss that Foxq1 levels are different in young and old <italic>Cdk1</italic> cKO mice.</p><disp-quote content-type="editor-comment"><p>The authors should take care when drawing conclusions about the impact of impaired hepatocyte proliferation on liver disease. The authors have clearly shown that complete loss of hepatic CDK1, and therefore induction of a proliferative defect in all hepatocytes, remodels lipid metabolism, promotes a diabetic-like phenotype and contributes to liver disease. Senescence, or other proliferative defects, will occur in a more mosaic fashion and might therefore not trigger all of the biology observed in the Cdk1Liv-/- mice. The authors should include a discussion of this potential limitation.</p></disp-quote><p>We totally agree and have discussed this by highlighting this limitation of the <italic>Cdk1</italic> cKO mice in the Discussion.</p><disp-quote content-type="editor-comment"><p>Significance</p><p>This study represents a conceptual advance and provides convincing evidence linking changes in hepatocyte proliferation, and ensuing metabolic reprogramming events, with disturbed systemic metabolism. The idea that altered hepatocyte proliferation directly contributes to liver disease is intriguing and this study certainly opens multiple angles for future research. It is a nice complement to work from Ogrodnik and colleagues (Nature Communications 8:15961, 2017) showing that defective FAO in senescent hepatocytes contributes to hepatic steatosis and provides important insights regarding the relationship between cellular metabolism, systemic metabolism and metabolic disease. This study will be of interest to a diverse audience including those interested in liver biology, senescence, cellular metabolism, systemic metabolism and metabolic disease. My area of research is cellular metabolism with a particular focus on cancer cell metabolism. I am involved in collaborative projects to investigate hepatocyte metabolism during development, regeneration and tumorigenesis so believe that I have sufficient expertise to evaluate all aspects of this study.</p><p>Reviewer's cross-commenting</p><p>I have no additional comments. There was clearly an overarching consensus amongst the reviewers regarding the quality of the study and impact of the findings. This is an important study that will be of interest to a diverse audience.</p></disp-quote><p>We thank this reviewer for the constructive comments and the support of our manuscript.</p></body></sub-article></article>